>A0KFR1|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQIRENIPKKEGVIRASDRGFGFLEVDEKTSYFVPPPYMKKVMHGDRVSALIRTEKEKEVAEPDALLE
QSVTRFVARVKMFRDRLNVVADHPLIKDAIKARVKKGLDEKEFKEGDWVVATLKRHALVDGNFSAEITQTIASQEDHNVP
WWVVLARHNLAQVEPADLPEWKVIEEEELPRTDLTATPFFTIDGAKTKDMDDALAIRKLDNGWELLVAIADPTAYVAEGS
ELDKEAAQRAFTVYMPGRNVPMIPRTLSDELCSLKEGEERNTLCARLLIAEDGLLLEETEFFAARISSHARLTYDDVSDW
AEHGKQLDIDAGVLAQLPLMKAMTEARIAWRTEHALVFPDRPDYDFELGENGEVLAIHVEPRRIANRMVEESMIAANICA
GRVLGKQVGYGIFNVHTGFDEESLDGAIDLLKSAEAPFEKEEIASLSGFCALRRWIDNLDTRWLDGKIRRFQSYALMSAE
PGAHYGLGLDAYATWTSPIRKYGDMVNHRLLKAVIAGKTPGERPSLELTEHLTACRRLHRMVERDIGDWLYVRYLKADAG
TDKVFNAEIIDVMRAGLKLRLRENGAVVFMPARHILDNKDRLECNWDNGRVYLDKTEVVYELGQIIEVKLTEAVEETRSL
IAKPAVELVPGPAPVAPTSEADATPADEAPKAE
>A0R5E1|IPR011129(3...67)|Probable cold shock protein A
MPQGTVKWFNAEKGFGFIAPEDGSADVFVHYTEIQGSGFRTLEENQKVEFEVGQSPKGPQATGVRTI
>A1AAQ4|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDGKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTFSTDGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETAYKVTDVIDVTIAEVRMETRSIIA
RPVA
>A1JM34|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHTQTPRVEGVVKGTEKGFGFLEVDGQKSYFIPPPQMKKVMHGDRIIATLHTDKDREIAEPETLVE
PFLSRFVGRVQRKDDRLSIVPDHPLLRDAIQCRPVRELTHDFQSGDWAVAEMRRHPLKGDRGFNADLTAFITDGEDHFVP
WWVTLARHNLEREAPVMVESALHDANLQREDLTALNFVTIDSASTEDMDDALQVQDNGDGSLLLTIAIADPTAYVDENSE
LDLIARKRAFTNYLPGFNIPMLPRDLSDNLCSLRPNERRPVLVCRVTIAADGTLGEDIHFSAAWVESKAKLVYDEVSDWL
EGSGDWQPQNADIAEQITLLKRVCEARSHWREQHALVFKDRPDYRFLLGEKGEVLDIIVEHRRIANRIVEECMIAANVCA
AIALRDNLGFGIYNVHTGFDPALVEQAANVLQANGVEADPQALLTLPGFCELRRHLDALPTQFLDSRIRRFQTFAEISTV
PGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAIITGQQAEKPQDEITVQLAERRRLNRMAERDVGDWLYARYLQPMAGT
DTRFPAEIIDVTRGGLRVRLLDNGAVAFIPAPFIHAVRDEMVCSQETGTVQIKGETVYSQSDKIEVRIAEVRMETRNVVA
RPVV
>A1SWZ6|IPR011129(23...79)|Exoribonuclease 2
MFQNNPLLSQLKKQIQEDIPKRQGKVKATDRGYGFLETDKGKRFFIPPSEMKKVLHGDQINAFIRGKGDKSTAEPNQLKK
TGSAVFIARLVIKQKNISIIPKNPLLKGFFKIKGSQSLQSRGYQDGDWVKVELVSHALEGNGFLTQIIEKIADASDPFAY
RLLTVATHNLANKAPEFDHPWKIIDPQLSRSDLTKTPFFTIDGVNTQDMDDALYIEADENGWKLTVAISDPSAYVPENSD
MDAEAKRRAFTLYLPNFNVPMLPRDLSDSLCSLKEGEKRATLCCTIHINKKGEIEGEPAFYGAWIKSHYRLNYTDVSNYL
ENEELSNDCWKPSTQLAEQLRTLDSLSLKRLQWRTDNNAVFKNQPDYTLKLNNKGEISEILCEPRRSANRLVEESMIAAN
ICAGDFLAKHKQQGVFNTHSGFSSERLGKVVSLLSEFGIESDIQTLATVTGYTKIRQQTNLLHNSYLDHRLRKLLSYADI
KNTPEAHFTLGVDHYATWTSPIRKYGDLLNHRLIKSVLLKEDNIQIDNEIGQVLNAARKLQRLAERDVNNILYSQYLKNQ
VESKWRYKAEIFDIIKAGIRVKIQENGATFFIPCSLLCKDSSDATKIDCNQALGKVIIAQQTELQLGDVIDVMLNNVKVE
SGQLIGKLAESLTISE
>A3N0B9|IPR011129(23...78)|Exoribonuclease 2
MFQNNPLLAQLKQQIEANKEYVEGTVKASDKAFGFLECDKKSYFIPPMEMKKVMHGDKVKAVVKREDDKEQVEIDSLLEP
MLDRFIAQVRFNKDNKLQLIVDHPSIKNIIPANTHKKVTETLESGDWVVAQLKTHPLRDDRFLFAQVTQFICKADDNFAP
WWVTLARHEQPREPVANEKSYELHDELDREDLTSLYFTTIDSPSTQDMDDALYIEPIKQGEVQTGWRLVVAIADPTAYIP
ENSNLEKAARQRCFTNYLPGFNIPMLPRELSDDLCSLVPNKKRPALVGYIETDLAGNITGDTRFVSAWVESKAKLAYDNV
SDYLEQVENAWQPESAETKQQIDWLHQFTLARIEWRRNNALLFKESGDYSFELNEDGSVRDIHVEYRRIANQMIEESMII
ANICCAKFLADNAKTGVFNTHAGFDPKNLELAQKFLLDTLSTDENRDALTAFYAPEKLATLEGYCEMRRSIDEFPEKFLE
LRLRRYLTFAEFKSEVAPHLGLGISHYATWTSPIRKYGDMVNHRLIKQVLLGKQAKTVEEGILVRLQEARRQNRLVERDI
ADWLYARYLFPMVEQAVEFDCEIADVSRGGVRAKVIANGAQIFVPFSTLHDKKEEMEFRPEEIALYIKGEKAYQIGQAVK
VKLTEVRLETRSIVGNII
>A4TJ37|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHTQTPRVEGVVKGTEKGFGFLEVDGQKSYFIPPPQMKKVMHGDRIIATLHTDKDREIAEPETLVE
PFLSRFVGRVQRKDDRLSIVPDHPLLRDAIQCRPVRELTHSFQNGDWAVAEMCRHPLKGDRAFQADLTAFITNGEDHFVP
WWVTLARHNLEREAPAMVESALNDAELEREDLTALNFVTIDSASTEDMDDALFVQDNGDGSWLLTIAIADPTAYVVENSE
LDLTARKRAFTNYLPGFNIPMLPRDLSDNLCSLRPNERRPVLVCRVTITEEGTLSNDIRFSAAWVESKAKLVYDDVSDWL
EGNNRWQPQDTAIAEQITLLKRICDARSNWRQQHALVFKDRPDYRFLLGEKGEVLDIIVEHRRIANRIVEECMIAANVCA
ALALREHLGFGIYNVHTGFDPALVEQAASVLKANGVGADPQALLTLPGFCELRRHLDALPTQFLDSRIRRFQTFAEISTV
PGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAMITGQQAEKPQEEITVQLAERRRLNRMAERDVGDWLYARYLQPQAGT
DTRFTAEIIDITRGGLRVRLLDNGAVAFIPAPFIHAVRDEVVCSQETGTVQIKGETVYSQSDKIEVRIAEVRMETRNVIA
RPVA
>A4WAX5|IPR011129(23...79)|Exoribonuclease 2
MLQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRVTAVIHTQKDRETAEPEELIE
PFLTRFVGKVHKKDDRLSIVPDHPLLKDAIPCRADRNCEHDFKEGDWAVAQMRRHPLKGDRGFYADLTHFITYSDDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERRDLTALNFVTIDSASTQDMDDALYVEEGADGKLHLTVAIADPTAWIAEGSK
LDDSAKVRAFTNYLPGFNIPMLPRELSDDLCSLRPNQIRPVLACRMTIAADGTIEDDIEFFAATIESKAKLAYDDVSNWL
EGAGNWKPESEAIAQQITLLQRVCLSRGEWRKTHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANICA
ARVLRDKLGFGIYNVHTGFDPANTEALAALLKTHDVHVDPQEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSYAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAIVKGETIARPQDEATVQMAERRRLNRMAERDVGDWLYARFLSDKAGT
DTRFAAEIIDISRGGMRVRLVENGAVAFIPAPFLHAVRDELVCSQENGSVQIKGETVYKVTDVIDVNIAEVRMETRSIIA
RPVV
>A5F0G1|IPR011129(23...79)|Exoribonuclease 2
MFQDNPRLAQLKQKIQETLPKKEGTIKASDKGFGFLEVDSKTSYFVPPPYMKKCMHGDKVVAFIRTENEREVAEPSELIE
QSLTRFIGRVKLFKGKLNVAPDHPQLKKLSLKAKTKKGLNEADFQEGDWVVAHLVRHPLKGDDGFFVQISHKITDANDKI
APWWVTLAENDLPNSEPAGIDDWQLKDDADLVREDLTALPFVTIDGESTKDMDDALYAQQLPNGDFALTIAIADPTAYIT
PEDEMDKVARERGFTIYLPGRNIPMLPRDLADELCSLMENQVRPALCCSVTIRKDGVIGDDIRFFAANIKSHARLVYDHV
SDWLETGSSEQWQPSEEIAQVVRDLYAFSQARANWCETHAVVFPDRPDYRFELSADNDVVAIHADMRRTANRLVEESMIT
ANICAGKTLQTTFGFGVFNTHAGFKAEKMADVVELMAVNGAPNADAETLATVEGFAALRRWLATQETSYLDNRIRKYQSY
SEIGNQPLPHFAMGLDVYATWTSPIRKYGDMINHRLLKAHILGKAPVQTPDETVGEELALHRKHHKIAERNVADWLYART
LADEPAKETRFQAEIFDINRPGMRVRLLENGAMAFIPGALILDNKERIECNGEDGTILIDKEVVYKLGDVLEIVLTEVNQ
ENRSLVGKPTQVFADLVSETQTSTEQPAEGAENNEPQA
>A5UFG3|IPR011129(23...78)|Exoribonuclease 2
MFQDNPLLAQLKQQIHDSKEQVEGVVKSTDKAYGFLECDKKTYFIAPPSMKKVMHGDKIKATIEKQGDKEQAEPESLIEP
MLTRFIAKVRFNKDKKLQVLVDHPNINQPIGAQQAKSVKEELQEGDWVVANLKTHPLRDDRFFYATINQFICRAEDELAP
WWVTLARHEQSRYPVRGAEPYEMLDQKTRENLTALHFVTIDSESTMDMDDALYIEPIAQNSTQTGWKLVVAIADPTAYIA
LDSQIEQEAKQRCFTNYLPGFNIPMLPRELSDELCSLIANETRPALVCYIETDLAGNITAKPNFVSAYVQSKAKLAYNKV
SDYLEQADNAWQPEMPEIAQQIHWLHQFTKARIQWRKTHSLFFKEKPDYTFVLAENGKVQEIKAEYRRIANQIVEEAMII
ANICAAQFLHEQAKTGIFNTHSGFDKKFLENAHNFLMANLANEQNQTELAERYSVENLATLNGYCQMRHDIEPIESDYLE
LRLRRYLTFAEFKSELAPHFGLGLEGYATWTSPIRKYSDMVNHRLIKAVLAKQPYEKPQNDVLARLQEARRQNRLVERDI
ADWLYCRYLADKVASNAEFEAEVQDVMRAGLRVQLLENGASLFIPAATLHNNKEEIQLNPDELALYIKGDRTYKIGDIVK
VKLTEVKEATRSIVGEILQ
>A6T7Z4|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKGTEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHSEKERESAEPESLVE
PFLTRFVGKVQKKDDRLAIVPDHPLLKDAIPCRAARGVEHDFKQGDWAVAEMRRHPLKGDRGFYAELTQFITFSDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLTRRDLTALDFVTIDSASTEDMDDALYAESTADGKLLLTVAIADPTAWIAEGSK
LDNAAKVRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLAADGTIEDNIEFFAATIESKAKLAYDDVSDWL
EGRGSWQPDSEAIAQQITLLKDVCQRRSEWRQTHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANICA
ARVLRDKLGFGVYNVHTGFDPANTEQLAALLKTHDVHVDPTEVLTLEGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAIIKGETIARPQDEATVQMAERRRLNRMAERDVADWLYARFLNDKAGT
DTRFAAEIIDVSRGGMRVRLVDNGAVAFIPAPFLHAVRDELVCSQENGTVQIKGEVVYKVTDVIDVTIAEVRMETRSIIA
RPAV
>A6VN85|IPR011129(23...78)|Exoribonuclease 2
MFQNNPLLSQLKQQLHDSKPHVEGVVKGTDKAYGFLETDKETFFIAPPAMKKVMHGDKIKATIETIGDKKQADPEELIEP
MLTRFIAKVRFNKDKKLQVLADHPNINQPIGAAQTKAVKEELHEGDWVVATLKTHPLRDDRFFYAQIVEFICRAEDEFAP
WWVTLARHQQSRYPVQGQDSYKMLDPQTRKDLTALHFVTIDSESTQDMDDALYIEPLEQNGEQTGWKLTVAIADPTAYIA
ADSQIEKDARQRCFTNYLPGFNIPMLPRELSDELCSLMENETRAALVCRLQTDLQGELQGKPEFLLADVQSKAKLAYNRV
SDYLEQAEGAWQPENETTKQQIHWLHRFALTRINWRKTHGLLFKEKPDYSFVLADNGHVQEIKAEYRRIANQIVEESMIV
ANICCAHYLADNAKTGIFNTHAGFDKKFLPNAHHFLMTNLSNAQNQDELTVRYSVENLATLEGYCRMRHDIEPIDGDYLE
FRLRRFLTFAEFKSELAPHFGLGLTGYATWTSPIRKYSDMVNHRLIKACIAEQACLKPSDDILTRLQEARKQNRMVERDI
ADWLYCRYLADKVENKPEFQAEVQDCMRGGLRVQLLENGASVFVPASTIHPNKEEIQVNSDELAFYINGERRYKIGDIVN
IQLTEVKEETRSLIGNLVL
>A7FI01|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHTQTPRVEGVVKGTEKGFGFLEVDGQKSYFIPPPQMKKVMHGDRIIATLHTDKDREIAEPETLVE
PFLSRFVGRVQRKDDRLSIVPDHPLLRDAIQCRPVRELTHSFQNGDWAVAEMCRHPLKGDRAFQADLTAFITNGEDHFVP
WWVTLARHNLEREAPAMVESALNDAELEREDLTALNFVTIDSASTEDMDDALFVQDNGDGSWLLTIAIADPTAYVVENSE
LDLTARKRAFTNYLPGFNIPMLPRDLSDNLCSLRPNERRTVLVCRVTITEEGALSNDIRFSAAWVESKAKLVYDDVSDWL
EGNNRWQPQDTAIAEQITLLKRICDARSNWRQQHALVFKDRPDYRFLLGEKGEVLDIIVEHRRIANRIVEECMIAANVCA
ALALRDHLGFGIYNVHTGFDPALVEQAASVLKANGVDADPQALLTLPGFCELRRHLDALPTQFLDSRIRRFQTFAEISTV
PGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAMITGQQAEKPQEEITVQLAERRRLNRMAERDVGDWLYARYLQPQAGT
DTRFTAEIIDITRGGLRVRLLDNGAVAFIPAPFIHAVRDEVVCSQETGTVQIKGETVYSQSDKIEVRIAEVRMETRNVIA
RPVA
>A7MMD8|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRVIAVIHTEKEKESAEPEELIE
PFLTRFVGRVQKKDDRLSIVPDHPLLKDAIPCRAERGVSHDFQNGDWAVAEMRRHPLKGDRGFYAELTQFITFGEDHFVP
WWVTLARHNLEREAPDGVATEMLDENLTREDLTALDFVTIDSASTEDMDDALYVEALDGDRLQLTVAIADPTAWIAEGSK
LDNIAKVRAFTNYLPGFNIPMLPRELSDDLCSLREGVQRPALVCRMIIEADGAISDDIHFFAAIIESKAKLAYDDVSDWL
EEKGDWQPGSEAIAAQIRLLQQICQRRSAWRTEHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANICA
ARVLRDKLGFGVYNVHAGFDPASTEQLATLLQSHGMHVDANDVLTLPGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAIIKGESATRPQDEATVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DSRFAAEIIDVSRGGMRVRLVDNGAVAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSVIA
RPVA
>A7ZLA9|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>A7ZZM6|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWKPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDEMVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>A8AG96|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKIQGKNDRLSIVPDHPLLKDAIPCRAARGVEHEFKEGDWAVAEMRRHPLKGDRSFYAELTQFITFADDHFVP
WWVTLARHNLEKEAPNGAATEMLDEGLVRQDLTELDFVTIDSASTEDMDDALYAQELGEGKLQLTVAIADPTAWIAEGSK
LDNIAKIRAFTNYLPGFNIPMLPRELSDDLCSLRAQEVRPALACRMTIAADGTIEDDITFFAATIKSKAKLAYDNVSDWL
ENTGSWQPESDAIAQQIRLLQRICLSRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEESMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDTGDVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETIARPQEETTQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
ETRFAAEIVDISRGGMRVRLVDNGAMAFIPAPFLHAVRDELVCSQESGTVQIKGETVYKVTNVIDVTIAEVRMETRSIIA
RPVA
>A8GF49|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRVEGVVKGTEKGFGFLEVDGQKSYFIPPPYMKKVMHGDRVSATLHTEKEREIAEPETLIE
PFLSRFVGRVQKRDDRLSIVPDHPLLKDAIQCRPVRGLNHNFQAGDWAVAEMCRHPLKGDRGFNADLTQFITDGEDHLAP
WWVTLARHNLEKEAPEMIAISEPDASLPREDLTALNFVTIDSASTEDMDDALFVQDNGDGSLQLTIAIADPTAYVEQGSP
LDEIARKRAFTNYLPGFNIPMLPRDLSDNLCSLRPNQRRPVLACRVTIGADGALADDIRFFAAEIESKAKLVYDEVSDWL
EGIAGWQPPSDDIAQQITLLKRVCDVRNSWRHQHALVFKDRPDYRFVLGEKGEVLEIVTEQRRTANRIVEECMIASNVCA
AIVLRDRLGFGIYNVHTGFDPLLVEQAVTVLQANGVEADAEKLLTLDGFCELRRHLDSQPTQFLDSRIRRSQTYAEISTT
PGPHYGLGLEAYATWTSPIRKYGDMVNHRLLKAIIAEQPAEKPQDEVTVQLAERRRLNRMAERDVGDWLYARYLKDKAGT
DERFNAEIIDVTRGGLRVRLLDNGAVAFIPAPFIHAVRDEMVCSQETGTVQIKGEVVYRQGDNLQVTIAEVRMETRSVIA
RPAA
>A9MQ20|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEALIE
PFLTRFVGKIQGKNDRLTIVPDHPMLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFAP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPTLTCRMIIAADGSIDDDIAFFAATIESKAKLAYDNVSDWL
ENSGTWQPDNEGIAQQIRLLHRICLSRGEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETIARPREDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
DTRFAAEIIDVSRGGMRVRLVDNGAVAFIPASFLHAVRDELVCSQENGTIQIKGETVYKVTDVIDVTIAEVRMDTRSIIA
RPAA
>A9MWU8|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNTAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPALACRMIIAADGTIDDDIAFFAATIESKAKLAYDNVSDWL
ENNGTWQPDNEGIAQQIRLLHRICLSRSEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGEAIARPQEDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
NTRFAAEIIDVSRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPAA
>A9R8T9|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHTQTPRVEGVVKGTEKGFGFLEVDGQKSYFIPPPQMKKVMHGDRIIATLHTDKDREIAEPETLVE
PFLSRFVGRVQRKDDRLSIVPDHPLLRDAIQCRPVRELTHSFQNGDWAVAEMCRHPLKGDRAFQADLTAFITNGEDHFVP
WWVTLARHNLEREAPAMVESALNDAELEREDLTALNFVTIDSASTEDMDDALFVQDNGDGSWLLTIAIADPTAYVVENSE
LDLTARKRAFTNYLPGFNIPMLPRDLSDNLCSLRPNERRPVLVCRVTITEEGTLSNDIRFSAAWVESKAKLVYDDVSDWL
EGNNRWQPQDTAIAEQITLLKRICDARSNWRQQHALVFKDRPDYRFLLGEKGEVLDIIVEHRRIANRIVEECMIAANVCA
ALALREHLGFGIYNVHTGFDPALVEQAASVLKANGVGADPQALLTLPGFCELRRHLDALPTQFLDSRIRRFQTFAEISTV
PGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAMITGQQAEKPQEEITVQLAERRRLNRMAERDVGDWLYARYLQPQAGT
DTRFTAEIIDITRGGLRVRLLDNGAVAFIPAPFIHAVRDEVVCSQETGTVQIKGETVYSQSDKIEVRIAEVRMETRNVIA
RPVA
>B0BP37|IPR011129(23...78)|Exoribonuclease 2
MFQNNPLLAQLKQQIEANKEYVEGTVKASDKAFGFLECDKKSYFIPPMEMKKVMHGDKVKAVVKREDDKEQVEIDSLLEP
MLDRFIAQVRFNKDNKLQLIVDHPSIKNIIPANTHKKVTETLESGDWVVAQLKTHPLRDDRFLFAQVTQFICKADDNFAP
WWVTLARHEQPREPVANEKSYELHDELDREDLTSLYFTTIDSPSTQDMDDALYIEPIKQGEVQTGWRLVVAIADPTAYIP
ENSNLEKAARQRCFTNYLPGFNIPMLPRELSDDLCSLVPNEKRPALVGYIETDLAGNITGDTRFVSAWVESKAKLAYDNV
SDYLEQVENAWQPESAETKQQIDWLHQFTLARIEWRRNNALLFKESGDYSFELNEDGSVRDIHVEYRRIANQMIEESMII
ANICCAKFLADNAKTGVFNTHAGFDPKNLESAQKFLLDTLSTDENRDALTAFYAPEKLATLEGYCEMRRSIDEFPEKFLE
LRLRRYLTFAEFKSEVAPHLGLGISHYATWTSPIRKYGDMVNHRLIKQVLLGKQAKTVEEGILVRLQEARRQNRLVERDI
ADWLYARYLFPMVEQAVEFDCEIADVSRGGVRAKVIANGAQIFVPFSTLHDKKEEMEFRPEEIALYIKGEKAYQIGQAVK
VKLTEVRLETRSIVGNII
>B1ITG7|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWKPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDEMVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>B1JKP2|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHTQTPRVEGVVKGTEKGFGFLEVDGQKSYFIPPPQMKKVMHGDRIIATLHTDKDREIAEPETLVE
PFLSRFVGRVQRKDDRLSIVPDHPLLRDAIQCRPVRELTHSFQNGDWAVAEMCRHPLKGDRAFQADLTAFITNGEDHFVP
WWVTLARHNLEREAPAMVESALNDAELEREDLTALNFVTIDSASTEDMDDALFVQDNGDGSWLLTIAIADPTAYVVENSE
LDLTARKRAFTNYLPGFNIPMLPRDLSDNLCSLRPNERRPVLVCRVTITEEGTLSNDIRFSAAWVESKAKLVYDDVSDWL
EGNNRWQPQDTAIAEQITLLKRICDARSNWRQQHALVFKDRPDYRFLLGEKGEVLDIIVEHRRIANRIVEECMIAANVCA
ALALREHLGFGIYNVHTGFDPALVEQAASVLKANGVGADPQALLTLPGFCELRRHLDALPTQFLDSRIRRFQTFAEISTV
PGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAIITGQQAEKPQEEITVQLAERRRLNRMAERDVGDWLYARYLQPQAGT
DTRFTAEIIDITRGGLRVRLLDNGAVAFIPAPFIHAVRDEVVCSQETGTVQIKGETVYSQSDKIEVRIAEVRMETRNVIA
RPVA
>B1LGE7|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETAYKVTDVIDVTIAEVRMETRSIIA
RPVA
>B1XBN7|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>B2K4J2|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHTQTPRVEGVVKGTEKGFGFLEVDGQKSYFIPPPQMKKVMHGDRIIATLHTDKDREIAEPETLVE
PFLSRFVGRVQRKDDRLSIVPDHPLLRDAIQCRPVRELTHSFQNGDWVVAEMCRHPLKGDRAFQADLTAFITNGEDHFVP
WWVTLARHNLEREAPAMVESALNDAELEREDLTALNFVTIDSASTEDMDDALFVQDNGDGSWLLTIAIADPTAYVVENSE
LDLTARKRAFTNYLPGFNIPMLPRDLSDNLCSLRPNERRPVLVCRVTITEEGTLSNDIRFSAAWVESKAKLVYDDVSDWL
EGNNRWQPQDTAIAEQITLLKRICDARSNWRQQHALVFKDRPDYRFLLGEKGEVLDIIVEHRRIANRIVEECMIAANVCA
ALALREHLGFGIYNVHTGFDPALVEQAASVLKANGVDADPQALLTLPGFCELRRHLDALPTQFLDSRIRRFQTFAEISTV
PGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAMITGQQAEKPQEEITVQLAERRRLNRMAERDVGDWLYARYLQPQAGT
DTRFTAEIIDITRGGLRVRLLDNGAVAFIPAPFIHAVRDEVVCSQETGTVQIKGETVYSQSDKIEVRIAEVRMETRNVIA
RPVA
>B2U0I4|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGAIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAMRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>B2VKS8|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKEKLHSQTPRVEGVVKGTEKGFGFLEVDAQKSYFIPPPFMKKVMHGDRVSAVIQSDKDREVADPETLIE
PFLTRFVGRVQKKDDRLSIIPDHPLLKDAIQCRPERSVKHDFQAGDWAVAEMRRHPLKGDRTFYAELTEFITTAEDHLAP
WWVTLSRHNLEREAPDVTTPQSMLDEQLEREDLTSLPFVTIDSASTEDMDDALYVEDAGNGALKLIVAIADPTAYVPVGS
KLDAVAAERAFTNYLPGFNIPMLPRQLSDDICSLRPHERRPVLACRITLAADGTPADDVQFFAAWIESHAKLAYNDVSDW
LETGGSSAWQPENEAIANQIRLLNRLCLARSEWRQAHALVFKDRPDFRFLLGEKGEVLDIIAEHRRIANRIVEESMILAN
ICAATVLRDRLGFGIYNVHLGFDEANAEQAAAVLANHGVTADPLAIATLEGFRNLRRELDALPTQFLDSRIRRFQSFAEV
STTPGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAIIKGEQSARPADELSLKMAERRRQNRMAERDVGDWLYSRFLQKA
AGSEQRFSAEVIDVSRGGMRVRLQENGAVAFIPAPFIHAVRDEMVCSNENGSVQIKGEVAYRVTDLIEVTIAEVRMETRS
IVARPVA
>B3GXJ4|IPR011129(23...78)|Exoribonuclease 2
MFQNNPLLAQLKQQIEANKEYVEGTVKASDKAFGFLECDKKSYFIPPMEMKKVMHGDKVKAVVKREDDKEQVEIDSLLEP
MLDRFIAQVRFNKDNKLQLIVDHPSIKNIIPANTHKKVTETLESGDWVVAQLKTHPLRDDRFLFAQVTQFICKADDNFAP
WWVTLARHEQPREPVANEKSYELHDELDREDLTSLYFTTIDSPSTQDMDDALYIEPIKQGEVQTGWRLVVAIADPTAYIP
ENSNLEKAARQRCFTNYLPGFNIPMLPRELSDDLCSLVPNEKRPALVGYIETDLAGNITGDTRFVSAWVESKAKLAYDNV
SDYLEQVENAWQPESAETKQQIDWLHQFTLARIEWRRNNALLFKESGDYSFELNEDGSVRDIHVEYRRIANQMIEESMII
ANICCAKFLADNAKTGVFNTHAGFDPKNLELAQKFLLDTLANDENRDALTALYAPEKLATLEGYCEMRRSIDEFPEKFLE
LRLRRYLTFAEFKSEVAPHLGLGISHYATWTSPIRKYGDMVNHRLIKQVLLGKQAKTVEEGILVRLQEARRQNRLVERDI
ADWLYARYLFPMVEQAVEFDCEIADVSRGGVRAKVIANGAQIFVPFSTLHDKKEEMEFRPEEIALYIKGEKAYQIGQAVK
VKLTEVRLETRSIVGNII
>B4EW02|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHAQTPRVEGLVKGTDKGFGFLEVDGQKSYFIPPPQMKKVMHGDRIIAAVHTNNDKESAEPEELVE
PFLTRFVGRVQKKEGDNRLWIIPDHPLLKDAIPCRPIKSLTHPFADQDWAVAEMRRHPLKGDKHFQAELTDFITDKDDHF
APWWVTLMRHQLERNAPEVDSETLTLHDDLPREDLTALSFVTIDSASTEDMDDALYIRKEENGQLSLYIAIADPTAYIQP
NSELDTIAAQRALTNYLPGFNIPMLPRELSDNLCSLRPNEKRPALVCQVGIMEDGALTDEIHFYSAWVESKAKLVYDNIS
DWLEGEETQWAPENEIVHEQVMLLKEMSEKRHVWREQHALVFKERPDYRFILDDSGNVLDIVAEKRRTANRIVEEAMITA
NICAAKVLSRNLGFGIYNVHTGFDPLYIDQVSQTLKEHGIETNADELLTLEGFCRLRRELDNQPNQFLDSRIRRFQNFAE
IKTEPGPHFGLGLEAYATWTSPIRKYSDILNHRLLKAIISKSAAEKPQDEDCVRIAERRRANRMAERDVGDWLYARFLKP
FAGTESTFNAEIIDITRGGIRVRLVENGAIAFIPAPFLHAVRDEIQCSQETGSVIIKGETAYKLNDIIPVRIEDVKLETR
NIVARPI
>B4T6U4|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNTAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPALACRMIIAADGTIDDDIAFFAATIESKAKLAYDNVSDWL
ENNGTWQPENEDIAQQIRLLHRICLSRSEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGEAIARPQEDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
NTRFAAEIIDVSRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPAA
>B4TJI0|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPALACRMIISADGTIDDDIAFFAATIESKAKLAYDNVSDWL
ENNGTWQPDNEGIAQQIRLLHRICLSRSEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGEAIARPQEDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
NTRFAAEIIDVSRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPAA
>B4TX11|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPALACRMIIAADGTIDDDIAFFAATIESKAKLAYDNVSDWL
ENNGTWQPDNEGIAQQIRLLHRICLSRSEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGEAIARPQEDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
NTRFAAEIIDVSRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPAA
>B5BIE3|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPALACRMIIAADGTIDDDIAFFAATIESKAKLVYDNVSDWL
ENNGTWQPENEGIAQQIRLLHRICLSRSEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGEAIARPQEDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
NTRFAAEIIDVSRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPAA
>B5DE31|IPR011129(40...108)|Y-box-binding protein 1
MSSEAETQQPPQPAADAESPSSPAAAATAGDKKVIATKVLGTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYL
RSVGDGETVEFDVVEGEKGAEAANVTGPGGVPVQGSKYAADRNRYRRYPRRRAPPRDYQENYQSDPEAEPREKREGAESA
PEGEMQQQQRRPTYPGRRRYPPYFVRRRYGRRPPYTNSQRGEMTEGGEGEENQGGPDQGNKPMRQNYYRGFRPSRGPSRP
RPVRDGEEDKENQSESGQNQEPRQRRYRRNFNYRRRRPQTTKPQDGKDSKAADASADKSAAPEAEQGGAD
>B5F571|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPALACRMIIAADGTIDDDIAFFAATIESKAKLAYDNVSDWL
ENNGTWQPDNEGIAQQIRLLHRICLSRSEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGEAIARPQEDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
NTRFAAEIIDVSRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPAA
>B5FU93|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPALACRMIISADGTIDDDIAFFAATIESKAKLAYDNVSDWL
ENNGTWQPDNEGIAQQIRLLHRICLSRSEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGEAIARPQEDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
NTRFAAEIIDVSRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPAA
>B5R490|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPALACRMIISADGTIDDDIAFFAATIESKAKLAYDNVSDWL
ENNGTWQPDNEGIAHQIRLLHRICLSRSEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGEAIARPQEDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
NTRFAAEIIDVSRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPAA
>B5R9Y0|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPALACRMIISADGTIDDDIAFFAATIESKAKLAYDNVSDWL
ENNGTWQPDNEGIAQQIRLLHRICLSRSEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGEAIARPQEDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
NTRFAAEIIDVSRGGMRVRLVDNGAIAFIPAPFLHAVHDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPAA
>B5XS03|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKGTEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHSEKDRESAEPETLVE
PFLTRFVGKVQKKDDRLAIVPDHPLLKDAIPCRAARGVEHDFKQGDWAVAEMRRHPLKGDRGFYAELTQFITFSDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLTRRDLTALDFVTIDSASTEDMDDALYVESTADGKLLLTVAIADPTAWIAEGSK
LDKAAKVRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACQMTLAADGTIEDNIEFFAATIESKAKLAYDDVSDWL
EGRGSWQPGSDAIAQQITLLKDVCQRRSEWRQTHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANICA
ARVLRDKLGFGVYNVHTGFDPANTEQLAALLKTHDVHVDPTEVLTLEGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAIIKGETIARPQDDATVQMAERRRLNRMAERDVADWLYARFLNDKAGT
DTRFAAEILDISRGGMRVRLVDNGAVAFIPAPFLHAVRDELVCSQENGTVQIKGEVVYKVTDVIDVTIAEVRMETRSIIA
RPAV
>B5YZR8|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVRKDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>B6IA03|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>B7L4C3|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>B7LRZ1|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKDRESAEPEELVE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVDHQFKEGDWAVAEMRRHPLKGDRSFYAELTQFITFGDDHFVP
WWVTLARHNLEREAPNGVATEMLDEGLVRQDLTALNFVTIDSASTEDMDDALYAEALPDGKLQLTVAIADPTAWIAEGSK
LDNVAKIRAFTNYLPGFNIPMLPRELSDDLCSLRAFEVRPALACRMTIAADGTIEDDIEFFAATIESKAKLVYDEVSDWL
ENSGNWQPENDAIAEQIRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKIGFGIYNVHMGFDPANADALAALLKTHGLHVDAQEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTQ
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAAIKGETASRPQDETTVQMTERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIIDISRGGMRVRLVDNGAVAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>B7LY47|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAMRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>B7MLW3|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDGKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTFSTDGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETAYKVTDVIDVTIAEVRMETRSIIA
RPVA
>B7N4A3|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDGKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETAYKVTDVIDVTIAEVRMETRSIIA
RPVA
>B7NVR1|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>B7UR96|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDGKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSTDGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRIAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETAYKVTDVIDVTIAEVRMETRSIIA
RPVA
>B7VSB8|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQIQETLPKKEGTIKATEKGFGFLEVDSKTSFFIPPPYMKKCVHGDKVIAIIRTEKEREVAEPEELIE
QGLTRFIARVKLFKGRLNVVPDHPQLKKLQLKAKAKKGLNPETLKEGDWVVAHIVQHPLKGDNGFLAQISEKITDADDKI
APWWVTLAQNDLPNSEPEGIDDWQIKDDADLERVDMTHVPFVTIDGESTKDMDDALYAKKKENGDFELTIAIADPTAYIS
PDDAMDKVARERGFTIYLPGRNIPMLPRDLADNLCSLIENEVRPALCCTVTVSKDGVIGDDINFFAANIKSHARLAYDHV
SDWLETGASEKWQPSEEIAAIVSDLHQFAQARSAWRSANAVVFPDRPDYRFELSEDNDVVAIHADMRRSANKLVEESMIS
ANICAGRVLKESFNQGVFNCHSGFKAEKLTDVLELVNPEAETPFTEEQIVSLEGFATLRRWLGSLDNSYYDNRIRKFQAY
SEISNEPAPHYAMGLDIYATWTSPIRKYGDMINHRMLKAHILRKTPTQTPDETIGDELALHRRHHGMAERNVGDWLYART
LANAPVEETRFQAEIFDINRAGMRVRLLENGAAAFIPGSLILNNKERIECNGDMGTVSIDKEMVYKLGDVLEVVLSEVNQ
ENRNLVAKPTQVFADLPSGPETTNETEA
>B7Z0E2|IPR011129(188...251;347...414;519...586;765...832;924...988)|RNA-binding protein Unr
MNTQSKVYRTGEEIYDNLPCDSYFNMNAIRNLGIPTTFPTIGTFTLDSTTLGLQPQGQGPSPQQQQHQQQQQQQQQQHQQ
NMHHHQHQQQHMQQQQQQQQHQQQHQQQQHQQQQQHQQQQQQQQQHPTIGMFDANEVNDVIQNPPQIGVFQSNSVLTNGA
GSGSSIFGSQSSNSSAAAADPSQTTRETGIIEKLLHSYGFIQCCERQARLFFHFSQFSGNIDHLKIGDPVEFEMTYDRRT
GKPIASQVSKIAPEVVLSEERVTGTVTTELRTDSANNVLNSSETTGRISYENRGECFFLPYTKDDVEGNVNLRAGDKVSF
QIATNQRGNLGACHIRLENPAQPVKYRGVVCSMKESFGFIERADVVKEIFFHFSEAEGNVELRPGDDVEFTIQTRSSASV
PPQGREFACNITRLAPGSVIFEDVDSTVYKGQVLKSLDRNNPVRQNNDPLPGRIRYRALDYSEVEVPFGDKDQKGDFTLR
HGDWVQFLLATDRRDQLQRATSIALLDETFKVSGEKREQGTIASLKEGFGFLRCVERQARLFFHFTEVLDTSREIDINDE
VEFTVIQEPGLAYNNSRLQAIRIKHLPPNSVQFETLVASNIEGCVTREAPKSPIKSQDRVEGGVITYEHADVKKTIMYFL
KDCEKPPRIGERVRFDIYMVKRNKECIAVNVQQVSLHQQQQQQQQQLHLNQSNAGANINQNDQLGGLSNGISSSSSNASL
QNGYVMHGSPGGSTSSVGSNNPVHLDEFKMENNNHAGSDAGQVYRGFIAVMKENFGFIETLSHDEEVFFHFSNYMGNPNW
LELGQEVEYTLARNGNTSVSGNCLPAENVRMLPKNSIPQPAVLETTHNGVVARPLRCINPDQQEYAGLIEILDELRTTVI
SQHEFGITSLVNKRDLLQKGDLVSFRIDESGRAACVNAVRQKKRATVDSIKGQFGFLNFEVEDGKKLFFHMSEVQGNTVA
LHPGDTVEFSVVTNQRNGKSSACNVLKINDRPDRLISRLKLNGDDTVPRLILIRAPKGPQGKGFSVLARHPRIPGNLVE
>B8D7G3|IPR011129(23...79)|Exoribonuclease 2
MFQNNPLLTQLKKNLHAKSPRVEGIVKSTERGFGFLEVDPQKSYFIPPKNMKNVMHGDKIIALLTTEKDREIVEPEKLIE
PFLNRFVGKIEKKDNRLFIVPDYPFLKDLITCQPNKNCINIFQNGDWAVAQLKKHKLKGDHLFYAELTEKITQEDDPLIP
WWVTLARHDLDRKEPLAEEDDLILKESDNRKDLTDLDFITIDNTNTKDIDDALFVSEKNNGDISLIVAIADPTAYIKHGS
KLDVIASKRIFTNYLPGFNIPMLPRNLSEDICSLNPNKRRPVLACHITVLKNGNISNKIEFFLAWIKSKSKLSYDHVSDW
IEKIGSWIPPTKSIANQILILHRLCLLRIKWRKKNAVLFKDSIEYRFHVSEHGKIIDVLIEKRRIAHKIIEESMIVANIS
AANFLSKNIGFGIYNVHSGFDLVNAENAVSFLRSYNLNFTVKEITTLKGFCNLRRVLNIISNNYIDSRIRRFQSFGDFST
IPGPHFALGFSEYATWTSPIRKYSDMINHRLLKSIIKKEKSIKPGEDIKIKISEQRRRNRMAERDVSDWLYTIFLQKKKY
QNQKFNAEITDISRSGIRARLIENGANVFIPGTLIHPIREELNFNQESGKVFINGIMHYKISDLIQVTLSDIRLKTRSII
AKPVFEKFK
>B8D959|IPR011129(23...79)|Exoribonuclease 2
MFQNNPLLTQLKKNLHAKSPRVEGIVKSTERGFGFLEVDPQKSYFIPPKNMKNVMHGDKIIALLTTEKDREIVEPEKLIE
PFLNRFVGKIEKKDNRLFIVPDYPFLKDLITCQPNKNCINIFQNGDWAVAQLKKHKLKGDHLFYAELTEKITQEDDPLIP
WWVTLARHDLDRKEPLAEEDDLILKESDNRKDLTDLDFITIDNTNTKDIDDALFVSEKNNGDISLIVAIADPTAYIKHGS
KLDVIASKRIFTNYLPGFNIPMLPRNLSEDICSLNPNKRRPVLACHITVLKNGNISNKIEFFLAWIKSKSKLSYDHVSDW
IEKIGSWIPPTKSIANQILILHRLCLLRIKWRKKNAVLFKDSIEYRFHVSEHGKIIDVLIEKRRIAHKIIEESMIVANIS
AANFLSKNIGFGIYNVHSGFDLVNAENAVSFLRSYNLNFTVKEITTLKGFCNLRRVLNIISNNYIDSRIRRFQSFGDFST
IPGPHFALGFSEYATWTSPIRKYSDMINHRLLKSIIKKEKSIKPGEDIKIKISEQRRRNRMAERDVSDWLYTIFLQKKKY
QNQKFNAEITDISRSGIRARLIENGANVFIPGTLIHPIREELNFNQESGKVFINGIMHYKISDLIQVTLSDIRLKTRSII
AKPVFEKFK
>B8F4C5|IPR011129(23...78)|Exoribonuclease 2
MFQNNPLLAQLKQQIEASKEYVEGVVKTSDKSYGFLECEKNSYFIPPAEMKKVMHGDKVKAVVKRDGDKEQVEIDSLLEP
MLERFIAQVRFNKDGKLQLAVDHPSINNFIPANTQKKVTEPLENGDWVVAQLKTHPLRDDRFFFAQVTQFICKADDNFAP
WWVTLARHEQPREPVANEKSYELQDQVEREDLTHLYFTTIDSASTKDMDDALYVEPISENGTQTGWRLVVAIADPTAYIP
EQSAIEKAARQRCFTNYLPGFNIPMLPRELSDDLCSLVPNEKRPALVGYIETDLSGNVVGEARFVSAWVQSKARLVYDEV
SDYLEKVENHWTPDCAETAQQIDWLHQFTLARIDWRSKNALLFKEQGDYSFELAEDGAVKAIHIDYRRIANQMIEEAMII
ANICAAQFLDKYAHTGVFNTHSGFDSKNLEPARKFLLDTLANDENRESLSERYSPERLSTLEGYCEMRRDIEQFPENFLE
MRLRRYLTFAEFKATSAPHLGLGISHYATWTSPIRKYGDMVNHRLIKQVLSNQTAKPVEETVLARLQEARKQNRMVERDI
ADWLYARYLEPMVEQNVEFDGEIQDVSRGGLRVKVIENGASVFVPFSTLHNNKEEMLFSPEEIALYIKGEKAYQIGQAVK
VKLKEVRVETRSVVGDVLI
>C0Q3R1|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNTAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPALACRMIIAADGTIDDDIAFFAATIESKAKLAYDNVSDWL
ENNGTWQPDNEGIAQQIRLLHRICLSRSEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGEAIARPQEDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
NTRFAAEIIDVSRGGMRVRLVDNGAIAFIPAPFLHAVRDALVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPAA
>C3LW69|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQKIQETLPKKEGTIKASDKGFGFLEVDSKTSYFVPPPYMKKCMHGDKVVAFIRTENEREVAEPSELIE
QSLTRFIGRVKLFKGKLNVAPDHPQLKKLSLKAKTKKGLNEADFQEGDWVVAHLVRHPLKGDDGFFVQISHKITDANDKI
APWWVTLAENDLPNSEPAGIDDWQLKDDADLVREDLTALPFVTIDGESTKDMDDALYAQQLPNGDFALTIAIADPTAYIT
PEDEMDKVARERGFTIYLPGRNIPMLPRDLADELCSLMENQVRPALCCSVTIRKDGVIGDDIRFFAANIKSHARLVYDHV
SDWLETGSSEQWQPSEEIAQVVRDLYAFSQARANWRETHAVVFPDRPDYRFELSADNDVVAIHADMRRTANRLVEESMIT
ANICAGKTLQTTFGFGVFNTHAGFKAEKMADVVELMAVNGAPNADAETLATVEGFAALRRWLATQETSYLDNRIRKYQSY
SEIGNQPLPHFAMGLDVYATWTSPIRKYGDMINHRLLKAHILGKAPVQTPDETVGEELALHRKHHKIAERNVADWLYART
LADEPAKETRFQAEIFDINRPGMRVRLLENGAMAFIPGALILDNKERIECNGEDGTVLIDKEVVYKLGDVLEIVLTEVNQ
ENRSLVGKPTQVFADLVSETQTSAEQPAEGAENNEPQV
>C4ZTY2|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>C6DK05|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRVEGVVKGTDKGFGFLEADGQKSYFIPPPHMKKVMHGDRITATLHTEKDREIVEPETLIE
PFLTRFVGRIHKKDDRLSITPDHPLLKDAIPCRAARDVTHTFQEGDWAVAEMRRHPLKGDRGFHAELTQYITTGDDPLVP
WWVTLSRHNLERAAPDVEATERHDGELVREDLTALSFVTIDSASTEDMDDALYVQDNGDGSLQLTIAIADPTAYVDAGSE
LDKIARQRAFTNYLPGFNIPMLPRSLSDDICSLRPDERRPVLACRVTIAADGALGDDIHFFAAWIESKAKLAYDNVSDWL
EEQGEWQPQNDAIAEQIRLLHRVCLARSEWRTTHALVFKDRPDYRFLLGEKGDVLDIVVEHRRIANRIVEEAMIAANVCA
AIVLRDKLGFGIYNVHNGFDPVSIDQAVTVLDTHGVQADAQTLLTLEGFCKLRRELDAQPTQFLDSRIRRFQSFAEVSIT
PGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAVITGQAAEKPQDDVTVQLAERRRLNRMAERDVGDWLYARYLSDKAGT
DVRFNAEIIDVTRGGLRVRLLDNGAVAFIPSSFIHAVRDELVCSQEMGTLAVKGDVVYRQGDTLDVVIAEVRLETRSVVA
KPAA
>C9RLJ9|IPR011129(291...357)|Transcription termination factor Rho
MPRTPKNQNLEQNTQTQSLTDLVYPESTGIPVPEYLGTVDKLPDNTEEVPQPKRRGRKPNPKTKARKEPALEQNVQAETE
PEFQEKKQPVDGIAAAEKRLAEQYGVANIDAIAEPIYTGEQNYKPAESTEENAFVSENTSEAVIPQNGDMAQAQAENQGE
VATDQNADPNAQQQGEAQAQNGEGQDDRRFNNQNGKFNKFNKNNKFNKNNRNNRNFQQQEEFVDDSATLPAPGSEAILKA
KENWLKFRKLSMSELQELAVQKEVDFRRMRKQSLNYILQSLENEGNIIYTEGVLEVTPQGHGFLRMPDQNYQTSADDVYV
SQNLIRKFNLKIGDTIEGLVRTPRDQDKYFSMRRIDRVNFEEPDKMRRRVAFEYLTPIHPEEKIHLEWNETEYSTRIMDL
FSPIGKGQRSIILAPPRTGKTVLLQNVTRAIAKNHPEIILITLLIDERPEEVTEMRDIITDIKEKAAEKGIEIKAEVVAS
TFDEPPEHHTRVANMVLEKAKRLVESQKDVVILLDSITRFARANNVVIPHSGKILSGGVDANAMQFPKKFFGAARKIQDK
IRTVKNEDGTISEEVQKNGSLTIIGTALIETGSRMDEVIFEEFKGTGNMELVLDRRIAEKRIWPAIDVFKSGTRKEERLL
TLLEQNAAWNFRRGSQNETETGIMENLLKLMSKLKTNAELLAVLSKPKV
>D0Z8E6|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRVEGVVKGTDKGFGFLEVDAQKSYFIPPPQMKKVMHGDRVRAAVQVDKEREIAEPEELLE
PFLTRFVGRIQKKENDERLSIIPDHSLLKDAIGCRPARGLDRAFRQGDWVLAEMRRHPLKGDRSFFAEITAFITDGSDHF
APWWVTLTRHDLARSAPQWQAGTLLEEGLAREDLCALPFVTIDSASTEDMDDALHVRENADGSLCLTIAIADPTAYVSAD
SPLDAEARHRAFTTYLPGFNIPMLPRDLSDDLCSLREGQRRPVLACEVTLDADGSLRDDIRFFSGWIESKAKLVYDRVSD
WLEGRGDWQPPSDDIAAQIRLLHRVANARTQWRQQHALVFRDRPDYRFVLDDHGDVTDIVAEPRRVANRIVEECMITANV
CAALVLRERLGFGIYNVHTGFDPALVEQAVSLLNANDVAANAEALLTLDGFCTLRRHLDSLPSTFLDSRIRRFQTFAEIS
TEPGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKALIAGAPATRPDPAMTLQLAERRRQNRMAERDVGDWLYARFLKDKV
NAPTPFNAEIIDISRGGMRVRLLENGAVAFIPASFIHAVRDEMVCSQENGTLQVKGSVVYRQGDTVPVTLSEVRLDTRSL
IARPFSA
>D3V184|IPR011129(23...79)|Exoribonuclease 2
MFQNNPLLAQLKQQLYSQTLRVEGLVKGTEKGFGFLEVDGQKSYFIPPPQMKKVMHGDRITAAIHTDKEKEIAEPEALIE
PFLTRFVGRVQKKENDNRLWIIPDHPLLKDTILCRPANQVTHNFENGDWAVAEMRRHPLKGDRGFQAEITGYIIKGDDHY
APWWVTLTRHSLQREAPTMPDCQLDDGSLERIDLTALDFVTIDSATTEDMDDALHIVKNNDGSLKLSIAIADPTAYIKAD
SELDKIAYQRSFTNYLPGFNIPMLPRELSDDLCSLRPKARRPALVCQVSILEDGQLGDDMQFFAAWVESKFKLAYDDVSD
WLEHQTGWKPESEAVTTQITLLQEMCERRNQWRHQYALVFKERPDYRFVLDKGGNVVDIVIDQRRSANRIVEEAMITANL
CAAKILRDKLGFGIYNVHTGFEPTQIDQVVDVLKENGIEAEANALLELDGFCQLRRELDQQPTQFLDSRIRRFQTFAEIR
PEPGPHFGLGFDAYATWTSPIRKYSDIINHRLLKAIIQQTEEEKPSEEVCLQLTERRRANRMAERDVGDWLYARFLHPHA
GTDKTFSAEIVDITRGGLRIRLVDNGAIAFVPGSFLHAVRDELQCSQETGSVLIKGEAVHRLNDIINVRIEEVRMETRNI
VARPVA
>E0J1Q3|IPR011129(5...69)|Cold shock-like protein CspE
MSKIKGNVKWFNESKGFGFITPEDGSKDVFVHFSAIQTNGFKTLAEGQRVEFEITNGAKGPSAANVIAL
>E0J500|IPR011129(5...69)|Cold shock-like protein CspC
MAKIKGQVKWFNESKGFGFITPADGSKDVFVHFSAIQGNGFKTLAEGQNVEFEIQDGQKGPAAVNVTAI
>E1WGN1|IPR011129(6...70)|Cold shock-like protein CspJ
MTTKITGLVKWFNPEKGFGFITPKDGSKDVFVHFSAIQSNEFRTLNENQEVEFSVEQGPKGPSAVNVVAL
>O30875|IPR011129(3...67)|Major cold shock protein
MAVGTVKWFNAEKGYGFIAPEDNSADVFVHFSAIQGNGFKELQENDRVEFETQDGPKGLQAANVTKL
>O32231|IPR011129(73...133;138...202)|Ribonuclease R
MEKEAFMEKLLSFMKEEAYKPLTVQELEEMLNITEAEEFKELVKALVALEEKGLIVRTRSDRYGIPEKMNLIKGKISAHA
KGFAFLLPEDTSLSDVFIPPNELNTAMNGDIVMVRLNSQSSGSRQEGTVIRILERAIQRVVGTYTETRNFGFVIPDDKKI
TSDIFIPKNGKNGAAEGHKVVVKLTSYPEGRMNAEGEVETILGHKNDPGIDILSVIHKHGLPGEFPADAMEQASSTPDTI
DEKDLKDRRDLRDQVIVTIDGADAKDLDDAVTVTKLDDGSYKLGVHIADVSHYVTENSPIDKEALERGTSVYLVDRVIPM
IPHRLSNGICSLNPKVDRLTLSCEMTINSQGQVTEHEIFQSVIKTTERMTYSDVNKILVDDDEELKQKYEPLVPMFKDME
RLAQILRDKRMDRGAVDFDFKEAKVLVDDEGAVKDVVIRERSVAEKLIEEFMLVANETVAEHFHWMNVPFIYRIHEEPNA
EKLQKFLEFVTTFGYVVKGTAGNIHPRALQSILDAVRDRPEETVISTVMLRSMKQAKYDPQSLGHFGLSTEFYTHFTSPI
RRYPDLIVHRLIRTYLINGKVDEATQEKWAERLPDIAEHTSSMERRAVDAERETDDLKKAEYMLDKIGEEFDGMISSVTN
FGMFVELPNTIEGLVHVSFMTDDYYRFDEQHFAMIGERTGNVFRIGDEITVKVVDVNKDERNIDFEIVGMKGTPRRPREL
DSSRSRKRGKPARKRVQSTNTPVSPAPSEEKGEWFTKPKKKKKKRGFQNAPKQKRKKKK
>O51891|IPR011129(52...118)|Transcription termination factor Rho
MNLTALKNMPVSELITLGEKMGLENLARMRKQDIIFAILKQHAKSGEDIFGDGVLEILQDGFGFLRSADSSYLAGPDDIY
VSPSQIRRFNLRTGDTISGKIRPPKEGERYFALLKVNAVNYDKPENARSKILFENLTPLHANSRLRMERGNGSTEDLTAR
VLDLASPIGRGQRGLIVAPPKAGKTILLQNIAQSIAYNHPDCVLMVLLIDERPEEVTEMQRLVKGEVVASTFDEPASRHV
QVAEMVIEKAKRLVEHKKDVIILLDSITRLARAYNTVVPASGKVLTGGVDANALHRPKRFFGAARNVEEGGSLTIIATAL
VDTGSKMDEVIYEEFKGTGNMELPLSRKIAEKRVFPAIDYNRSGTRKEELLTLPDELQKMWILRKIIHPMSEIDAMEFLL
NKLSMTKTNDEFFDMMKRS
>O54310|IPR011129(2...65)|Cold shock-like protein
MRGKVKWFDSKKGYGFITKDEGGDVFVHWSAIEMEGFKTLKEGQVVEFEIQEGKKGPQAAHVKVVE
>O65639|IPR011129(12...77)|Cold shock protein 1
MASEDQSAARSTGKVNWFNASKGYGFITPDDGSVELFVHQSSIVSEGYRSLTVGDAVEFAITQGSDGKTKAVNVTAPGGG
SLKKENNSRGNGARRGGGGSGCYNCGELGHISKDCGIGGGGGGGERRSRGGEGCYNCGDTGHFARDCTSAGNGDQRGATK
GGNDGCYTCGDVGHVARDCTQKSVGNGDQRGAVKGGNDGCYTCGDVGHFARDCTQKVAAGNVRSGGGGSGTCYSCGGVGH
IARDCATKRQPSRGCYQCGGSGHLARDCDQRGSGGGGNDNACYKCGKEGHFARECSSVA
>O67031|IPR011129(69...135)|Transcription termination factor Rho
MTQQTAQQEQQKSEVKIYSREELKQKTLAELQKIGKELGLTRTTGLKKEELIEKILKAQLEKSRLVFVKGVLEILPEGYG
FLRMPENNYMPSWNDVYVAPSQIKKFGLRTGDTIEGFARLPRENEKYKALIRMESVNGLPPDPEILKRRPQFEKLTPLHP
MERFKLEYDPNELSTRVVSLIAPIGKGQRGLIVAPPKAGKTVLLQKIAQAIIRNHPEVYLIILLIDERPEEVTEMRRIVK
DKAEVVASTFDEPPERHMQVAEIVVEKAKRMVELKKDVVILMDSLTRFTRASNAVTPPTGRVLTGGIEITAFQRPKKFFG
AARNIEEGGSLTIIATALVETGSKMDDVIYEEFKGTGNMEIHLDRRLMERRIFPAINIEKSGTRKEELLLEPWELQRIWV
LRKFLSTMDPVEAMEFLLEKLRRFKTNEEFLKAMNA
>O67327|IPR011129(4...68)|Cold shock-like protein
MSFRGTVKWFSKDKGYGFITREDTNADVFVHFTDIQMEGFKTLQKGQKVEFDVVEDTKGPRAKNVRVLGE
>O67834|IPR011129(69...125)|Ribonuclease R
MDKEKLEKEVIKLLSKKKKPLHFLQIAKALGLGKKERKTLKKVMRKLKKEGKVKVVKGKYEYTGEEVVTGTVIAYPGGFG
FLEVEGGKDIYIPPFEMVKVFHGDVVKAKVTEFKGKKEVRIIKVLKRAKKDIVAKVVFEDEQCYVVPLDENAHHRILLSK
KDCQKLKEGEVVVLKITQFPTKKSPARGKVIEVLGNPKEKFIAIDVIIRKYNLPTSYPEKVIKEVEAIPEEIPEEEIKRR
RDLREQLCFTIDPEKAGDFDDAVAIELTPEGYYKLYVHIADVSYYVREGTETDKEAYKRGFTYYFPDRALHMLPEKLSAK
LCSLRPNEDKLAFTVEMVFDESGNLKAYDIYESVIRSKARLTYNEALALIVGDPALEKKFPNLVEPLRMMETLYRILSRK
RWEMGSIDFDLPEAEVIVDEYGEPTAIYPYERHVAHRIIEHFMISANETVALHLEHAGYPCLYRVHEPPDEEKVENLLEI
LEGLGYKVKRPHEYTPKFFQKIIEDFEGRPEENLVRFLTLRAMARAKYSPHNVGHFGLALEHYAHFTSPIRRYPDIIVHR
LLKKALRGEEIDYEKTLAYLEEAGNHLSKQERIADEAEMEAIDYLKARYMKGRIGEEFIGIITGVVAFGFFVELEENLVE
GLVKINTLTDDEYVFDEPAHRLVGVRTGKVFRLGDHVKVRCIAVDEERARVEFELIEKLEKHETL
>O75534|IPR011129(27...90;187...248;350...413;520...582;675...738)|Cold shock domain-containing protein E1
MSFDPNLLHNNGHNGYPNGTSAALRETGVIEKLLTSYGFIQCSERQARLFFHCSQYNGNLQDLKVGDDVEFEVSSDRRTG
KPIAVKLVKIKQEILPEERMNGQVVCAVPHNLESKSPAAPGQSPTGSVCYERNGEVFYLTYTPEDVEGNVQLETGDKINF
VIDNNKHTGAVSARNIMLLKKKQARCQGVVCAMKEAFGFIERGDVVKEIFFHYSEFKGDLETLQPGDDVEFTIKDRNGKE
VATDVRLLPQGTVIFEDISIEHFEGTVTKVIPKVPSKNQNDPLPGRIKVDFVIPKELPFGDKDTKSKVTLLEGDHVRFNI
STDRRDKLERATNIEVLSNTFQFTNEAREMGVIAAMRDGFGFIKCVDRDVRMFFHFSEILDGNQLHIADEVEFTVVPDML
SAQRNHAIRIKKLPKGTVSFHSHSDHRFLGTVEKEATFSNPKTTSPNKGKEKEAEDGIIAYDDCGVKLTIAFQAKDVEGS
TSPQIGDKVEFSISDKQRPGQQVATCVRLLGRNSNSKRLLGYVATLKDNFGFIETANHDKEIFFHYSEFSGDVDSLELGD
MVEYSLSKGKGNKVSAEKVNKTHSVNGITEEADPTIYSGKVIRPLRSVDPTQTEYQGMIEIVEEGDMKGEVYPFGIVGMA
NKGDCLQKGESVKFQLCVLGQNAQTMAYNITPLRRATVECVKDQFGFINYEVGDSKKLFFHVKEVQDGIELQAGDEVEFS
VILNQRTGKCSACNVWRVCEGPKAVAAPRPDRLVNRLKNITLDDASAPRLMVLRQPRGPDNSMGFGAERKIRQAGVID
>O83281|IPR011129(151...217)|Transcription termination factor Rho
MKVSVGTVVGQGELGLEEGIVGNQIVSEDSAADVGECDAYGGRKKLVIRSRSRRRVVTPKALEVEKRPRRALRFKQNFCP
EDAETSESSADVKGRARLLIDDLTEMGMHALRDFAVQRGISQEDVVVMKKSDIIFHVLKNHTENGGVIFASGSLEILPDG
YGFLRSPQNSYLPGSDDIYVSPSQIRLFNLKTGDTIYGQIRSPKEGERFFAMLRVETVNFEEVAKVQDRVPFDSLTPLYP
REKLNLETRTEDISTRVMNLFCPIGKGQRALIVAPPRTGKTILMQKIANAITQNHPEVYLIVLLIDERPEEVTDMERTVD
AEVISSTFDEQATRHVQIAEIVLERAKRLVEHRKDVVILLDSITRLARAYNQTMPTSGKVLSGGVDSNALHKPKRFFGAA
RNVEEGGSLTIIATALIETGSRMDEVIFEEFKGTGNMEINLDRRLSDRRLFPAVSIKKSGTRKEELLLTEEEMQRIWVLR
KVINPMDDAEIVELLIDKMRKTKNNEAFLRSMNTGAFSS
>O84402|IPR011129(20...84)|Ribonuclease R
MGKAKNKKKFLKNRKQVLVPGTLFVHSRKGFGFVSPDQPELYPFDIFISASDLKGALDGDHVLVALPFSLRGGEKRKGVI
HKVLSRGKTVLVGTIVSLINPTLAMVYVNTIGPEHPLKAELLPKRTYKLGDRLLLKTPVWKENYPSREPPPLAMLEFIGN
ISNAKTDFPVIKAEFSITEEFPDAVVQEASQFLQKHVTQALHSRKDLRDLLCFTIDSSSAKDFDDAVSLTYDHEGNYILG
VHIADVSHYVTPNSALDREAAKRCNSIYFPGKVIPMLPSALSDNLCSLKPNVDRLAVSVFMTFSKEGFLSDYRILRSVIR
SKYRMTYDEVDEIIEKKQTHPISKTILKMAELSRIFSDIREQRGCTRLVLPSFTMSLDNLQEPVALIENKQTAAHKLIEE
FMLKANEVIAYHISHQGITMPFRTHEPPNEESLLVFQETAKAMGFTITQTPAQEPDYQYLLQETTAGHPLEPILHSQFVR
SMKTASYSTENKGHYGLCLDYYTHFTSPIRRYVDLIVHRLLFHPLSVEEEHLEQIVRACSSQERIAAKAEGAFVNIKKAR
FLKKFIEEQPATLYKAFIITASPEGISFVLPEFCHEGFIPAAKLPQAYVLQTKIGLEELPEHLRPGAVISVQLASVTLLT
QSIEWTLVEATTKAKAKRTSKKKKTESVTTKEKKKSPAKKKKGATKTKKGSGKN
>P0A105|IPR011129(6...69)|Cold shock protein CapB
MSNRQTGTVKWFNDEKGFGFITPQSGDDLFVHFKAIQSDGFKSLKEGQQVSFIATRGQKGMQAEEVQVI
>P0A106|IPR011129(6...69)|Cold shock protein CapB
MSNRQTGTVKWFNDEKGFGFITPQSGDDLFVHFKAIQSDGFKSLKEGQQVSFIATRGQKGMQAEEVQVI
>P0A1D9|IPR011129(6...70)|Cold shock-like protein CspH
MSRKMTGIVKTFDCKSGKGLITPSDGRKDVQVHISACRQHETEALIPGIRVEFCRINGLRGPTAANVYLS
>P0A1E0|IPR011129(6...70)|Cold shock-like protein CspH
MSRKMTGIVKTFDCKSGKGLITPSDGRKDVQVHISACRQHETEALIPGIRVEFCRINGLRGPTAANVYLS
>P0A295|IPR011129(52...118)|Transcription termination factor Rho
MNLTELKNTPVSELITLGESMGLENLARMRKQDIIFAILKQHAKSGEDIFGDGVLEILQDGFGFLRSADSSYLAGPDDIY
VSPSQIRRFNLRTGDTISGKIRPPKEGERYFALLKVNEVNYDKPENARNKILFENLTPLHANSRLRMERGNGSTEDLTAR
VLDLASPIGRGQRGLIVAPPKAGKTMLLQNIAQSIAYNHPDCVLMVLLIDERPEEVTEMQRLVKGEVVASTFDEPASRHV
QVAEMVIEKAKRLVEHKKDVIILLDSITRLARAYNTVVPASGKVLTGGVDANALHRPKRFFGAARNVEEGGSLTIIATAL
IDTGSKMDEVIYEEFKGTGNMELHLSRKIAEKRVFPAIDYNRSGTRKEELLTTQEELQKMWILRKIIHPMGEIDAMEFLI
NKLAMTKTNDDFFEMMKRS
>P0A296|IPR011129(52...118)|Transcription termination factor Rho
MNLTELKNTPVSELITLGESMGLENLARMRKQDIIFAILKQHAKSGEDIFGDGVLEILQDGFGFLRSADSSYLAGPDDIY
VSPSQIRRFNLRTGDTISGKIRPPKEGERYFALLKVNEVNYDKPENARNKILFENLTPLHANSRLRMERGNGSTEDLTAR
VLDLASPIGRGQRGLIVAPPKAGKTMLLQNIAQSIAYNHPDCVLMVLLIDERPEEVTEMQRLVKGEVVASTFDEPASRHV
QVAEMVIEKAKRLVEHKKDVIILLDSITRLARAYNTVVPASGKVLTGGVDANALHRPKRFFGAARNVEEGGSLTIIATAL
IDTGSKMDEVIYEEFKGTGNMELHLSRKIAEKRVFPAIDYNRSGTRKEELLTTQEELQKMWILRKIIHPMGEIDAMEFLI
NKLAMTKTNDDFFEMMKRS
>P0A352|IPR011129(3...67)|Cold shock-like protein CspA
METGVVKWFNAEKGYGFITPEAGGKDLFAHFSEIQANGFKSLEENQRVSFVTAMGPKGPQATKIQIL
>P0A353|IPR011129(3...67)|Cold shock-like protein CspA
METGVVKWFNAEKGYGFITPEAGGKDLFAHFSEIQANGFKSLEENQRVSFVTAMGPKGPQATKIQIL
>P0A354|IPR011129(3...67)|Cold shock-like protein CspA
METGVVKWFNAEKGYGFITPEAGGKDLFAHFSEIQANGFKSLEENQRVSFVTAMGPKGPQATKIQIL
>P0A355|IPR011129(3...66)|Cold shock-like protein CspLA
MEQGTVKWFNAEKGFGFIERENGDDVFVHFSAIQGDGFKSLDEGQAVTFDVEEGQRGPQAANVQKA
>P0A356|IPR011129(3...66)|Cold shock-like protein CspLA
MEQGTVKWFNAEKGFGFIERENGDDVFVHFSAIQGDGFKSLDEGQAVTFDVEEGQRGPQAANVQKA
>P0A357|IPR011129(3...66)|Cold shock-like protein CspLB
MQTGTVKWFNSEKGFGFIEVEGGDDVFVHFSAIEGEGFKTLDEGQSVEFEIVEGQRGPQAEKVTKL
>P0A358|IPR011129(3...66)|Cold shock-like protein CspLB
MQTGTVKWFNSEKGFGFIEVEGGDDVFVHFSAIEGEGFKTLDEGQSVEFEIVEGQRGPQAEKVTKL
>P0A361|IPR011129(3...66)|Major cold shock protein
MAQGTVKWFNAEKGFGFISTENGQDVFAHFSAIQTNGFKTLEEGQKVAFDVEEGQRGPQAVNITKLA
>P0A362|IPR011129(6...70)|Cold shock-like protein CspB
MSNKMTGLVKWFDAGKGFGFISPADGSKDVFVHFSAIQGNDYKTLDEGQNVEFSIEQGQKGPSAVNVVAL
>P0A363|IPR011129(6...70)|Cold shock-like protein CspB
MSNKMTGLVKWFDAGKGFGFISPADGSKDVFVHFSAIQGNDYKTLDEGQNVEFSIEQGQKGPSAVNVVAL
>P0A968|IPR011129(3...67)|Cold shock-like protein CspD
MEKGTVKWFNNAKGFGFICPEGGGEDIFAHYSTIQMDGYRTLKAGQSVQFDVHQGPKGNHASVIVPVEVEAAVA
>P0A969|IPR011129(3...67)|Cold shock-like protein CspD
MEKGTVKWFNNAKGFGFICPEGGGEDIFAHYSTIQMDGYRTLKAGQSVQFDVHQGPKGNHASVIVPVEVEAAVA
>P0A970|IPR011129(3...67)|Cold shock-like protein CspD
MEKGTVKWFNNAKGFGFICPEGGGEDIFAHYSTIQMDGYRTLKAGQSVQFDVHQGPKGNHASVIVPVEVEAAVA
>P0A971|IPR011129(3...67)|Cold shock-like protein CspD
MEKGTVKWFNNAKGFGFICPEGGGEDIFAHYSTIQMDGYRTLKAGQSVQFDVHQGPKGNHASVIVPVEVEAAVA
>P0A972|IPR011129(5...69)|Cold shock-like protein CspE
MSKIKGNVKWFNESKGFGFITPEDGSKDVFVHFSAIQTNGFKTLAEGQRVEFEITNGAKGPSAANVIAL
>P0A973|IPR011129(5...69)|Cold shock-like protein CspE
MSKIKGNVKWFNESKGFGFITPEDGSKDVFVHFSAIQTNGFKTLAEGQRVEFEITNGAKGPSAANVIAL
>P0A974|IPR011129(5...69)|Cold shock-like protein CspE
MSKIKGNVKWFNESKGFGFITPEDGSKDVFVHFSAIQTNGFKTLAEGQRVEFEITNGAKGPSAANVIAL
>P0A975|IPR011129(5...69)|Cold shock-like protein CspE
MSKIKGNVKWFNESKGFGFITPEDGSKDVFVHFSAIQTNGFKTLAEGQRVEFEITNGAKGPSAANVIAL
>P0A976|IPR011129(6...70)|Cold shock-like protein CspF
MSRKMTGIVKTFDGKSGKGLITPSDGRIDVQLHVSALNLRDAEEITTGLRVEFCRINGLRGPSAANVYLS
>P0A977|IPR011129(6...70)|Cold shock-like protein CspF
MSRKMTGIVKTFDGKSGKGLITPSDGRIDVQLHVSALNLRDAEEITTGLRVEFCRINGLRGPSAANVYLS
>P0A978|IPR011129(6...70)|Cold shock-like protein CspG
MSNKMTGLVKWFNADKGFGFITPDDGSKDVFVHFTAIQSNEFRTLNENQKVEFSIEQGQRGPAAANVVTL
>P0A979|IPR011129(6...70)|Cold shock-like protein CspG
MSNKMTGLVKWFNADKGFGFITPDDGSKDVFVHFTAIQSNEFRTLNENQKVEFSIEQGQRGPAAANVVTL
>P0A980|IPR011129(6...70)|Cold shock-like protein CspG
MSNKMTGLVKWFNADKGFGFITPDDGSKDVFVHFTAIQSNEFRTLNENQKVEFSIEQGQRGPAAANVVTL
>P0A981|IPR011129(6...70)|Cold shock-like protein CspG
MSNKMTGLVKWFNADKGFGFITPDDGSKDVFVHFTAIQSNEFRTLNENQKVEFSIEQGQRGPAAANVVTL
>P0A982|IPR011129(6...70)|Cold shock-like protein CspH
MSRKMTGIVKTFDRKSGKGFIIPSDGRKEVQVHISAFTPRDAEVLIPGLRVEFCRVNGLRGPTAANVYLS
>P0A983|IPR011129(6...70)|Cold shock-like protein CspH
MSRKMTGIVKTFDRKSGKGFIIPSDGRKEVQVHISAFTPRDAEVLIPGLRVEFCRVNGLRGPTAANVYLS
>P0A984|IPR011129(6...70)|Cold shock-like protein CspH
MSRKMTGIVKTFDRKSGKGFIIPSDGRKEVQVHISAFTPRDAEVLIPGLRVEFCRVNGLRGPTAANVYLS
>P0A985|IPR011129(6...70)|Cold shock-like protein CspH
MSRKMTGIVKTFDRKSGKGFIIPSDGRKEVQVHISAFTPRDAEVLIPGLRVEFCRVNGLRGPTAANVYLS
>P0A986|IPR011129(6...70)|Cold shock-like protein CspI
MSNKMTGLVKWFNPEKGFGFITPKDGSKDVFVHFSAIQSNDFKTLTENQEVEFGIENGPKGPAAVHVVAL
>P0A987|IPR011129(6...70)|Cold shock-like protein CspI
MSNKMTGLVKWFNPEKGFGFITPKDGSKDVFVHFSAIQSNDFKTLTENQEVEFGIENGPKGPAAVHVVAL
>P0A9X9|IPR011129(6...70)|Cold shock protein CspA
MSGKMTGIVKWFNADKGFGFITPDDGSKDVFVHFSAIQNDGYKSLDEGQKVSFTIESGAKGPAAGNVTSL
>P0A9Y0|IPR011129(6...70)|Cold shock protein CspA
MSGKMTGIVKWFNADKGFGFITPDDGSKDVFVHFSAIQNDGYKSLDEGQKVSFTIESGAKGPAAGNVTSL
>P0A9Y1|IPR011129(6...70)|Cold shock protein CspA
MSGKMTGIVKWFNADKGFGFITPDDGSKDVFVHFSAIQNDGYKSLDEGQKVSFTIESGAKGPAAGNVTSL
>P0A9Y2|IPR011129(6...70)|Cold shock protein CspA
MSGKMTGIVKWFNADKGFGFITPDDGSKDVFVHFSAIQNDGYKSLDEGQKVSFTIESGAKGPAAGNVTSL
>P0A9Y3|IPR011129(6...70)|Cold shock protein CspA
MSGKMTGIVKWFNADKGFGFITPDDGSKDVFVHFSAIQNDGYKSLDEGQKVSFTIESGAKGPAAGNVTSL
>P0A9Y4|IPR011129(6...70)|Cold shock protein CspA
MSGKMTGIVKWFNADKGFGFITPDDGSKDVFVHFSAIQNDGYKSLDEGQKVSFTIESGAKGPAAGNVTSL
>P0A9Y5|IPR011129(6...70)|Cold shock protein CspA
MSGKMTGIVKWFNADKGFGFITPDDGSKDVFVHFSAIQNDGYKSLDEGQKVSFTIESGAKGPAAGNVTSL
>P0A9Y6|IPR011129(5...69)|Cold shock-like protein CspC
MAKIKGQVKWFNESKGFGFITPADGSKDVFVHFSAIQGNGFKTLAEGQNVEFEIQDGQKGPAAVNVTAI
>P0A9Y7|IPR011129(5...69)|Cold shock-like protein CspC
MAKIKGQVKWFNESKGFGFITPADGSKDVFVHFSAIQGNGFKTLAEGQNVEFEIQDGQKGPAAVNVTAI
>P0A9Y8|IPR011129(5...69)|Cold shock-like protein CspC
MAKIKGQVKWFNESKGFGFITPADGSKDVFVHFSAIQGNGFKTLAEGQNVEFEIQDGQKGPAAVNVTAI
>P0A9Y9|IPR011129(5...69)|Cold shock-like protein CspC
MAKIKGQVKWFNESKGFGFITPADGSKDVFVHFSAIQGNGFKTLAEGQNVEFEIQDGQKGPAAVNVTAI
>P0A9Z0|IPR011129(5...69)|Cold shock-like protein CspC
MAKIKGQVKWFNESKGFGFITPADGSKDVFVHFSAIQGNGFKTLAEGQNVEFEIQDGQKGPAAVNVTAI
>P0AG30|IPR011129(52...118)|Transcription termination factor Rho
MNLTELKNTPVSELITLGENMGLENLARMRKQDIIFAILKQHAKSGEDIFGDGVLEILQDGFGFLRSADSSYLAGPDDIY
VSPSQIRRFNLRTGDTISGKIRPPKEGERYFALLKVNEVNFDKPENARNKILFENLTPLHANSRLRMERGNGSTEDLTAR
VLDLASPIGRGQRGLIVAPPKAGKTMLLQNIAQSIAYNHPDCVLMVLLIDERPEEVTEMQRLVKGEVVASTFDEPASRHV
QVAEMVIEKAKRLVEHKKDVIILLDSITRLARAYNTVVPASGKVLTGGVDANALHRPKRFFGAARNVEEGGSLTIIATAL
IDTGSKMDEVIYEEFKGTGNMELHLSRKIAEKRVFPAIDYNRSGTRKEELLTTQEELQKMWILRKIIHPMGEIDAMEFLI
NKLAMTKTNDDFFEMMKRS
>P0AG31|IPR011129(52...118)|Transcription termination factor Rho
MNLTELKNTPVSELITLGENMGLENLARMRKQDIIFAILKQHAKSGEDIFGDGVLEILQDGFGFLRSADSSYLAGPDDIY
VSPSQIRRFNLRTGDTISGKIRPPKEGERYFALLKVNEVNFDKPENARNKILFENLTPLHANSRLRMERGNGSTEDLTAR
VLDLASPIGRGQRGLIVAPPKAGKTMLLQNIAQSIAYNHPDCVLMVLLIDERPEEVTEMQRLVKGEVVASTFDEPASRHV
QVAEMVIEKAKRLVEHKKDVIILLDSITRLARAYNTVVPASGKVLTGGVDANALHRPKRFFGAARNVEEGGSLTIIATAL
IDTGSKMDEVIYEEFKGTGNMELHLSRKIAEKRVFPAIDYNRSGTRKEELLTTQEELQKMWILRKIIHPMGEIDAMEFLI
NKLAMTKTNDDFFEMMKRS
>P0AG32|IPR011129(52...118)|Transcription termination factor Rho
MNLTELKNTPVSELITLGENMGLENLARMRKQDIIFAILKQHAKSGEDIFGDGVLEILQDGFGFLRSADSSYLAGPDDIY
VSPSQIRRFNLRTGDTISGKIRPPKEGERYFALLKVNEVNFDKPENARNKILFENLTPLHANSRLRMERGNGSTEDLTAR
VLDLASPIGRGQRGLIVAPPKAGKTMLLQNIAQSIAYNHPDCVLMVLLIDERPEEVTEMQRLVKGEVVASTFDEPASRHV
QVAEMVIEKAKRLVEHKKDVIILLDSITRLARAYNTVVPASGKVLTGGVDANALHRPKRFFGAARNVEEGGSLTIIATAL
IDTGSKMDEVIYEEFKGTGNMELHLSRKIAEKRVFPAIDYNRSGTRKEELLTTQEELQKMWILRKIIHPMGEIDAMEFLI
NKLAMTKTNDDFFEMMKRS
>P0AG33|IPR011129(52...118)|Transcription termination factor Rho
MNLTELKNTPVSELITLGENMGLENLARMRKQDIIFAILKQHAKSGEDIFGDGVLEILQDGFGFLRSADSSYLAGPDDIY
VSPSQIRRFNLRTGDTISGKIRPPKEGERYFALLKVNEVNFDKPENARNKILFENLTPLHANSRLRMERGNGSTEDLTAR
VLDLASPIGRGQRGLIVAPPKAGKTMLLQNIAQSIAYNHPDCVLMVLLIDERPEEVTEMQRLVKGEVVASTFDEPASRHV
QVAEMVIEKAKRLVEHKKDVIILLDSITRLARAYNTVVPASGKVLTGGVDANALHRPKRFFGAARNVEEGGSLTIIATAL
IDTGSKMDEVIYEEFKGTGNMELHLSRKIAEKRVFPAIDYNRSGTRKEELLTTQEELQKMWILRKIIHPMGEIDAMEFLI
NKLAMTKTNDDFFEMMKRS
>P0C0F0|IPR011129(1...45)|Major cold shock protein
EKGFGFISTENGQDVFAHFSAIQTNGFKTLEEGQKVAFDVEEGQR
>P0C0F1|IPR011129(3...66)|Major cold shock protein
MAQGTVKWFNAEKGFGFISTENGQDVFAHFSAIQTNGFKTLEEGQKVAFDVEEGQRGPQAVNITKLA
>P0CH92|IPR011129(53...119)|Transcription termination factor Rho 1
MLDLSELKKKTIEDLLKIAEDLGVVSNGRMLKQEIIFHLMKKVVSDGGAAIGGGVVEILSDGFGFLRSPEANYAASGDDV
YISAGQIKKFNLRTGDIVSGEIRAPSEKERYFTLVKAHSINFTDMAKLQRYVHFDDLIPLYPEERILLECNDPISVSKKD
ISMRVIDIVAPLGKGQRALIVAPPRAGKTIILQQIAHSISVNHPDIELIVLLIGERPEEVTDMCRSVKGEVVSSTFDEPG
YRHVQLAEIVIEKAKRMVEHKKNVVILLDSITRLARAYNSVIPSSGKVLTGGVDSNALQRPKRFFGAARNIENGGSLTII
ATALIETGSKMDEVIFEEFKGTGNCEIILDRKISDKRVYPAIDISKSGTRKEDMLIDSVCLKKVWLLRRLLSSMGSVEAM
EFLRDKLLITKDNNEFFDMMNS
>P0CH93|IPR011129(53...119)|Transcription termination factor Rho 2
MLDLSELKKKTIEDLLKIAEDLGVVSNGRMLKQEIIFHLMKKVVSDGGAAIGGGVVEILSDGFGFLRSPEANYAASGDDV
YISAGQIKKFNLRTGDIVSGEIRAPSEKERYFTLVKAHSINFTDMAKLQRYVHFDDLIPLYPEERILLECNDPISVSKKD
ISMRVIDIVAPLGKGQRALIVAPPRAGKTIILQQIAHSISVNHPDIELIVLLIGERPEEVTDMCRSVKGEVVSSTFDEPG
YRHVQLAEIVIEKAKRMVEHKKNVVILLDSITRLARAYNSVIPSSGKVLTGGVDSNALQRPKRFFGAARNIENGGSLTII
ATALIETGSKMDEVIFEEFKGTGNCEIILDRKISDKRVYPAIDISKSGTRKEDMLIDSVCLKKVWLLRRLLSSMGSVEAM
EFLRDKLLITKDNNEFFDMMNS
>P0CL01|IPR011129(6...70)|Cold shock-like protein CspJ
MTTKITGLVKWFNPEKGFGFITPKDGSKDVFVHFSAIQSNEFRTLNENQEVEFSVEQGPKGPSAVNVVAL
>P0DA48|IPR011129(3...66)|Major cold shock protein
MAQGTVKWFNAEKGFGFISTENGQDVFAHFSAIQTNGFKTLEEGQKVAFDVEEGQRGPQAVNITKLA
>P0DA49|IPR011129(3...66)|Major cold shock protein
MAQGTVKWFNAEKGFGFISTENGQDVFAHFSAIQTNGFKTLEEGQKVAFDVEEGQRGPQAVNITKLA
>P16989|IPR011129(92...160)|Y-box-binding protein 3
MSEAGEATTTTTTTLPQAPTEAAAAAPQDPAPKSPVGSGAPQAAAPAPAAHVAGNPGGDAAPAATGTAAAASLATAAGSE
DAEKKVLATKVLGTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGEKGAEAANVTGP
DGVPVEGSRYAADRRRYRRGYYGRRRGPPRNYAGEEEEEGSGSSEGFDPPATDRQFSGARNQLRRPQYRPQYRQRRFPPY
HVGQTFDRRSRVLPHPNRIQAGEIGEMKDGVPEGAQLQGPVHRNPTYRPRYRSRGPPRPRPAPAVGEAEDKENQQATSGP
NQPSVRRGYRRPYNYRRRPRPPNAPSQDGKEAKAGEAPTENPAPPTQQSSAE
>P18395|IPR011129(27...90;187...248;350...413;520...582;675...738)|Cold shock domain-containing protein E1
MSFDPNLLHNNGHNGYPNGTSAALRETGVIEKLLTSYGFIQCSERQARLFFHCSQYNGNLQDLKVGDDVEFEVSSDRRTG
KPIAIKLVKIKPEIHPEERMNGQVVCAVPHNLESKSPAAPGQSPTGSVCYERNGEVFYLTYTSEDVEGNVQLETGDKINF
VIDNNKHTGAVSARNIMLLKKKQARYQGVVCAMKEAFGFIERGDVVKEIFFHYSEFKGDLETLQPGDDVEFTIKDRNGKE
VATDVRLLPQGTVIFEDISIEHFEGTVTKVIPKVPSKNQNDPLPGRIKVDFVIPKELPFGDKDTKSKVTLLEGDHVRFNI
STDRRDKLERATNIEVLSNTFQFTNEAREMGVIAAMRDGFGFIKCVDRDARMFFHFSEILDGNQLHIADEVEFTVVPDML
SAQRNHAIRIKKLPKGTVSFHSHSDHRFLGTVEKEATFSNPKTTSPNKGKDKEAEDGIIAYDDCGVKLTIAFQAKDVEGS
TSPQIGDKVEFSISDKQRPGQQIATCVRLLGRNSNSKRLLGYVATLKDNFGFIETANHDKEIFFHYSEFSGDVDSLELGD
MVEYSLSKGKGNKVSAEKVNKTHSVNGITEEANPTIYSGKVIRPLRGVDPTQIEYQGMIEIVEEGDMKGEVYPFGIVGMA
NKGDCLQKGESVKFQLCVLGQNAQTMAYNITPLRRATVECVKDQFGFINYEVGDSKKLFFHVKEVQDGIELQAGDEVEFS
VILNQRTGKCSACNVWRVCEGPKAVAAPRPDRLVNRLKNITLDDASAPRLMVLRQPRGPDNSMGFGAERKIRQAGVID
>P21499|IPR011129(86...145)|Ribonuclease R
MSQDPFQEREAEKYANPIPSREFILEHLTKREKPASRDELAVELHIEGEEQLEGLRRRLRAMERDGQLVFTRRQCYALPE
RLDLVKGTVIGHRDGYGFLRVEGRKDDLYLSSEQMKTCIHGDQVLAQPLGADRKGRREARIVRVLVPKTSQIVGRYFTEA
GVGFVVPDDSRLSFDILIPPDQIMGARMGFVVVVELTQRPTRRTKAVGKIVEVLGDNMGTGMAVDIALRTHEIPYIWPQA
VEQQVAGLKEEVPEEAKAGRVDLRDLPLVTIDGEDARDFDDAVYCEKKRGGGWRLWVAIADVSYYVRPSTPLDREARNRG
TSVYFPSQVIPMLPEVLSNGLCSLNPQVDRLCMVCEMTVSSKGRLTGYKFYEAVMSSHARLTYTKVWHILQGDQDLREQY
APLVKHLEELHNLYKVLDKAREERGGISFESEEAKFIFNAERRIERIEQTQRNDAHKLIEECMILANISAARFVEKAKEP
ALFRIHDKPSTEAITSFRSVLAELGLELPGGNKPEPRDYAELLESVADRPDAEMLQTMLLRSMKQAIYDPENRGHFGLAL
QSYAHFTSPIRRYPDLTLHRAIKYLLAKEQGHQGNTTETGGYHYSMEEMLQLGQHCSMAERRADEATRDVADWLKCDFML
DQVGNVFKGVISSVTGFGFFVRLDDLFIDGLVHVSSLDNDYYRFDQVGQRLMGESSGQTYRLGDRVEVRVEAVNMDERKI
DFSLISSERAPRNVGKTAREKAKKGDAGKKGGKRRQVGKKVNFEPDSAFRGEKKTKPKAAKKDARKAKKPSAKTQKIAAA
TKAKRAAKKKVAE
>P21573|IPR011129(38...106)|Y-box-binding protein 1
MSSEVETQQQQPDALEGKAGQEPAATVGDKKVIATKVLGTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRS
VGDGETVEFDVVEGEKGAEAANVTGPEGVPVQGSKYAADRNHYRRYPRRRGPPRNYQQNYQNNESGEKAEENESAPEGDD
SNQQRPYHRRRFPPYYSRRPYGRRPQYSNAPVQGEEAEGADSQGTDEQGRPARQNMYRGFRPRFRRGPPRQRQPREEGNE
EDKENQGDETQSQPPPQRRYRRNFNYRRRRPENPKSQDGKETKAAETSAENTSTPEAEQGGAE
>P21574|IPR011129(43...111)|Y-box-binding protein 2-A
MSEAEAQEPEPVPQPESEPEIQKPGIAAARNQANKKVLATQVQGTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPR
KFLRSVGDGETVEFDVVEGEKGAEAANVTGPGGVPVKGSRFAPNRRRFRRRFYRPRADTAGESGGEGVSPEQMSEGERGE
ETSPQQRPQRRRPPPFFYRRRFRRGPRPNNQQNQGAEVTEQSENKDPVAPTSEALASGDDPQRPPPRRFRQRFRRPFRPR
PAPQQTPEGGDGETKAESGEDPRPEPQRQRNRPYVQRRRRQGATQVAATAQGEGKAEPTQHPASEEGTPSDSPTDDGAPV
QSSAPDPGIADTPAPE
>P27484|IPR011129(10...75)|Glycine-rich protein 2
MAEESGQRAKGTVKWFSDQKGFGFITPDDGGEDLFVHQSGIRSEGFRSLAEGETVEFEVESGGDGRTKAVDVTGPDGAAV
QGGRGGGGGGGGRGGGGYGGGSGGYGGGGRGGSRGYGGGDGGYGGGGGYGGGSRYGGGGGGYGGGGGYGGGGSGGGSGCF
KCGESGHFARDCSQSGGGGGGGRFGGGGGGGGGGGCYKCGEDGHFARECTSGGR
>P29174|IPR011129(1...54)|Cold shock domain-containing protein E1
FGFINYEVGDSKKLFFHVKEVQDGIELQAGDEVEFSVILNQRTGKCSACNVWRVCEGPKAVAAPRPDRLVNRLKNITLDD
ASAPRLMVLRQPRGPDNSMGFGAERKIRQAGVID
>P30850|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>P30851|IPR011129(86...145)|Ribonuclease R
MSQDPFQEREAEKYANPIPSREFILEHLTKREKPASRDELAVELHIEGEEQLEGLRRRLRAMERDGQLVFTRRQCYALPE
RLDLVKGTVIGHRDGYGFLRVEGRKDDLYLSSEQMKTCIHGDQVLAQPLGADRKGRREARIVRVLVPKTSQIVGRYFTEA
GVGFVVPDDSRLSFDILIPPDQIMGARMGFVVVVELTQRPTRRTKAVGKIVEVLGDNMGTGMAVDIALRTHEIPYIWPQA
VEQQVAGLKEEVPEEAKAGRVDLRDLPLVTIDGEDARDFDDAVYCEKKRGGGWRLWVAIADVSYYVRPPTPLDREARNRG
TSVYFPSQVIPMLPEVLSNGLCSLNPQVDRLCMVCEMTVSSKGRLTGYKFYEAVMSSHARLTYTKVWHILQGDQDLREQY
APLVKHLEELHNLYKVLDKAREERGGISFESEEAKFIFNAERRIERIEQTQRNDAHKLIEECMILANISAARFVEKAKEP
ALFRIHDKPSTEAITSFRSVLAELGLELPGGNKPEPRDYAELLESVADRPDAEMLQTMLLRSMKQAIYDPENRGHFGLAL
QSYAHFTSPIRRYPDLTLHRAIKYLLAKEQGHQGNTTETGGYHYSMEEMLQLGQHCSMAERRADEATRDVADWLKCDFML
DQVGNVFKGVISSVTGFGFFVRLDDLFIDGLVHVSSLDNDYYRFDQVGQRLMGESSGQTYRLGDRVEVRVEAVNMDERKI
DFSLISSERAPRNVGKTAREKAKKGDAGKKGGKRCQVGKKVNFEPDSAFRGEKKTKPKAAKKDARKAKKPSAKTQKIAAA
TKAKRAAKKKVAE
>P32081|IPR011129(3...66)|Cold shock protein CspB
MLEGKVKWFNSEKGFGFIEVEGQDDVFVHFSAIQGEGFKTLEEGQAVSFEIVEGNRGPQAANVTKEA
>P33561|IPR011129(150...216)|Transcription termination factor Rho
MDKKNGGFDLESEIRRLDVSKEFKIEDNLKKKVVKVVAKKDSASSVTKSADLSGVKDSNGVIFSDFDYDIPSSGLENNIK
TLEQSNIIKFFNGKDYVEIEKLYDKPITEVRKIVEGLGTNHTIAVTMKKTELIFLLVKILSENNIDVLFTGVLDVLSDGY
GFLRTASNSYLSGGNDVYVSPSQIRLFNLRTGDILYGQIRSPRDGERFFAMVKIKSINDQDPTFAQNRIPFDNLTPLYPN
VKLNLEYENCNISTRLINLFSPIGKGQRALIVSPPKAGKTTLLQKIANAITTNYSDVILMILLIDERPEEVTDMIRSVKG
EVIASNFDEQASRHVQVAEMVIEKAKRLVENKKDVVILLDSITRLARAYNQTMPTSGKILSGGVDSNALHKPKRFFGSAR
NIEEGGSLTIIATALVDTGSKMDEVIFEEFKSTGNMELILDRSLADRRLFPAINIKKSGTRKEELLLSEEERSKILLIRR
ILGGVDDYEGVEVLIEKMKKSKNNEIFLKTMSNGN
>P36995|IPR011129(6...70)|Cold shock-like protein CspB
MSNKMTGLVKWFNADKGFGFISPVDGSKDVFVHFSAIQNDNYRTLFEGQKVTFSIESGAKGPAAANVIITD
>P38527|IPR011129(59...125)|Transcription termination factor Rho
MSEEQKTISISELESMNIKQLYEIAKSLGIPRYTSMRKRDLIFAILKAQTESTGYFFGEGVLEIHPEGFGFLRRIEDNLL
PSNDDIYISPSQIRKFNLNTGDIISGVIRKPKEGEKYFAMIKIEAINYRPVEAVNDRVNFDNLTPDYPRERFILETDPKI
YSTRLIDLFAPIGKGQRGMIVAPPKAGKTTILKEIANGIAENHPDTIRIILLIDERPEEVTDIRESTNAIVIAAPFDMPP
DKQVKVAELTLEMAKRLVEFNYDVVILLDSLTRLARVYNIVVPPSGKLLTGGVDPAALYKPKRFFGAARNTREGGSLTII
ATALVETGSKMDEVIFEEFKGTGNMELVLSRQLANKRIFPAINLLLSGTRREELLLDEETLKKVWLLRRMLSAMTEEEGL
TLILNKLSETSSNEEFLKLIDKEKARY
>P39158|IPR011129(3...66)|Cold shock protein CspC
MEQGTVKWFNAEKGFGFIERENGDDVFVHFSAIQSDGFKSLDEGQKVSFDVEQGARGAQAANVQKA
>P40611|IPR011129(90...152)|Ribonuclease R
MSDNIPNDPFADRESQNYENPIPSREFILEFLEQAGVPMNRNDLFEALKLAGEEQYEGLRRRLRAMERDGQLVFTRRQCY
ALPEKLEMVKGYVIGHKDGHGWVRPEGSVGKDDDILLPHHQMKNIIHGDFVLVQPTDNSKRGRREGRLVRVLEERNSQIV
GRFFLEYGYSYVVPDDSRISQDILIPNEHKAGARMGNVVVIEITDRGSRSRGMMGKVVEVLGENMAPGMETQIAIRTHQI
PYEWPEAVEKQIVNLGEEVPEEAKVGRVDLRELPLVTIDGEDARDFDDAVFCEKKKDGGWRLWVAIADVSYYVRPDSALD
KEAINRGNSVYFPSQVVPMLPEVLSNGLCSLNPQVDRLCMVCEMTISESGKLSSYKHYEAVMNSHARLTYSKVSAILEGD
EELRERYQPLVSHLEELHAMYKVLKEARDQRGAIEFETVETKFIFNAERKIESIEPVIRNDAHKIIEECMILANIASASL
VEKAKEPALYRIHESPGELRLQGFRDFLSELGLELKGGLEPSPTDYADLARQIAGRQDQELIQTMLLRSMKQAVYNADNA
GHFGLALKRYAHFTSPIRRYPDLLLHRAIKYLIAKEEGRNQDRWTPTGGYHYSFDDMDFYGEQCSMTERRADDATREVAD
WLKCEYMQDHVGDELEGVIANVTSFGFFVRLTDLHIDGLVHISTLANDYYQFDPIGQRLIGESFGNIYRLGDAVKVKVLA
VNLDDKQIDFELVETSRKLRGEGKTAKKRAAEAKRKAKEKKRAATRSSSKESATARAVPAIEPTKRPEQTDSGRKRKGPK
RGDDDSAKKPKVKKAHKKKPHSKPKKTKRTKQDAQ
>P41016|IPR011129(3...66)|Cold shock protein CspB
MQRGKVKWFNNEKGYGFIEVEGGSDVFVHFTAIQGEGFKTLEEGQEVSFEIVQGNRGPQAANVVKL
>P41018|IPR011129(1...57)|Cold shock protein CspB
IKWFNSEKGFGFIEVEGQDDVFVHFSAIQGEGFKCLEEGQAVSFEIVEGNRGPQAAN
>P41824|IPR011129(34...102)|Y-box factor homolog
MADTEKQPEVEENQPDQEQNEEQKEKKIIASQVSGTVKWFNVKSGYGFINRDDTKEDVFVHQTAIVKNNPRKYLRSVGDG
EKVEFDVVEGEKGNEAANVTGPEGSNVQGSKYAADRRRFRRGGWYPRFRGGGRGGRPRQDMDDGAPDFMPSPRGRGRGRP
YYQNRRYFGPPRRGGGRQYLEGEGEYQLQRDQGFRGARRPFYRPLLRTTSQGLLRRWLLRLPRRTTQGRTSQARRRERPW
GLPQRQRPKPRQR
>P42016|IPR011129(3...66)|Cold shock protein CspB
MQRGKVKWFNNEKGYGFIEVEGGSDVFVHFTAIQGEGFKSLEEGQEVSFEIVQGNRGPQAANVVKL
>P44440|IPR011129(23...78)|Exoribonuclease 2
MFQDNPLLAQLKQQIHDSKEQVEGVVKSTDKAYGFLECDKKTYFIAPPSMKKVMHGDKIKATIEKQGDKEQAEPEALIEP
MLTRFIAKVRFNKDKKLQVLVDHPSINQPIGAQQAKSVKEELQEGDWVVANLKTHPLRDDRFFYATINQLICRADDELAP
WWVTLARHEQSRYPVRGAEPYEMLDQKTRENLTALHFVTIDSESTMDMDDALYIEPIAQNSTQTGWKLVVAIADPTAYIA
LDSQIEQEAKQRCFTNYLPGFNIPMLPRELSDELCSLIANETRPALVCYIETDLTGNITAKPHFVSAYVQSKAKLAYNKV
SDYLEQADNAWQPEMPETAQQIHWLHQFTKARIQWRKTHSLFFKEKPDYAFVLAENGKVQEIKAEYRRIANQIVEEAMII
ANICAAQFLHEQAKTGIFNTHSGFDKKFLENAHNFLMANLANEQNQTELAERYSVENLATLNGYCQMRHDIEPIESDYLE
LRLRRYLTFAEFKSELAPHFGLGLEGYATWTSPIRKYSDMVNHRLIKAVLAKQPYEKPQNDVLARLQEARRQNRLVERDI
ADWLYCRYLADKVASNAEFEAEVQDVMRAGLRVQLLENGASLFIPAATLHNNKEEIQLNPDELALYIKGERTYKIGDMVK
VKLTEVKEATRSIVGEILQ
>P44619|IPR011129(53...119)|Transcription termination factor Rho
MHLTELKNTPVSDLVKLGEEQMGLENLARLRKQDIVFAILKQHAKSGEDIFGGGVLEILPDGFGFLRSADSSYLAGPDDI
YVSPSQIRRFNLQTGDKIEGKIRPPKEGERYFALLKVDQVNDDKPEVSRSKILFENLTPLHANSRLRMERGNGSTEDLTA
RILDLASPIGKGQRGLIVAPPKAGKTMLLQNIAQSITHNYPDVELIVLLIDERPEEVTEMQRSVKGEVIASTFDEPATRH
VQVAEMVIEKAKRSVEHKKDVVILLDSITRLARAYNTVTPASGKILSGGVDANALHRPKRFFGAARNVEEGGSLTIIATA
LVDTGSKMDEVIFEEFKGTGNMELHLSRKIAERRVFPAIDFKRSGTRKEDLLTTADELQKMWILRKILNPMDEVDAMEFL
IDKLMMAKTNEEFFEVMKRS
>P44907|IPR011129(94...153)|Ribonuclease R
MTKKRKNLINQDPHYKRELEKYGNPIPSREFILTVIRDNNAPMNRDEILTALSIRNEDQIEAMRRRLRAMENDGQLVFTK
RKRYALPEKLDLFKGTVIGHREGFGFLQVDGKKDDLFIPNHQMQRVMHGDFVLAQPAGLDRRGRREVRIVRVLESRKKQI
VGRFFLENGFGYVVPDDSRIGRDILVPNEHRNGARMGQVVVVELQERSASFNQPIGVITEILGDNMAKGMEVEIALRNHD
ILHKFPSAVEKYVKKFTEEVSEEAKKGRVDLRNLPLVTIDGEDARDFDDAVYCEKHGKGWKLWVAIADVSYYVRLRSTLD
VEAHNRGNSVYFPNRVVPMLPEILSNGLCSLNPQVDRLCMVCEMQISAKGKLTDYRFYEAVMNSHARLTYTKVAKMLEGD
EELRTRYSTLVPHLEELYKLYQALLSARHQRGAIDFETIETKFIFNAMGRIERIEPVVRNDAXKIIEECMXLANIAAANF
MEKHKEPALYRIHATPSEEKLTSFRTFLSEFGLTLEGGLKPTTKDYAALLEKVKERPDHELIQTMLLRSLSQAVYHADNI
GHFGLALEEYAHFTSPIRRYPDLTLHRGIKYLLAKEQGAKRKTTDTGGYHYSFDEMDLLGNHCSMTERRADDATREVADW
LKCEYMQDHVGGEFSGVISSVTGFGLFVRLDDLFIDGLVHISTLENDYYQFDAAKQRLIGENSGMQYRLGDKVRIKVEAV
HLENKMVDFSLIGSERKPRRAGKTAKEKAKKVFKELPSKASKKRKSAVKKKDVSKKTSRKRK
>P45441|IPR011129(43...111)|Y-box-binding protein 2-B
MSEAEPRETEAVTQPEPAPEIHKPDIVPPRNQINKKLLATQVQGTVKWFNVRNGYGFINRNDSKEDVFVHQTAIKKNNPR
KFLRSVGDGETVEFDVVEGEKGAEAANVTGPGGVPVKGSRFAPNRRRFRRQFYRPRADTAGESGGEGVSPEQMSEGEKGE
ETSPQQRPQRRRPPPFFYRRRFRRGPRPNNQQNQGAEVTDQSENKDPAAPTSEALASGDGQQRPPPRRFQQRFRRPFRPR
PPPPQTPEGGDGEAKAEGEPQRQRNRPYVQRRRRQQPPTVQGESKAEPSEHPASEEGTPSDAPTDDGAPVETSEAGVEDT
TAPE
>P45835|IPR011129(235...296)|Transcription termination factor Rho
MTETDLITVGENTDDTELTNAVTTDTPDVKATAATVSLGSLSTMVLPELRALANQAGVKGTSGMRKSELIAAIEECRGQA
NGTSVNDGPSRDHGGSATAISTEALAAQEEQNYAIVEVSRRERRGASREADVTAGTSTAEATESDCQGTADDDTRTLQGG
QSDTKTEERGPDVGNDQGVEQQSSSLQPRGDDDGEGRQGRRGRRFRDRDRRRRGERSGDGAEAELRQDDVVQPVAGILDV
LDNYAFVRTSGYLAGPHDVYVSMSMVRKNGLRRGDAVTGAVRVPREGEQGHQRQKFNPLVRLDSINGGSVEDAKKRPEFG
KLTPLYPNQRLRLETTPDRLTTRVIDLIMPIGKGQRALIVSPPKAGKTTILQDIANAITRNNLECHLMVVLVDERPEEVT
DMQRSVKGEVIASTFDRPPSDHTSVAELAIERAKRLVEQGKDVVVLLDSITRLGRAYNNASPASGRILSGGVDSTALYPP
KRFLGAARNIEEGGSLTIIATAMVETGSTGDMVIFEEFKGTGNAELKLDRKIAERRVFPAVDVNPSGTRKDELLLSPDEF
GIVHKLRRVLSGLDSHQAIDLLMSQLRKTKTNYEFLVQVSKTTPGSMDDD
>P46449|IPR011129(3...67)|Cold shock-like protein CspD
MEIGIVKWFNNAKGFGFISAEGVDADIFAHYSVIEMDGYRSLKAGQKVQFEVLHSDKGSHATKIIPIADTQE
>P47350|IPR011129(83...144)|Ribonuclease R
MKVLTELQKQIFTIVKKENGKPIPPGIVVRMMENSPNFPGKHLIYRAIDDLLDWAILRKAGGVTNQLLVNYEPAEPLLDK
KLQGILTLGNKNSGFIRSLDDDKTVYYVHYSNLTGALDGDLVEFCKLDKPQFGDKFDAAVITILKRARILYAGNFLVDQN
EFALEYKIVADNPRFYLTMIVNPDSIPNNLASNTKIAFQIDEYDPDNNLCKVSVQQVLGNNDDPLINIKAIMLDNSIVFE
TNDVVEQHANKLSFDTEEQHKAYRQDLTDLAFVTVDPTTSKDLDDAIYVKTIPTGFVLYVAIADVAHYVNRNSEIDIEAK
HKTSSIYLPGHYVVPMLPEQLSNQLCSLNPAQKRYVVVCEISFDNQGRIKTNKLYPATIISKNRFSYDQVNKWLNNKSEL
NCDETVINSLKAAFTLSDLIQAQRQKRGTIDLSHKETEIVVDEHYFPIKINFLVHDKAETMIENLMVVANETVAWVLTNN
KIALPYRVHPRPSKKKLQSLIETVGELNITKPQFNLDTVTSSQIASWLNENKDNPSYEIFVILLLRTLGKAFYSVNPLMH
FSIGSNHYTHFTSPIRRYIDLTIHRLLWMHLFTPDQFTDNERDQLKQELEKIADTVNDTEIKIINCERNANDYLTTLLLS
KQIGKTFSGFISAITSFGIFMRMDENNFDGLIKITTIPDDFFIFEKEKMVLKGRKTNKVYKIGDRLEAKLSEIDFIQKRA
ILTLI
>P48859|IPR011129(3...67)|Cold shock protein ScoF
MASGTVKWFNSEKGFGFIAQDGGGPDVFAHYSNINAQGYRELQEGQAVTFDITQGQKGPQAENITPA
>P51777|IPR011129(3...66)|Cold shock protein CspD
MQNGKVKWFNNEKGFGFIEVEGGDDVFVHFTAIEGDGYKSLEEGQEVSFEIVEGNRGPQASNVVKL
>P52152|IPR011129(52...118)|Transcription termination factor Rho
MNLTELKKMPVPNLVALAQSMDIEGVGRSRKQDLIFAILKAQAKKGEDIYGDGVLEILSDGFGFLRSADASYLAGPDDIY
VSPSQIRRFALRTGDTISGKIRPPKDGERYFALLKVNDINFDRPENAKSKILFENFTPLFAQKRLTLEIGNGSTEDITAR
TIDLVAPIGKGQRGLIVSPPKAGKTMMLQNIAQSIGHNHPDCYLIVLLIDERPEEVTEMARSVRGEVISSTFDEPATRHV
QVAEMVIEKAKRLVEHKRDVVILLDSITRLARAYNTVVPSSGKVLTGGVDANALQRPKRFFGAARNVEEGGSLTILATAL
VDTGSRMDDVIYEEFKGTGNMEIHMDRRIAEKRIFPAININRSGTRREELLMGQAELQKMWILRKILHPMDELAAMEFLH
DKLKATKTNDEFFSSMKG
>P52153|IPR011129(62...126)|Transcription termination factor Rho
MTVTEVAPQALPFQELQEKILPELHLLAAGLGIENYRKLKKDALALAIMEKQADAEGQSLARGYLDITSDGYGFLQADLL
DPASRSVLVTAGVIKQYHLRTGDEVIGRARKPRENERYGSLVRVEAVNGLDPEAARQRPRFDDLTPTFPDQQLVLEDPST
DDGLSLRVVDLLVPIGRGQRALIVAPPKAGKTTLLKKIANSITKNYPDVTVMVLLVDERPEEVTDFRESVQGAQVIASTF
DEPPQHHVRVAEFVHERARRIVEEGGHVVILLDSITRLARANNLVTPPTGRTLSGGLDSNALHWPKRFLGAARNIREGGS
LTILATALVETGSRMDDVIFEEFKGTGNAELVLSRRLEERRIFPALDILKSGTRREELLLQPEVLKKMWLLRKVISDMDP
ADAMEMLLGRMGKTRNNVEFLAALAG
>P52154|IPR011129(311...377)|Transcription termination factor Rho
MTESTEQTTPTNGGGLASLKLAQLQALASQLGIAGGSRMRKADLVTAISDHQRGGSVADRDAAERAAQAPAAPAAETAPA
AASSEDAAPAAERPARRRSRRADADTSAPAAAQDGQPQAEAREAQTEQAPRETASDQDRSGGSEARDEGEDRPQSERRSR
GRRRAGDDDAQQGQDRRSDGAQGEDGADADRRGDREDRDDNGRENGRGRNGRNGRDRDNGRDRENGRENSRDRENGRDGS
REQRGDKSEDGGRGDGGRGDRSRRDDRDDEGGRNRRNRRNRNERGRNRRGRGGPEVDETELTEDDVLQPVAGILDVLDNY
AFVRTSGYLPGPNDVYVSLAMVKKYGLRKGDAVVGPIAPRDGEKQQHHGGGSNRQKFNALVKISSVNGQPAVEHPQRVEF
GKLVPLYPQERLRLETDPKLIGPRVIDLVSPIGKGQRGLIVSPPKAGKTMILQSIANAIKTNNPEVHLMMVLVDERPEEV
TDMQRSVDGEVIASTFDRPADDHTTLAELAIERAKRLVEMGRDVVVLLDSMTRLGRAYNLAAPASGRILSGGVDSSALYP
PKKFFGAARNIENGGSLTILATALVETGSRMDEVIFEEFKGTGNMELRLSRHLAERRIFPAVDVNASGTRREEALLSQEE
VKIMWKLRRVLSGLEQQQALDLLTNKIKDTASNAEFLMLVSKTTLGSKGDD
>P52155|IPR011129(52...118)|Transcription termination factor Rho
MNLTELKQKPITDLLQLAEEMGIENMARSRKQDVIFSLLKKHAKSGEEISGDGVLEILQDGFGFLRSADASYLAGPDDIY
VSPSQIRRFNLRTGDTIVGKIRPPKEGERYFALLKVDTINFDRPENAKNKILFENLTPLFPTVRMKMEAGNGSTEDLTGR
VIDLCAPIGKGQRGLIVAPPKAGKTIMLQNIAANIARNNPEVHLIVLLIDERPEEVTEMQRTVRGEVVASTFDEPPTRHV
QVAEMVIEKAKRLVEHKKDVVILLDSITRLARAYNTVIPSSGKVLTGGVDAHALEKPKRFFGAARNIEEGGSLTIIATAL
VETGSKMDEVIYEEFKGTGNMELPLDRRIAEKRVFPAININRSGTRREELLTADDELQRMWILRKLLHPMDEVAAIEFLI
DKLKTTKTNDEFFLSMKRK
>P52156|IPR011129(56...122)|Transcription termination factor Rho
MNERLNLADLKAKTPADLLAMAEEWEIENAPSMRKGEMMFSILKEHAEEGYEVGGDGVLEVLQDGFGFLRSPEANYLPGP
DDIYVSPEILRQFSLRTGDTIEGVIVAPRENERYFSLTRVTKINFDDPERARHKVHFDNLTPLYPDERLKMEVDDPTMKD
RSARIIDLVAPIGKGQRGLIVAPPRTGKTVLLQNIAHSIATNHPECYLIVLLIDERPEEVTDMQRSVKGEVVSSTFDEPA
TRHVAVAEMVIEKAKRLVEHKRDVVILLDSITRLGRAFNTVVPSSGKVLTGGVDANALQRPKRFFGAARNIEEGGSLTII
ATALIDTGSRMDEVIFEEFKGTGNSEIVLDRKVADKRVFPAMDILKSGTRKEDLLVDKSDLQKTYVLRRILNPMGTTDAI
EFLISKLRQTKSNAEFFDSMNT
>P52157|IPR011129(335...401)|Transcription termination factor Rho
MSDTTDLMGARVEETAAAPATDASAPATGAGSRRRRGTGLEGMVLAELQQVASGLGIRGTARMRKSQLIEVIKEAQAAGG
APAKAAPAAADTAGETKPKRRSTSRTRTGDEAPAEKAEKAGKADKKADKAAADKAAAQQQIEIPGQPTPKVNASAEQAAP
ADDAPSERRRRRATSDAGSPSATDTTVAVETRAEPKADTSAPQQSQGHQQGQGDARSDAEGGDGRRRDRRDRGDRDRGDR
GDRGDRGDRGDRGERGRDRRNKGDDQQNQGGGRQDRQQQGGGGRQDRQQHDDGYDDDGSGRRGRRGRYRDRRGRRGRDEI
QEPQINEDDVLIPVAGILDILDNYAFIRTSGYLPGPNDVYVSLAQVRKNGLRKGDHLTGAVRQPKEGERREKFNALVRLD
SVNGMAPEHGRGRPEFNKLTPLYPQDRLRLETDPGVLTTRIIDLVAPIGKGQRGLIVAPPKTGKTMIMQAIANAITHNNP
ECHLMVVLVDERPEEVTDMQRSVKGEVISSTFDRPAEDHTTVAELAIERAKRLVELGHDVVVLLDSITRLGRAYNLAAPA
SGRILSGGVDSTALYPPKRFFGAARNIEDGGSLTILATALVDTGSRMDEVIFEEFKGTGNAELKLDRKLADKRIFPAVDV
DASGTRKEEILLGSDELAITWKLRRVLHALDQQQAIELLLDKMKQTKSNAEFLIQIQKTTPTPGNGD
>P54084|IPR011129(95...154)|Ribonuclease R
MPETQEPASLNERDPMFEREKEKYERPIVSREYILSYLEGTGRPLTLEDIIAELEVAEDDQEALRRRLRAMERDGQLVRN
RRGAYGIVAAMELVRGTVSAHPDGFGFLIPEAGGKDLFLSPREMRKVFHGDTILGRAVGEDRRGRIEGAVVRILERALKH
IVGRYYADNGVHYVVPEDRRIPQEFAVVEGEGEGLTPVHGQIVILEITQYPDGRNMPQGHVVEILGEHMAPGMEVEIAVR
NYGLPHQWPDEVLAEIKQFSETVPETMKAGRRDLRDLPLVTIDGADAKDFDDAVYAEVIENGFRLTVAIADVATYVCPDS
ALDREAVTRGNSVYFPRRVIPMLPEILSNGLCSLNPHVDRLCMFCEMEMDAAGRSTGFRFDRGIIGSQRRFTYDEVAAIL
AGDAELRAQDAAMVPHLEALHSLYESFAKARERRGTIEF
>P54584|IPR011129(3...67)|Cold shock protein
MAQGTVKWFNAEKGFGFITPDDSDGDVFVHYSEIQTGGFKTLDENARVQFEIGQGAKGPQATGVTLV
>P55390|IPR011129(4...69)|Probable cold shock protein y4cH
MMATGTVKWFNATKGFGFIQPDDGSADVFVHISAVERAGLRELKDGQKISYELVKDRKSGKMSADNLQA
>P56466|IPR011129(74...140)|Transcription termination factor Rho
MNENAPTHKSSHKVKTHTPVSGYHIEDLRTYPTEKLLEIANKLKVENPQEFKRQDLMFEILKTQVTQGGYILFTGILEIM
PDGYGFLRGFDGSFSDGHNDTYVSPSQIRRFALRNGDIVTGQVRSPKDQEKYYALLKIEAINYSPSDEIRNRPLFDNLTP
LFPDEQIKLEYEPTKVTGRMLDLFSPVGKGQRALIVAPPRTGKTELMKELAQGITSNHPEVELIILLVDERPEEVTDMQR
SVKGQVFSSTFDLPANNHIRIAELVLERAKRRVEMGKDVVVLLDSITRLARAYNAVTPSSGKVLSGGVDANALHRPKRFF
GAARNIEEGGSLTIIATALIETGSRMDEVIFEEFKGTGNSEIVLARNIADRRIYPAFDILKSGTRKDNILLGKDRLTKVW
VLRNVMQQMDDIEALSFVYSKMQQTKDNEEFLNLMNEK
>P57354|IPR011129(23...79)|Exoribonuclease 2
MFQNNPLLTQLKKNLHAKSPRVEGIVKSTERGFGFLEVDPQKSYFIPPKNMKNVMHGDKIIALLTTEKDREIVEPEKLIE
PFLNRFVGKIEKKDNRLFIVPDYPFLKDLITCQPNKNCINIFQNGDWAVAQLKKHKLKGDHLFYAELTEKITQEDDPLIP
WWVTLARHDLDRKEPLAEDDDLILKESDNRKDLTDLDFITIDNTNTKDIDDALFVSEKNNGDISLIVAIADPTAYIKHGS
KLDVIASKRIFTNYLPGFNIPMLPRNLSEDICSLNPNKRRPVLACHITVLKNGNISNKIEFFLAWIKSKSKLSYDHVSDW
IEKIGSWIPPTKSIANQILILHRLCLLRIKWRKKNAVLFKDSIEYRFHVSEHGKIIDVLIEKRRIAHKIIEESMIVANIS
AANFLSKNIGFGIYNVHSGFDLVNAENAVSFLRSYNLNFTVKEITTLKGFCNLRRVLNIISNNYIDSRIRRFQSFGDFST
IPGPHFALGFSEYATWTSPIRKYSDMINHRLLKSIIKKEKSIKPGEDIKIKISEQRRRNRMAERDVLDWLYTIFLQKKKY
QNQKFNAEITDISRSGIRARLIENGANVFIPGTLIHPIREELNFNQESGKVFINGIMHYKISDLIQVTLSDIRLKTRSII
AKPVFEKFK
>P57407|IPR011129(5...69)|Cold shock-like protein CspC
MAKIKGQVKWFNESKGFGFITPSDGSKDVFVHFSSIQGNGFKTLTEGQNVEFEIQDGQKGPAAVNVFSL
>P57628|IPR011129(86...145)|Ribonuclease R
MVVDPYQKREAKRYKNPIPSREYISSCLRTSQDLISQKNLEKKFGINNQESKKALRRRLRAMERDGQVIYTSNRCYVAPE
SLKIVKGKVIGHRDGYGFLRTETLKEDLWLSSEQMKSCIHGDIILAHIVETHGKRRSSARFLKLLQPNNILIVGRYYIDD
KIKFVIPDDTRFNFKIFIFSAIKDDISIGSIVSVKLKQHPIRNSRVQGFIVEILGKEMGTNLAIEIALRTHLIPSLWSKE
VKKQVYEISRKINQYDFKNRTDLRHFPFFTIDDEDARDFDDAVFCKRKANPEEGWILWVAIADVSCYVQPNTPLDKAALE
RGTSVYFPSLVIPMLPEKISTDLCSLKPNVERLCLICEMSLSKQGELISYKHYEGIICSHGRFTYNEIFKIWNGDIFLRS
KYKKFLKDIENLSCLQNIFNKDNISKKGIYFENIEPKFVLDSNLRIKSIYQNIRNDAHKFIESCMILANVASARFVEKYK
YPVLFRNHDRPKKDNVVSLRLFLNELGFTLLGGDSPESVHYSNLLKNVSDRPEYEMIQTVLLRSMTQAVYSPDNRGHFGL
SLSSYVHFTSPIRRYPDLILHRVIKYLLFKDKNTSKSNYNFYSAHLYSTGEIKKIGAHCSITERRADEANRDVIDWLKCD
FMYKKIGCILNGVISNVTTFGFFVRLNQFFIDGLVHINSLNDDYYYFDSLGLKLIGKSTKNTYCLGDALKVKVISVNLNE
KKIELSLYKSS
>P57652|IPR011129(52...118)|Transcription termination factor Rho
MNLTALKNMPVSELITLGEKMGLENLARMRKQDIIFAILKQHAKSGEDIFGDGVLEILQDGFGFLRSADSSYLAGPDDIY
VSPSQIRRFNLRTGDTIAGKIRPPKEGERYFALLKVNEVNYDKPENARSKILFENLTPLHANSRLRMERGNGSTEDLTAR
VLDLASPIGRGQRGLIVAPPKAGKTILLQNIAQSIAYNHPDCVLMVLLIDERPEEVTEMQRLVKGEVVASTFDEPASRHV
QVAEMVIEKAKRLVEHKKDVIILLDSITRLARAYNTVVPASGKVLTGGVDANALHRPKRFFGAARNVEEGGSLTIIATAL
VDTGSKMDEVIYEEFKGTGNMELPLSRKIAEKRVFPAIDYNRSGTRKEELLTLPDELQKMWILRKIIHPMSEIDAMEFLL
NKLAMTKTNDEFFDMMKRS
>P58726|IPR011129(6...70)|Cold shock-like protein CspJ
MTTKITGLVKWFNPEKGFGFITPKDGSKDVFVHFSAIQSNEFRTLNENQEVEFSAEQGPKGPSAVNVVAL
>P59107|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLTIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTSLDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWKPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISSE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
GTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>P62169|IPR011129(2...65)|Cold shock-like protein CspC
MQGRVKWFNAEKGFGFIEREDGDDVFVHFSAIQQDGYKSLEEGQQVEFDIVDGARGPQAANVVKL
>P62170|IPR011129(2...65)|Cold shock-like protein CspC
MQGRVKWFNAEKGFGFIEREDGDDVFVHFSAIQQDGYKSLEEGQQVEFDIVDGARGPQAANVVKL
>P62171|IPR011129(2...65)|Cold shock-like protein CspC
MQGRVKWFNAEKGFGFIEREDGDDVFVHFSAIQQDGYKSLEEGQQVEFDIVDGARGPQAANVVKL
>P62960|IPR011129(58...126)|Y-box-binding protein 1
MSSEAETQQPPAAPAAALSAADTKPGSTGSGAGSGGPGGLTSAAPAGGDKKVIATKVLGTVKWFNVRNGYGFINRNDTKE
DVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGEKGAEAANVTGPGGVPVQGSKYAADRNHYRRYPRRRGPPRNYQQNY
QNSESGEKNEGSESAPEGQAQQRRPYRRRRFPPYYMRRPYARRPQYSNPPVQGEVMEGADNQGAGEQGRPVRQNMYRGYR
PRFRRGPPRQRQPREDGNEEDKENQGDETQGQQPPQRRYRRNFNYRRRRPENPKPQDGKETKAADPPAENSSAPEAEQGG
AE
>P62961|IPR011129(58...126)|Y-box-binding protein 1
MSSEAETQQPPAAPAAALSAADTKPGSTGSGAGSGGPGGLTSAAPAGGDKKVIATKVLGTVKWFNVRNGYGFINRNDTKE
DVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGEKGAEAANVTGPGGVPVQGSKYAADRNHYRRYPRRRGPPRNYQQNY
QNSESGEKNEGSESAPEGQAQQRRPYRRRRFPPYYMRRPYARRPQYSNPPVQGEVMEGADNQGAGEQGRPVRQNMYRGYR
PRFRRGPPRQRQPREDGNEEDKENQGDETQGQQPPQRRYRRNFNYRRRRPENPKPQDGKETKAADPPAENSSAPEAEQGG
AE
>P63237|IPR011129(5...69)|Cold shock-like protein CspE
MSKIKGNVKWFNESKGFGFITPEDGSKDVFVHFSAIQSNGFKTLAEGQSVEFEITEGAKGPSAANVISL
>P63238|IPR011129(5...69)|Cold shock-like protein CspE
MSKIKGNVKWFNESKGFGFITPEDGSKDVFVHFSAIQSNGFKTLAEGQSVEFEITEGAKGPSAANVISL
>P63849|IPR011129(3...67)|Probable cold shock protein A
MPQGTVKWFNAEKGFGFIAPEDGSADVFVHYTEIQGTGFRTLEENQKVEFEIGHSPKGPQATGVRSL
>P66029|IPR011129(227...288)|Transcription termination factor Rho
MTDTDLITAGESTDGKPSDAAATDPPDLNADEPAGSLATMVLPELRALANRAGVKGTSGMRKNELIAAIEEIRRQANGAP
AVDRSAQEHDKGDRPPSSEAPATQGEQTPTEQIDSQSQQVRPERRSATREAGPSGSGERAGTAADDTDNRQGGQQDAKTE
ERGTDAGGDQGGDQQASGGQQARGDEDGEARQGRRGRRFRDRRRRGERSGDGAEAELREDDVVQPVAGILDVLDNYAFVR
TSGYLPGPHDVYVSMNMVRKNGMRRGDAVTGAVRVPKEGEQPNQRQKFNPLVRLDSINGGSVEDAKKRPEFGKLTPLYPN
QRLRLETSTERLTTRVIDLIMPIGKGQRALIVSPPKAGKTTILQDIANAITRNNPECHLMVVLVDERPEEVTDMQRSVKG
EVIASTFDRPPSDHTSVAELAIERAKRLVEQGKDVVVLLDSITRLGRAYNNASPASGRILSGGVDSTALYPPKRFLGAAR
NIEEGGSLTIIATAMVETGSTGDTVIFEEFKGTGNAELKLDRKIAERRVFPAVDVNPSGTRKDELLLSPDEFAIVHKLRR
VLSGLDSHQAIDLLMSQLRKTKNNYEFLVQVSKTTPGSMDSD
>P67808|IPR011129(60...128)|Y-box-binding protein 1
MSSEAETQQPPAAPPAAPALSAADTKPGTTGSGAGSGGPGGLTSAAPAGGDKKVIATKVLGTVKWFNVRNGYGFINRNDT
KEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGEKGAEAANVTGPGGVPVQGSKYAADRNHYRRYPRRRGPPRNYQQ
NYQNSESGEKNEGSESAPEGQAQQRRPYRRRRFPPYYMRRPYGRRPQYSNPPVQGEVMEGADNQGAGEQGRPVRQNMYRG
YRPRFRRGPPRQRQPREDGNEEDKENQGDETQGQQPPQRRYRRNFNYRRRRPENPKPQDGKETKAADPPAENSSAPEAEQ
GGAE
>P67809|IPR011129(60...128)|Y-box-binding protein 1
MSSEAETQQPPAAPPAAPALSAADTKPGTTGSGAGSGGPGGLTSAAPAGGDKKVIATKVLGTVKWFNVRNGYGFINRNDT
KEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGEKGAEAANVTGPGGVPVQGSKYAADRNHYRRYPRRRGPPRNYQQ
NYQNSESGEKNEGSESAPEGQAQQRRPYRRRRFPPYYMRRPYGRRPQYSNPPVQGEVMEGADNQGAGEQGRPVRQNMYRG
YRPRFRRGPPRQRQPREDGNEEDKENQGDETQGQQPPQRRYRRNFNYRRRRPENPKPQDGKETKAADPPAENSSAPEAEQ
GGAE
>P71478|IPR011129(3...66)|Cold shock protein 1
MKNGTVKWFNADKGYGFITGEDGNDVFVHFSAIQTDGFKTLEEGQKVTFDEESSDRGPQAANVVPQ
>P72188|IPR011129(6...64)|Cold shock protein CapA
MSQRQSGTVKWFNDEKGFGFITPQGGGDDLFVHFKAIESDGFKSLKEGQTVSFVAEKGQKGMQA
>P72191|IPR011129(1...58)|Temperature acclimation protein A
FNDEKGFGFITPESGPDLFVHFRAIQGNGFKSLKEGQKVTFIAVQGQKGMQADKVQAEA
>P72192|IPR011129(6...63)|Temperature acclimation protein B
MSQRQSGTVKWFNDEKGFGFITPESGPDLFVHFRAIQGNGFKSLKEGQKVTFIAVQGQKGMQA
>P72366|IPR011129(3...67)|Cold shock-like protein CspA
MATGTVKWFNDAKGFGFITQDGGGEDVFCHHSAINMDGFRTLQEGQKVEFEVTRGPKGLQAQNVRSIP
>P75529|IPR011129(83...144)|Ribonuclease R
MKVLTDLQKRIFAIVKKENGKPIPPGIVVRMMENQAGFPGKQQVYRAIDDLLEWHIFRKSGGATNQLLINYELADPVLDQ
KFQGILNLGNKNTGFVRPLDDDKTVYYIHFSNLAGALDGDLVEFCPLDKPQVGDKFDAAVLKIVKRSRVLYAGNFLIEYS
DFGQEFRIVADNPRFYLTPIVNKASVPAELESNTKVAFQIDEYDPANNLCKVSIQQILGNNDEPLINLKAIMLDHSIVFE
DNDVVEQQAAKLQFDEKEQSKPYRKDLTELAFVTIDPATSKDLDDAIYVKRTDKGFVLYVAIADVAYYVQRNSELDIEAR
HKTSSIYLPGYYVVPMLPERLSNELCSLNPNEKRYVVVCELNFDHEARLNFSEVYPATIVSQRRFAYSEVNDWLEDSDAL
KDESATVLESLKAGFTLSELIAEQRKKKGTIDLSHSETEVVVDQNYYPIEIRFLTHGKAETMIENLMVVANEAVAWTLTN
HKVHLPYRVHPRPSKKKLQMLLENIVELKITQPNFVLDTVTSTQIAAWLKENKDNPSYDIFVILLLRTLGKAFYIVNPLI
HFSIGSHHYTHFTSPIRRYADLTVHRLLWMNLFTPERFTDTEREQLNAELEQICETINDTEIKINGCERTANDYLTTLYL
SKQVGQTFHGFISAITSFGIFMRMDENNFDGLIKITSIPEDFFVFEKDRMVLRGKRTNKVFRIGDRLTAKLTEIDTVQKR
AILTLV
>P91599|IPR011129(50...116)|Protein lin-28
MSTVVSEGRNGGNERYSPQDELPDLENLKLTDDMRVPSFDRLPSPTPRYYGSCKWFNVSKGYGFVIDDITREDLFVHQSN
LNMQGFRSLDEGERVSYYIQERSNGKGREAYAVSGEVEGQGLKGSRIHPLGRKKAVSLRCFRCGKFATHKAKSCPNVKTD
AKVCYTCGSEEHVSSICPERRRKHRPEQVAAEEAEAARLAAETAASSPRGDHDD
>P92186|IPR011129(54...120)|Protein lin-28
MSTVVSEGRNDGNNRYSPQDEVEDRLPDVVDNRLTENMRVPSFERLPSPTPRYFGSCKWFNVSKGYGFVIDDITGEDLFV
HQSNLNMQGFRSLDEGERVSYYIQERSNGKGREAYAVSGEVEGQGLKGSRIHPLGRKKAVSLRCFRCGKFATHKAKSCPN
VKTDAKVCYTCGSEEHVSSICPERRRKHRPEQVAAEEAEAARMAAEKSSPTTSDDDIREKNSNSSDE
>P95459|IPR011129(6...69)|Major cold shock protein CspA
MSNRQNGTVKWFNDAKGFGFITPESGNDLFVHFRSIQGTGFKSLQEGQKVSFVVVNGQKGLQADEVQVV
>P96349|IPR011129(3...66)|Cold shock protein 2
MKNGTVKWFNADKGFGFITGEDGTDVFVHFSAIQTDGFKTLDEGQKVTYDEEQGDRGPQATNVQPQ
>P9WHF2|IPR011129(227...288)|Transcription termination factor Rho
MTDTDLITAGESTDGKPSDAAATDPPDLNADEPAGSLATMVLPELRALANRAGVKGTSGMRKNELIAAIEEIRRQANGAP
AVDRSAQEHDKGDRPPSSEAPATQGEQTPTEQIDSQSQQVRPERRSATREAGPSGSGERAGTAADDTDNRQGGQQDAKTE
ERGTDAGGDQGGDQQASGGQQARGDEDGEARQGRRGRRFRDRRRRGERSGDGAEAELREDDVVQPVAGILDVLDNYAFVR
TSGYLPGPHDVYVSMNMVRKNGMRRGDAVTGAVRVPKEGEQPNQRQKFNPLVRLDSINGGSVEDAKKRPEFGKLTPLYPN
QRLRLETSTERLTTRVIDLIMPIGKGQRALIVSPPKAGKTTILQDIANAITRNNPECHLMVVLVDERPEEVTDMQRSVKG
EVIASTFDRPPSDHTSVAELAIERAKRLVEQGKDVVVLLDSITRLGRAYNNASPASGRILSGGVDSTALYPPKRFLGAAR
NIEEGGSLTIIATAMVETGSTGDTVIFEEFKGTGNAELKLDRKIAERRVFPAVDVNPSGTRKDELLLSPDEFAIVHKLRR
VLSGLDSHQAIDLLMSQLRKTKNNYEFLVQVSKTTPGSMDSD
>P9WHF3|IPR011129(227...288)|Transcription termination factor Rho
MTDTDLITAGESTDGKPSDAAATDPPDLNADEPAGSLATMVLPELRALANRAGVKGTSGMRKNELIAAIEEIRRQANGAP
AVDRSAQEHDKGDRPPSSEAPATQGEQTPTEQIDSQSQQVRPERRSATREAGPSGSGERAGTAADDTDNRQGGQQDAKTE
ERGTDAGGDQGGDQQASGGQQARGDEDGEARQGRRGRRFRDRRRRGERSGDGAEAELREDDVVQPVAGILDVLDNYAFVR
TSGYLPGPHDVYVSMNMVRKNGMRRGDAVTGAVRVPKEGEQPNQRQKFNPLVRLDSINGGSVEDAKKRPEFGKLTPLYPN
QRLRLETSTERLTTRVIDLIMPIGKGQRALIVSPPKAGKTTILQDIANAITRNNPECHLMVVLVDERPEEVTDMQRSVKG
EVIASTFDRPPSDHTSVAELAIERAKRLVEQGKDVVVLLDSITRLGRAYNNASPASGRILSGGVDSTALYPPKRFLGAAR
NIEEGGSLTIIATAMVETGSTGDTVIFEEFKGTGNAELKLDRKIAERRVFPAVDVNPSGTRKDELLLSPDEFAIVHKLRR
VLSGLDSHQAIDLLMSQLRKTKNNYEFLVQVSKTTPGSMDSD
>P9WP74|IPR011129(3...67)|Probable cold shock protein A
MPQGTVKWFNAEKGFGFIAPEDGSADVFVHYTEIQGTGFRTLEENQKVEFEIGHSPKGPQATGVRSL
>P9WP75|IPR011129(3...67)|Probable cold shock protein A
MPQGTVKWFNAEKGFGFIAPEDGSADVFVHYTEIQGTGFRTLEENQKVEFEIGHSPKGPQATGVRSL
>Q00436|IPR011129(38...106)|B box-binding protein
MSSEVETQEQQPDALEGKAGQEPAATVGEKKVIATKVLGTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRS
VGDGETVEFDVVEGEKGAEAANVTGPGPVPVQGSKYAADRNNYRRYPRRRGPPRNYQQNYQNSESGEKAEGNESAPEGEG
TNQQRPCPRRRYPPPFYSRRPYGRRPQYSNVPVQGESAEGAESQGAGEQGRPVRQNMYRGFRPQFRRGPPRQRQPREDGN
EEDKENQGDETQSHACHLMRRYRRNFNYRRRRPENPKPQDGKETKAAETSAENTSAPEAEQGGAE
>Q01761|IPR011129(3...66)|Cold shock-like protein 7.0
MATGTVKWFNAEKGFGFIAQDGGGPDVFVHYSAINATGFRSLEENQVVNFDVTHGEGPQAENVSPA
>Q02146|IPR011129(17...78)|Ribonuclease R 2
MVQLSELASALNQTESKGVFSKHPKGFGFVHPEDATDKTNDIYIGKNDTKFAMDGDKVTVKVTYPKTEKRGASGQITKIN
ERAVVDTVGTYRSLSNRQVKALGYKGRIELYNDRISDTLYIKQPLSGVQEEDVVSLKITQYPTNTKTFEGKITGIIGHKG
EVGLDILEVLCAMKIPQEFSSETLAEAEAFSEKLTDSDLQDREDYRNEITYTIDGDDSKDLDDAIHVKKLSNWHFELGVH
IADVSHYVTEGSSLDEEAYSRATSVYVTDRVVPMLPVKLSNNLCSLNEAQERLTMSCLMEIDDKGKIVSYKISPSVIKTT
YRMTYNNVNKMIHQGQEGHREALENFFKITDSIKVAVELHEILETMRKDRGMIEFDESEAKIILDEKGHPIEIVKRDRDT
AERMIESFMLMANETVALDFQKKKLPSLYRVHDNPKEKSFAKLMEAAANAGFSLNSDSHQAINFFADEIKGTSSEKALTY
QLRHTMSTAVYSEKNTKHFGLAATNYTHFTSPIRRYPDLIIHRLLHLYPSDHSNHTKDEWKERLPEIASHSSDMEHRAVV
TERIIDAMKKAEYMSERIGEVYTGTITGLQKFGIFVALDNTVEGLIRVPNLHTGTTEELEFDEEASIFKGKKSETVYQIG
QEIKIRVIAANKRKGTVDFEQIAPE
>Q03222|IPR011129(55...120)|Transcription termination factor Rho
MKDVSISSLENMKLKELYELARHYKISYYSKLTKKELIFAILKANAEQEDLLFMEGVLEIIQSEGFGFLRPINYSPSSED
IYISASQIRRFDLRNGDKVSGKVRPPKENERYYGLLHVEAVNGDDPESAKERVHFPALTPLYPDRQMVLETKPNFLSTRI
MDMMAPVGFGQRGLIVAPPKAGKTMLLKEIANSITANQPEAELIVLLIDERPEEVTDIERSVAGDVVSSTFDEVPENHIK
VAELVLERAMRLVEHKKDVIILMDSITRLARAYNLVIPPSGRTLSGGIDPAAFHRPKRFFGAARNIEEGGSLTILATALV
DTGSRMDDVIYEEFKGTGNMELHLDRSLAERRIFPAIDIRRSGTRKEELLVPKEHLDRLWSIRKTMSDSPDFAEKFMRKM
KKTKTNQEFFDILNQEWKQANLSSARR
>Q057Q9|IPR011129(22...78)|Exoribonuclease 2
MFYNNPLLIKLKNKLYKKKKIEGIVKSTTKGFGFLEVDSKKTYFIPSKNMKKVIHGDRIIGLIKLENNKEIVYPKILIEP
FLKKFIGSILKKNNIIYIQANYPYIKDLIFYRYKTSVFRSWKNGDWVIAELDTHSLRDNNHFSINILKFISEKNDPLTPW
NVILSKYNLEKKSPKINFNYILNNNNLKDKRIDLTYLDFITIDNSNTQDIDDALFVKKTKKNKLTLIVAIADPTEYILIN
TKVDDIAKKRVFTNYLPGFNISMLPKEFSEDLCSLKPHVKRPVLACKIIIDNEGKILMKKTKFFLAWIESKGKLSYQNVS
NWLEKLGNWQPDNKKIKKQILLLYKMYKIRNMWRKKNALIFPDNIEYKFHLSKTWEILNISVEKRSIAHKIVEESMISAN
ICAASFLKKKLGFGLYNSHSGFDTFNAKNAINFLKKYNIIFTLEEIMTLSGFCKLKRKLNKLSNKYINYRIQKFQSFGEI
SLIPKPHFSLGLPYYATWTSPIRKYSDMINHRLIKSIIIGKKKISPPDTNIIPQIIHRKYKIRMALKEIEEWLYFKYYNK
KKSDKKKYQANIIDISKGGIKARLLKTGAYIFIPVTYIHKIRHELNLNSEKGIIYIKNKIYYKVSDIIIVSLLKINNGNK
KIIATMIN
>Q06066|IPR011129(57...125)|Y-box-binding protein 1
MSSEAETQPPAAPVPAAPAAAPADSKPNGGSGNGSSGLASAAPPAGGDKKVIATKVLGTVKWFNVRNGYGFINRNDTKED
VFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGEKGAEAANVTGPGGVPVQGSKYAADRNHYRRYPRRRGPPRNYQQNYQ
NSESGEKNEGAENIPEGQAQQRRPYRRRRYPPYYMRRPYGRRPQYSNPPVQGEIVEGADNQGAGEQGRPVRQNMYRGYRP
RFRRGPPRQRQPREDGNEEDKENQGDETQGQQPPQRRYRRNFNYRRRRPENPKPQDGKETKTAEPPAENTSAPEAEQGGA
E
>Q06447|IPR011129(52...118)|Transcription termination factor Rho
MHVSELQTLHISKLLELAEEHGIENANRFRKQDLVFAIVRQMMKKGEGFTCSGTLEILPDGFGFLRSADTSYLAGPDDIY
VSPTQIRRFNLHTGDTIEGSVRVPKDNERYFALVRLDSINGDHPEVCRHKILFENLTPLFPTEQLKLERDLKSEENLTGR
AIDLISPIGKGQRALLVAPPKIGKTVMLENIAHEVTANYPEVELIVLLIDERPEEVTEMSRSVRGEVVSSTFDEPAQRHV
QVAEMVLEKAKRMVEHKKDVVILLDSITRLARAYNTVVPASGKILTGGVDANALHRPKRFFGAARNVEEGGSLTIIATAL
VETGSRMDDVIYEEFKGTGNMELHLDRRIAEKRLFPAININKSGTRREELLVPNDQLQRMWLLRKFLHPMDEIEATEFLN
GKIKASKNNDDFFELMRGK
>Q0T5B1|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLTIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTSLDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWKPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
GTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>Q0TI78|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDGKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSTDGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETAYKVTDVIDVTIAEVRMETRSIIA
RPVA
>Q1C7L1|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHTQTPRVEGVVKGTEKGFGFLEVDGQKSYFIPPPQMKKVMHGDRIIATLHTDKDREIAEPETLVE
PFLSRFVGRVQRKDDRLSIVPDHPLLRDAIQCRPVRELTHSFQNGDWAVAEMCRHPLKGDRAFQADLTAFITNGEDHFVP
WWVTLARHNLEREAPAMVESALNDAELEREDLTALNFVTIDSASTEDMDDALFVQDNGDGSWLLTIAIADPTAYVVENSE
LDLTARKRAFTNYLPGFNIPMLPRDLSDNLCSLRPNERRPVLVCRVTITEEGTLSNDIRFSAAWVESKAKLVYDDVSDWL
EGNNRWQPQDTAIAEQITLLKRICDARSNWRQQHALVFKDRPDYRFLLGEKGEVLDIIVEHRRIANRIVEECMIAANVCA
ALALREHLGFGIYNVHTGFDPALVEQAASVLKANGVGADPQALLTLPGFCELRRHLDALPTQFLDSRIRRFQTFAEISTV
PGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAMITGQQAEKPQEEITVQLAERRRLNRMAERDVGDWLYARYLQPQAGT
DTRFTAEIIDITRGGLRVRLLDNGAVAFIPAPFIHAVRDEVVCSQETGTVQIKGETVYSQSDKIEVRIAEVRMETRNVIA
RPVA
>Q1CIZ7|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHTQTPRVEGVVKGTEKGFGFLEVDGQKSYFIPPPQMKKVMHGDRIIATLHTDKDREIAEPETLVE
PFLSRFVGRVQRKDDRLSIVPDHPLLRDAIQCRPVRELTHSFQNGDWAVAEMCRHPLKGDRAFQADLTAFITNGEDHFVP
WWVTLARHNLEREAPAMVESALNDAELEREDLTALNFVTIDSASTEDMDDALFVQDNGDGSWLLTIAIADPTAYVVENSE
LDLTARKRAFTNYLPGFNIPMLPRDLSDNLCSLRPNERRPVLVCRVTITEEGTLSNDIRFSAAWVESKAKLVYDDVSDWL
EGNNRWQPQDTAIAEQITLLKRICDARSNWRQQHALVFKDRPDYRFLLGEKGEVLDIIVEHRRIANRIVEECMIAANVCA
ALALREHLGFGIYNVHTGFDPALVEQAASVLKANGVGADPQALLTLPGFCELRRHLDALPTQFLDSRIRRFQTFAEISTV
PGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAMITGQQAEKPQEEITVQLAERRRLNRMAERDVGDWLYARYLQPQAGT
DTRFTAEIIDITRGGLRVRLLDNGAVAFIPAPFIHAVRDEVVCSQETGTVQIKGETVYSQSDKIEVRIAEVRMETRNVIA
RPVA
>Q1LTG8|IPR011129(23...79)|Exoribonuclease 2
MFQDHPLLIQLKQQLYDKELRMVGVVKSTDKGFGFLEVNAQKSYFIPPLFMKKVMHGDKISAVLRIVNNRAIAEPETLIE
PFLSRFVGKVQIKNDKLALLPKHPLIKEIIPASQPRSMKNTQLCHGDWVIAEMCHHPLDGYRYFYAKITELITTKDDNFA
HWRVTLAHYNLEREAPAMPKYLTIQDNGLIREDLTELNFITIDHASTEDIDDALHVAYGTNGALVLTIAIADPTAWIIAG
SQLDCIARDRAFTNYLPGFNIPMLPRMLSEDLCSLRAYEKRPALVCQVTMQHDGTLNEDMRFFAAWIESKAKLSYDEVSD
WIENIGFWQPQNNAIAEQIRMLHIVCQARSSWRKQHALVFKDKPDYRFILEENGNVKNIIAEPRRIAKRMIEEAMITANI
CAARVLRDNLGFGLYNTHNGFDTTLIDQVVAILQKHNISVDATQLLTLEGFCALRRKLNTMSTSYLDSRIRRFQTLSELK
TEPGPHFGLGLEVYATWTSPIRKYSDMMNHRLLKALIGAGKAERPKTDITFRMSERRRQNRIAERDVEDWLYASFLKNQV
GSHIRYSAEIIDIYRNGMRIRLLDNGAIAFIPALLIHNIRDELICNQDIGIVQIQGKERYRQGDTIEVYIKEVHIDNRSI
IAKIV
>Q1RC77|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDGKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTFSTDGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRLDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETAYKVTDVIDVTIAEVRMETRSIIA
RPVA
>Q1RHK6|IPR011129(6...70)|Cold shock-like protein CspA
MTTNIVGKVKWFNPTKNFGFIEQENGGKDVFVHRSAVDAAGLAGLNEGQDVIFDLEDKNGKISAVNLRIK
>Q1RIJ6|IPR011129(79...145)|Transcription termination factor Rho
MSITNKESPEQLNNPEFNNHYAENGNIINLKELKRKLPEELQAQAEELKIENVSSLRKQELVFAILKKSVEQGGSIVGEG
VLEVLPDGFGFLRSPEVNYLAGPDDIYISPSQIRRFGLRTGDTVEGRIRAPKEGERYFALLKVNKVNFEDPSKAYHRVNF
DNLTPLYPDEKLGLELEDNSKDFSTRVIELVAPMGKGQRALIVAPPRTGKTVLLQNIAHAITTNNPEVFLIVLLIDERPE
EVTDMQRSVRGEVVSSTFDEPASRHVQLAEMVIEKAKRLVEHKKDVVILVDAITRLARAYNTVVPSSGKVLTGGVDANAL
QRPKRFFGAARNIENGGSLTIIGTALIETGSRMDEVIFEEFKGTGNSEIVLDRKIADKRIYPAIDITRSGTRKEDLLVDK
IVLNKMWVLRRIIDPMGSSEAIEFLLKKLEHTKTNNEFFEMMKSPAERK
>Q28618|IPR011129(60...128)|Y-box-binding protein 1
MSSEAETQQPPAAPPAAPALSAAETKPGTTGSGAGSGGPGGLTSAAPAGGDKKVIATKVLGTVKWFNVRNGYGFINRNDT
KEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGEKGAEAANVTGPGGVPVQGSKYAADRNHYRRYPRRRGPPRNYQQ
NYQNSESGEKNEGSESAPEGQAQQRRPYRRRRFPPYYMRRPYGRRPQYSNPPVQGEVMEGADNQGAGEQGRPVRQNMYRG
YRPRFRRGPPRQRQPREDGNEEDKENQGDETQGQQPPPSRYRRNFNYRRRRPDNPKPQDGKETKAADPPAENSSAPEAEQ
GGAE
>Q2FH36|IPR011129(3...66)|Cold shock protein CspA
MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQDGYKSLEEGQAVEFEVVEGDRGPQAANVVKL
>Q2FYN2|IPR011129(3...66)|Cold shock protein CspA
MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQDGYKSLEEGQAVEFEVVEGDRGPQAANVVKL
>Q2NST6|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRVEGVVKGTEKGFGFLEVDAQKSYFISPPFMKKVMHGDKISAVVRTEKEREIAEPEELIE
PFLTRFIGRVQVKDERLAVVPDHPLIKEVIPTRPQHGVDQMFQTGDWAVAEMRRHPLKGDRQFYAEITALVTRADDHFAP
WWVTLARHNLERAAPTMPEGVSLQEDGPAREDLTALDFITIDSASTEDMDDAIHLAPAPNGAWVMTVAIADPTAWVPAGS
PLDNIARERAFTNYLPGFNIPMLPRALSDDLCSLRAHERRPALACRVTVRPNGTLADDARFFTAWIESKGKLAYDNVSDW
LENLGSWQPETEAIADQIRLLHDVCLARSAWRQRHALVFKDRPDYRFVLNEKGNVDDIVVEPRRIANRMIEEAMITANVC
AARVLRDGLGYGLYNVHHGFDPLLVDQAVAILHSHQIEVDPADLLTLEGFCALRRRLDAQPTSYLDSRIRRFQTFAEVST
VPGPHFGLGLDAYATWTSPIRKYGDMINHRLLKALIGVGDAERPNEEVTLRLAERRRQNRMAERDVGDWLYARFLQPKAG
SDSRFAAEIIDISRGGMRVRLLNNGAVAFIPAPFIHSVRDELVCSQDTGTVQVKGEERYRQGDTLDVTLAEVRMENRSVI
ARPV
>Q2YY16|IPR011129(3...66)|Cold shock protein CspA
MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQDGYKSLEEGQAVEFEVVEGDRGPQAANVVKL
>Q31ZY2|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGAIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAMRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>Q32GP4|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRCHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARILRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>Q38896|IPR011129(16...81)|Cold shock domain-containing protein 4
MSGGGDVNMSGGDRRKGTVKWFDTQKGFGFITPSDGGDDLFVHQSSIRSEGFRSLAAEESVEFDVEVDNSGRPKAIEVSG
PDGAPVQGNSGGGGSSGGRGGFGGGGGRGGGRGGGSYGGGYGGRGSGGRGGGGGDNSCFKCGEPGHMARECSQGGGGYSG
GGGGGRYGSGGGGGGGGGGLSCYSCGESGHFARDCTSGGAR
>Q3Z135|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAKKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
GTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRGIIA
RPVA
>Q41188|IPR011129(12...77)|Cold shock protein 2
MSGDNGGGERRKGSVKWFDTQKGFGFITPDDGGDDLFVHQSSIRSEGFRSLAAEEAVEFEVEIDNNNRPKAIDVSGPDGA
PVQGNSGGGSSGGRGGFGGGRGGGRGSGGGYGGGGGGYGGRGGGGRGGSDCYKCGEPGHMARDCSEGGGGYGGGGGGYGG
GGGYGGGGGGYGGGGRGGGGGGGSCYSCGESGHFARDCTSGGR
>Q44078|IPR011129(1...46)|Major cold-shock protein
EKGFGFISPTDGSKDVFVHFSAIQTPGFKTLDEGQRVEFTIEQGQK
>Q44317|IPR011129(1...46)|Major cold-shock protein
EKGFGFISPADGSKDVFVHFSAIQSTSFKTLDEGQRVEFTIEQGQK
>Q45096|IPR011129(4...67)|Major cold shock protein CspA
MTVTGQVKWFNNEKGFGFIEVPGENDVFVHFSAIETDGFKSLEEGQKVSFEIEDGNRGPQAKNVIKL
>Q45097|IPR011129(2...65)|Cold shock-like protein CspB
MNGKVKWFNNEKGFGFIEMEGSEDVFVHFSAIQSDGYKALEEGQEVSFDITEGNRGPQAANVAKL
>Q45099|IPR011129(3...66)|Cold shock-like protein CspD
MQTGKVKWFNGEKGFGFIEVEGGEDVFVHFSAIQGDGFKTLEEGQEVSFEIVDGNRGPQAANVTKN
>Q45100|IPR011129(4...54)|Cold shock-like protein CspE
MTLTGKVKWFNSEKGFGFIEVADGSDVFVHFSAITGDGFKSLDEGQEVSFEVED
>Q45KJ4|IPR011129(31...102)|Protein lin-28 homolog B
MAEAGASKGGEEPGRLPEHEEEEESPLWHGAGHCKWFNVRMGFGFISMSSREGSPLESPVDVFVHQSKLYMEGFRSLKEG
EPVEFTYKKSSKGLESIRVTGPGGSPCLGSERRPKGKTVQKRKPKGDRCYNCGGLDHHAKECSLPPQPKKCHYCQSIMHM
VANCPHKTVSQQPTSSQGRHEAEPQPSTSAFLREGGGTYGYSSPSYSQEGRSEISERSGRSPQEASSSKLSASPEEPSRK
GPSVQKRKKT
>Q45KJ5|IPR011129(35...106)|Protein lin-28 homolog A
MGSVSNQQFAGAKPGEEPSGDSPKAENESQPLHGSGICKWFNVRMGFGFLSMTAKGGAMLDSPVDVFVHQSKLHMEGFRS
LKEGEAVEFTFKKSSKGLESIRVTGPGGVFCIGSERRPKSKSLQKRRSKGDRCYNCGGLDHHAKECKLPPQPKKCHFCQS
ISHMVANCPAKAQQSPSSQGKPAYFREKEDMHSSALLPETRE
>Q45KJ6|IPR011129(29...100)|Protein lin-28 homolog B
MAEGGASKGEEPEKLPGLAEDEPQVLHGTGHCKWFNVRMGFGFISMISREGNPLDIPVDVFVHQSKLFMEGFRSLKEGEP
VEFTFKKSPKGLESIRVTGPGGSPCLGSERRPKGKTLQKRKPKGDRCYNCGGLDHHAKECSLPPQPKKCHYCQSIMHMVA
NCPHKLAAQLPASSQGRQEAESQPCSSAAPREVGGGHGCTVLFPQEVKSEMAEHSDRSPQEVSSTKAFAAIGEQNKKGPL
IQKRKKT
>Q46051|IPR011129(1...45)|Major cold shock protein
DKGFGFITPDDGSKDVFVHFSAIQNDGYKSLDEGQKVSFTIESGAK
>Q46363|IPR011129(68...127)|Acetazolamide conferring resistance protein zam
MDYSIATLLSYFVDDKLVAGKFLEKKLGCESPEAIEALQIALDALEKMGVLVKERGKYNRVTREDVVEARLRCSSKGFCF
AIQDDEDATDIYVREGNLSNAWNGDRVLVKVIKDGTRRKSPEEQVHLILDRANPSLLAQVKKSEDNYRAVPLDDRLLFEL
ELQDKEQNLGEAVDHLVHVSVLRYPIAQHPPLGEVTKVLGSDAEAAADTDIVSCKHDLPLGWTPEAIEALQSLPKVIEPG
ELKKRTWITAKLQLVTFGDGPRGETLPWQEVALSLESQANQWQVGIHITDIAHYIAEDSLLDQLARKRGTTVYLEEQICP
LFPEGLIGRCSLIPDEDRLALSFFLTVDDRGEVTGFEYHSSVVKVDHQLDFSEVQTALADIESVSGELKPYGGLLQELFF
QICPLIKSQRLQRGSFNLQTETASPRLDEGRLGVIMTQETLPIRSLLAELMVVLQREVALQLQALGIPGLYCGQVAPEGE
DLTDIVKLAGNLDLGVKIDLEGDIIPQHYHHLSQGFESLPAKAVLNHLLANTLKIEKYFSHPAPHFALAYDSGYTHCVSP
AQRYGDLVIQRLLKLVLTEGRDRRTKQMKTGVELNAHTCRNQISWNVLPPNLQETIEGDLHQLVLGLNDREQTAEDAEKD
LLGLKKAEKMKARAGEIFRGLITGVQSYGFFVQIFDLLAEGLVHVSSLKDDWYEFRSRQCALVGRKSRTSYRLGNEVDVQ
VRSVDYYRQQIDLGAVNNAPKDSANMDFDDDDEDGDEREEQDTMDWDAMEDGDDDEGGAVIF
>Q46664|IPR011129(6...70)|Major cold shock protein
MSGKMTGIVKWFNADKGFGFITPDDGSKDVFVHFSAIQNDGYKSLDEGQKVSFTIESGAKGPAAGNVTSL
>Q48493|IPR011129(1...45)|Major cold shock protein
SKGFGFISPKDGSKDVFVHFSAIQSDSFKTLNEGQEVSFTIENGAK
>Q49XK3|IPR011129(3...66)|Cold shock protein CspA
MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQEGYKSLEEGQSVEFEVVEGDRGPQAANVVKL
>Q4L6A7|IPR011129(3...66)|Cold shock protein CspA
MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQDGYKSLEEGQSVEFEVVEGDRGPQAANVVKL
>Q4QJL5|IPR011129(23...78)|Exoribonuclease 2
MFQDNPLLAQLKQQIHDSKEQVEGVVKSTDKAYGFLECDKKTYFIAPPSMKKVMHGDKIKATIEKQGDKEQAEPEALIEP
MLTRFIAKVRFNKDKKLQVLVDHPSINQPIGAQQAKSVKEELQEGDWVVANLKTHPLRDDRFFYATINQFICRADDELAP
WWVTLARHEQSRYPVQGAEHYEMLDQKTRENLTALHFVTIDSESTMDMDDALYIEPIAQNSTQTGWKLVVAIADPTAYIA
LDSQIEQEAKQRCFTNYLPGFNIPMLPRELSDELCSLIANETRPALVCYIETDLAGNITAKPHFVSAYVQSKAKLAYNKV
SDYLEQADNAWQPETPETAQQIHWLHQFTKARIQWHKTHSLLFKEKPDYAFVLAENGKVQEIKAEYRRIANQIVEEAMII
ANICAAQFLHEQAKTGIFNTHSGFDKKFLENAHHFLMANLANEQNQTELAERYSVENLATLNGYCQMRHDIEPIESDYLE
LRLRRYLTFAEFKSELAPHFGLGLEGYATWTSPIRKYSDMVNHRLIKAVLAKQPYEKTQNDVLARLQEARRQNRLVERDI
ADWLYCRYLAPKVAENVEFNAEVQDVMRGGLRVQLLENGASMFIPASTLHNNKEEMQVNSDEIALYIKGERTYKIGDIVK
VKLTEVKEATRSIVGEILQ
>Q4ULF7|IPR011129(82...148)|Transcription termination factor Rho
MNTTNKESTEELNNTESNNNHNNFAENGNIINLKQLKRKLPEELQAQAEELKIENINSLLKQELVFAILKKSVEQGGLIV
GEGVLEVLPDGFGFLRSPEVNYLAGPDDIYISPSQIRRFGLRTGDTVEGQIRAPKAGERYFALLKVNRVNFEDPSKAYHR
VHFDNLTPLYPDEKLGLELENNSKDSKDFSTRVIELVAPMGKGQRALIVAPPRTGKTVLLQNIAHAITTNNPEVFLIVLL
IDERPEEVTDMQRSVRGEVVSSTFDEPASRHVQLAEMVIEKAKRLVEHKKDVVILVDAITRLARAYNTVVPSSGKVLTGG
VDANALQRPKRFFGAARNIENGGSLTIIGTALIETGSRMDEVIFEEFKGTGNSEIVLDRKIADKRIYPAIDITRSGTRKE
DLLVDKIILNKMWVLRRIIDPMGSSEAIEFLLKKLENTKTNGEFFEMMKSPERPKNGL
>Q4UMU5|IPR011129(6...70)|Cold shock-like protein CspA
MATNIVGKVKWYNSTKNFGFIEQENGGKDVFVHKSAVDAAGLHSLEEGQYVIFDLEEKQGKAYAVNLRIK
>Q51929|IPR011129(1...46)|Major cold shock protein
EKGFGFLTQNNGGADVFVHFRAIASEGFKTLTEGQKVSFDVEQGQK
>Q52287|IPR011129(1...46)|Major cold shock protein
EKGFGFITQDNGGADVFVHFRAIASEGFKTLAEGQKVSFEVEQGQK
>Q53816|IPR011129(1...45)|Major cold shock protein
DKGFGFITPDDGSKDVFVHFSAIQNDGYKSLDEGQKVSFTIESGAK
>Q53984|IPR011129(1...45)|Major cold shock protein
EKGFGFISTENGQDVFAHFSAIQTNGFKTLEEGQKVEFDVEEGQR
>Q56178|IPR011129(1...45)|Major cold shock protein
DKGFGFITPDDGSKDVFVHFSAIQNDGYKSLDEGQKVSFTIESGAK
>Q56922|IPR011129(1...45)|Major cold shock protein
DKGFGFITPADGSKDVFVHFSAIQSNDFKTLDEGQKVEFSIENGAK
>Q57NV9|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNTAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPALACRMIIAADGTIDDDIAFFAATIESKAKLAYDNVSDWL
ENNGTWQPDNEGIAQQIRLLHRICLSRSEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGEAIARPQEDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
NTRFAAEIIDVSRGGMRVRLVDNGAIAFIPAPFLHAVRDALVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPAA
>Q5EB47|IPR011129(35...106)|Protein lin-28 homolog A
MGSVSNQEITGGLPKSLDETADIHKSDESLIFQGSGVCKWFNVRMGFGFLTMTKKEGTDLETPVDVFVHQSKLHMEGFRS
LKEGESVEFTFKKSSKGLESTRVTGPGGAPCIGSERRPKVKGQQKRRQKGDRCYNCGGLDHHAKECKLPPQPKKCHFCQS
PNHMVAQCPAKASQAANLEEQPISEEQELIPETME
>Q5HG18|IPR011129(3...66)|Cold shock protein CspA
MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQDGYKSLEEGQAVEFEVVEGDRGPQAANVVKL
>Q5HPE0|IPR011129(3...66)|Cold shock protein CspA
MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQEGYKSLEEGQSVEFEVVEGDRGPQAANVVKL
>Q5PCZ6|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPALACRMIIAADGTIDDDIAFFAATIESKAKLVYDNVSDWL
ENNGTWQPENEGIAQQIRLLHRICLSRSEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGEAIARPQEDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
NTRFAAEIIDVSRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPAA
>Q5X9L4|IPR011129(3...66)|Major cold shock protein
MAQGTVKWFNAEKGFGFISTENGQDVFAHFSAIQTSGFKTLEEGQKVAFDVEEGQRGPQAVNITKLA
>Q61CX7|IPR011129(54...120)|Protein lin-28
MSTVVSEGRNGGNERYSPQDDVSKELPDINGLSLEETMGIPSFDRLPSPTPRYFGSCKWFNVSKGYGFVIDDNTGEDLFV
HQSNLNMQGFRSLDEGERVSYYIQERSNGKGKEAYAVSGEVEGQGLKGSRIHPLGRKKAVSLRCFRCGKFATHKAKGCPN
VKTDAKVCYTCGSEEHVSSVCPERRRKHRPEQVAAEEAEAARLAQEEADRSSPEENERKDGKLVEQKETETADKAGK
>Q62764|IPR011129(84...152)|Y-box-binding protein 3
MSEAGEATTGGTTLPQAAADAPAAAPPDPAPKSPAASGAPQAPAPAALLAGSPGGDAAPGPAPASSAPAGSEDAEKKVLA
TKVLGTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGEKGAEAANVTGPDGVPVEGS
RYAADRRRYRRGYYGRRRGPPRNYAGEEEEEGSGSSEGFEPPAADGQFSGARNQLRRPQYRPPYRQRRFPPYHVGQTFDR
RSRVFPHPNRMQAGEIGEMKDGVPEGAQLQVHRNPTYRPRFRRGPARPRPAPAIGEAEDKENQQAANGPNQPSARRGFRR
PYNYRRRPRPLNAVSQDGKETKAGEAPTENPAPATEQSSAE
>Q63430|IPR011129(71...136)|Cold shock domain-containing protein C2
MTSESTSPPVVPPLHSPKSPVWPTFPFHRESSRIWERGGGVSPRDLPSPLPTKRTRTYSATARASAGPVFKGVCKQFSRS
QGHGFITPENGSEDIFVHVSDIEGEYVPVEGDEVTYKMCPIPPKNQKFQAVEVVLTQLAPHTPHETWSGQVVGS
>Q65SI5|IPR011129(23...78)|Exoribonuclease 2
MFQNNPLLSQLKQQLHDSKPHVEGVVKGTDKAYGFLETEKETFFIAPPAMKKVMHGDKIKAAIETIGDKKQAEPEELIEP
MLTRFIAKVRFNKDKKLQVLVDHPNINQPIGAAQAKTVKQELKEGDWVVATLKTHPLRDDRFFYAQIAEFICSAEDEFAP
WWVTLARHEQSRYPVQGQEVYSMLDTETRRDLTALHFVTIDSENTQDMDDALYIEPVTAPNDEQTGWKLAVAIADPTAYI
ALDSQIEKDARKRCFTNYLPGFNIPMLPRELSDELCSLMENETRAALVCRLETDMQGEIVGEPEFILAQVQSKAKLAYNN
VSDYLEQVENAWQPENESTQQQINWLHQFALVRINWRKKHGLLFKEKPDYSFVLADNGHVREIKAEYRRIANQIVEESMI
IANICCAHYLAKNAQTGIFNTHVGFDKKFLPNAHNFLMANLSNEENQQELAERYSVENLATLAGYCRMRHDIEPIEGDYL
EFRLRRFLTFAEFKSELAPHFGLGLTGYATWTSPIRKYSDMVNHRLIKACLANRECVKPSDETLARLQEARKQNRMVERD
IADWLYCRYLADKVESNPEFRAEVQDCMRGGLRVQLLENGASVFVPASSIHPNKDEIQVNTDELALYINGERRYKIGDIV
NIRLTEVKEETRSLIGNLV
>Q66AH3|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHTQTPRVEGVVKGTEKGFGFLEVDGQKSYFIPPPQMKKVMHGDRIIATLHTDKDREIAEPETLVE
PFLSRFVGRVQRKDDRLSIVPDHPLLRDAIQCRPVRELTHSFQNGDWVVAEMCRHPLKGDRAFQADLTAFITNGEDHFVP
WWVTLARHNLEREAPAMVESALNDAELEREDLTALNFVTIDSASTEDMDDALFVQDNGDGSWLLTIAIADPTAYVVENSE
LDLTARKRAFTNYLPGFNIPMLPRDLSDNLCSLRPNERRPVLVCRVTITEEGTLSNDIRFSAAWVESKAKLVYDDVSDWL
EGNNRWQPQDTAIAEQITLLKRICDARSNWRQQHALVFKDRPDYRFLLGEKGEVLDIIVEHRRIANRIVEECMIAANVCA
ALALREHLGFGIYNVHTGFDPALVEQAASVLKANGVDADPQALLTLPGFCELRRHLDALPTQFLDSRIRRFQTFAEISTV
PGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAMITGQQAEKPQEEITVQLAERRRLNRMAERDVGDWLYARYLQPQAGT
DTRFTAEIIDITRGGLRVRLLDNGAVAFIPAPFIHAVRDEVVCSQETGTVQIKGETVYSQSDKIEVRIAEVRMETRNVIA
RPVA
>Q68W69|IPR011129(6...70)|Cold shock-like protein CspA
MATNIVGKVKWYNSTKNFGFIEQDNGGKDVFVHKSAIEAAGLHSLKERQEVIFDIEEKQGKAYAINLRVK
>Q68WL0|IPR011129(81...147)|Transcription termination factor Rho
MNTTNKQLTEELNNTESNNDHNDFAENNIINLKQLKRKLPEELQVQAEELKIENISSLLKQELVFAILKKSVEQGGLIVG
DGVLEVLPDGFGFLRSPEVNYLAGPDDIYISPSQIRRFGLRTGDTVEGQIRAPKAGERYFALLKVNRVNFDDPVNAYHRV
HFDNLTPLYPDEKLGLELENNSKDSKDFSTRVIELVAPMGKGQRALIVAPPRTGKTVLLQNIAHAITTNNPEVFLIVLLI
DERPEEVTDMQRSVRGEVVSSTFDEPASRHVQLAEMVIEKAKRLVEHKKDVVILVDAITRLARAYNTVVPSSGKVLTGGV
DANALQRPKRFFGAARNIENGGSLTIIGTALIETGSRMDEVIFEEFKGTGNSEIVLDRKIADKRIYPAIDITRSGTRKED
LLVDKIILNKMWVLRRIIDPMGSSEAIEFLLKKLENTKTNYEFFEMMKSPERSRNGL
>Q6D5S7|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSKTPRVEGVVKGTDKGFGFLEADGQKSYFIPPPHMKKVMHGDRITATLHTEKDREIVEPETLIE
PFLTRFVGRIHKKDDRLSITPDHPLLKEAIPCRAARDVTDDFQEGDWAVAEMRRHPLKGDRGFHAELTQYITTGDDPLVP
WWVTLSRHNLERSAPEVETTERHDGELVREDLTALNFVTIDSASTEDMDDALYVQDNGDGSLQLTIAIADPTAYVDAGSE
LDNIARQRAFTNYLPGFNIPMLPRALSDDICSLRPNERRPVLACRVTIAADGALGDDIHFFAASIESKAKLAYDNVSDWL
ENQGEWQPQNEEIAEQIRLLHRLCLARSEWRTTHALVFKDRPDYRFLLGEKGEVLDIVVEHRRIANRIVEESMIAANVCA
AIVLRDKLGFGIYNVHNGFDPASIEQAVAVLDTHGVQADAQTLLTLDGFCTLRRELDAQPTQFLDSRIRRFQSFAEVSTT
PGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAVITGQAAEKPQDDVTVQLAERRRLNRMAERDVGDWLYARYLKDKAGT
DIRFNAEIIDVTRGGLRVRLLDNGAVVFIPSSFIHAVRDELVCSQEMGTLSVKGEVVYRQGDTLDVIIAEVRLETRGIVA
KPAA
>Q6G9F9|IPR011129(3...66)|Cold shock protein CspA
MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQDGYKSLEEGQAVEFEVVEGDRGPQAANVVKL
>Q6GH06|IPR011129(3...66)|Cold shock protein CspA
MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQDGYKSLEEGQAVEFEVVEGDRGPQAANVVKL
>Q6ZN17|IPR011129(31...102)|Protein lin-28 homolog B
MAEGGASKGGGEEPGKLPEPAEEESQVLRGTGHCKWFNVRMGFGFISMINREGSPLDIPVDVFVHQSKLFMEGFRSLKEG
EPVEFTFKKSSKGLESIRVTGPGGSPCLGSERRPKGKTLQKRKPKGDRCYNCGGLDHHAKECSLPPQPKKCHYCQSIMHM
VANCPHKNVAQPPASSQGRQEAESQPCTSTLPREVGGGHGCTSPPFPQEARAEISERSGRSPQEASSTKSSIAPEEQSKK
GPSVQKRKKT
>Q7A0X3|IPR011129(3...66)|Cold shock protein CspA
MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQDGYKSLEEGQAVEFEVVEGDRGPQAANVVKL
>Q7A2R8|IPR011129(3...66)|Cold shock protein CspA
MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQDGYKSLEEGQAVEFEVVEGDRGPQAANVVKL
>Q7A5P3|IPR011129(3...66)|Cold shock protein CspA
MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQDGYKSLEEGQAVEFEVVEGDRGPQAANVVKL
>Q7MEL4|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQIQENLPKKEGTIKATEKGFGFLEVDSKTSFFIPPAYMKKCMHGDKVIAIIRTENEREVAEPQELVE
QMLNRFIGRVKMFKGKLNVVPDHPQLKKMSLKAKTKKGLNPQEFAEGDWVVGHLIRHPLKDDNGFFVEISEKITDADDKI
APWWVTLAENDLPNSEPAGIDDWQIKDDADLERIDMTHIPFVTIDGESTKDMDDALYAKKNDAGDFELTIAIADPTAYIT
PDDEMDKVARERGFTIYLPGRNIPMLPRDLADELCSLIEGEIRPALCCTVTVSKDGVIGDDIQFFAANIKSHARLAYDNV
SDWLETGSCEKWQPSEEIAAIVRDLYEFSQARAEWREKNAVVFPDRPDYRFELSEDNDVVAIHADMRRSANRLVEESMIT
ANICAGKTLQAHFGTGVFNCHAGFKPEKIADVVELVNPEGTLEFTAESIATREGFAALRRWLSKQETTYLDNRIRKFQTY
SEVSNQPLPHYAMGLDIYATWTSPIRKYGDMINHRMLKALILNKEPVQKPDDSVGEELALHRKHHKIAERNVADWLYART
LADAPENQTLFTGEIFDINRAGMRIRLLENGAAAFIPGSLIIDNKERIECNGDLGTVSIDKEVVYKLGDVLEVVLADVNQ
ENRSLVAKPTQVFAELPVVEETQN
>Q7N4F5|IPR011129(23...79)|Exoribonuclease 2
MFQNNPLLAQLKQQLHSQTLRVEGLVKGTEKGFGFLEVDGQKSYFIPPPHMKKVMHGDRVTAAIHTDKEREIAEPETLIE
PFLNRFVGRIQKKENDNRLWITPDHPLLKDAIPCRPTNQVTHPFQHGDWAVAEMRHHPLKGSRGFHAEITGYITESDNHY
APWWVTLTRHNLERDAPAMTADCQMNDGDLERIDLTSLDFVTIDSATTEDMDDALHIAKQDDGSLKLSIAIADPTAYIAA
GSELDQIAHQRAFTNYLPGFNIPMLPRDLSENLCSLRPNARRPALVCQVSILEDGQLGDDIAFFSTWVESKAKLVYDEVS
DWLEKTGTWEPASEAIKTQITLLKEMSDRRNQWRHQNALIFKDRPDYRFILDENGYVLDIVVEQRRTANRIVEEAMITSN
LCAAKILRDKLGFGIYNVHMGFEPLQIEQVVELLQENDIDAKTEELLTLDGFCKLRRELDKKPTQFLDSRIRRFQTFAEI
KPEPGPHFGLGFDAYATWTSPIRKYSDMINHRLLKAIIQKTDVEQPSEETCLQLAERRRLNRMAERDVGDWLYARFLQPH
AGTEQRFTAEIIDITRGGLRVRLADNGAVAFIPAPFLHAVRDELQCSQETGTVIIKGEVAYQLNDIIDVRIDEVRMETRN
IVARPTA
>Q7NXP1|IPR011129(52...118)|Transcription termination factor Rho
MHLSDLKHLHVSELVEMAISNEIDGANRLRKQDLIFALLKNQAKKGESIFGEGTLEVLPDGFGFLRSPDTSYLAGPDDIY
VSPSQIRRFNLHTGDSIEGEIRTPKDGERYFALVKVDKVNGEAPENSKHKILFENLTPLFPTEQFKLEREIRAEENITGR
IIDLISPIGKGQRALLVAPPKSGKTVMLQHIAHAITANHPEAVLIVLLIDERPEEVTEMQRSVRGEVVSSTFDEPATRHV
QVAEMVIEKAKRLVEHKKDVVILLDSITRLARAYNTVVPASGKVLTGGVDANALQRPKRFFGAARNVEEGGSLTIVATAL
IDTGSRMDDVIYEEFKGTGNSEIHLDRRMAEKRIFPALNINRSGTRREELLVPQDQLQRIWVLRKLLYPMDDLEAMEFLQ
DKIKATKSNQAFFDSMRR
>Q7UGV0|IPR011129(145...211)|Transcription termination factor Rho
MHPSRMALIRPPLFSSYRFGSLLMEPSSTPGPARNARRSNRRMRHPDKDVDKRVRELDAERDPLSLPEEIVSEVTRAGGR
VGIPAKDQSPKQALNINDLQKLEHDELLALAETEGLQEIAALPRQELVFRLLKARMSANGLMYGEGTLEILPDGFGFLRS
AQYHYLSCPDDIYVSPSQIRRFGLHTGSHVAGQIRPPKENERYFALLRIEAINHADPMQRQRQKPFDDLTPLHPRTRIVT
EHDSQELSTRVVDLFTPIGFGQRGLIVSPPRAGKTMLMQSLARGVLNNYPDAYVVVLLIDERPEEVTDMEREIQSPQCEV
ISSTFDEPPARHIQVAQMVVEKAKRMVESGTDVVIFLDSITRLARAFNSDSDSATGKLLTGGLDAGAMQKPKSIFGSARK
VEEGGSLTILATALVDTGSRMDDVIFEEFKGTGNLEIVLDQDLVARRVWPAIDLTRSGTRREEMLLDQEEHRRIETLRRD
LAEHSPVDSMTELIKRMRKTQNNAEFLMSVHPQD
>Q7VLX8|IPR011129(23...78)|Exoribonuclease 2
MFQNNPLLAQLKQQIEANKEYVEGKVKASDKNFGFLEADKKSYFIPPLEMKKVMHGDNVKAVIKREGDKESVEIDSLIDP
MLDRFIARVRFNKDGKLQLAVDHPQIRLNIPATTHKKVTEQLANDDWVVAQLKSHPLRDDRFFFAQVTEFICKADDHFAP
WWVTLARHQQPRESVKTEQSYTLQDQSPREDLSHLYFTTIDSPSTQDMDDALFIEPITENAIQQGWRLVVAIADPTAYIA
EDSNIEHAARQRCFTNYLPGFNIPMLPRELSDDLCSLVPNKKRPALVVYIETDLNGNLIKDASFHTAWVESKAKLAYDNV
SDYLEGVEQAWQPDCAELKQQIYWLHQFTQARIQWRSKNALLFKEQMDYNFELNADGSVKSIQIQYHRIANQIIEEAMII
ANICCAQFLAKHAKTGIFNSHAGFDPKNYEAVQTFLLNTLATDENRSELTDLFSPTQLATLDGYCAMRRYIEDFPEKFLE
LRLRRYLTFAEFKAEVAPHFGLGISHYATWTSPIRKYGDIVNHRLIKQVLLNQPIKHIESTILARLQEARRQNRLVERDI
ADWLYARYLLPIATQGVEFDCEITDISRGGIRAKVLENGAQIFIPCSTLHENKDEIDFIPEEIALYTKGEKIYQIGQATR
VKLTDVRLETRSVLGNIIK
>Q803L0|IPR011129(35...106)|Protein lin-28 homolog A
MPPANPHLNHTGGCTKTEEEEAASSEEDSGSFHGSGVCKWFNVRMGFGFLSMTHREGICLDSPVDVFVHQSKLHMEGFRS
LKEGEAVEFTFKRSSKGLESLQVTGPGGAPCVGSEKKPKGTQKRRSKGDRCFNCGGPNHHAKECQLPPQPKKCHFCQSIS
HMVANCPIKAQQLSPGSQGKSTTSTGEEEDMSHTPLLPESTD
>Q816H3|IPR011129(3...66)|Cold shock-like protein CspD
MQTGKVKWFNSEKGFGFIEVEGGDDVFVHFSAIQGDGFKTLEEGQEVSFEIVEGNRGPQAANVTKN
>Q81DK5|IPR011129(4...67)|Cold shock-like protein CspE
MTLTGKVKWFNSEKGFGFIEVADGNDVFVHFSAITGDGFKSLDEGQEVSFEVEEGNRGPQAKNVVKL
>Q81GQ6|IPR011129(4...67)|Major cold shock protein CspA
MAVTGQVKWFNNEKGFGFIEVPGENDVFVHFSAIETDGFKSLEEGQKVSFEIEEGNRGPQAKNVIKL
>Q81K90|IPR011129(3...66)|Cold shock-like protein CspD
MQTGKVKWFNSEKGFGFIEVEGGDDVFVHFSAIQGDGFKTLEEGQEVSFEIVEGNRGPQAANVTKN
>Q81QK2|IPR011129(4...67)|Cold shock-like protein CspE
MTLTGKVKWFNSEKGFGFIEVEGGNDVFVHFSAITGDGFKSLDEGQEVSFEVEDGNRGPQAKNVVKL
>Q81TW8|IPR011129(4...67)|Major cold shock protein CspA
MAVTGQVKWFNNEKGFGFIEVPGENDVFVHFSAIETDGFKSLEEGQKVSFEIEEGNRGPQAKNVIKL
>Q83RI9|IPR011129(5...69)|Cold shock-like protein CspC
MAKIKGQVKWFNESKGFGFITPADGSKDVFVHFSAIQGNGLKTLAEGQNVEFEIQDGQKGPAAVNVTAI
>Q87IJ9|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQIQENLPKKEGSIKATDKGFGFLEVDSKTSFFIPPAYMKKCIHGDKVVAIIRTENEREVAEPQELIE
QSLTRFIGRVKMFKGKLNVVPDHPQLKKLSLKAKLKKGLKPDNFAEGDWVVAHLVRHPLKGDNTFFVEISEKITDADDKI
APWWVTLAQNDLPNSEPAGIENWELKDDADLERIEMTHVPFVTIDGESTKDMDDALYAKKTESGDFELTIAIADPTAYIT
PEDEMDKVARERGYTIYLPGRNIPMLPRDLADNLCSLIEGEIRPAICCTVTVSKDGVIGDDIKFFAANIKSHARLAYDHV
SDWLENGNSDAWQPSEEIATIVRDLYEFSLARAEWREKNAVVFPDRPDYRFELSEDNDVIAIHADMRRSANRLVEESMIT
ANICAGRTLREKFETGVFNTHAGLKPEKIEEVVQLVNPEGTLEFTAESIATLEGFAALRRWLAVQETSYLDNRIRKFQAY
SEVGNQPLPHYAMGLDIYATWTSPIRKYGDMINHRMLKAVILDKEPVQKPDDQVGEELALHRKHHKIAERNVSDWLYART
LADEPSKQTCFTGEIFDINRAGARVRLLENGAAAFIPGALILDNKERIECNGDNGTISIDKEVVYKLGDTLEIVLADVNQ
ENRSLVAKPTQVFADQPAPQTEQTVSEE
>Q89A22|IPR011129(52...118)|Transcription termination factor Rho
MNLTALKNIPVSELIFLGDNAGLENLARMRKQDIIFSILKQHAKSGEDIFGDGVLEILQDGFGFLRSSDSSYLAGPDDIY
VSPSQIRRFNLRTGDTISGKIRPPKEGERYFALLKVNKVNYDKPENARSKILFENLTPLHANSRLRMERGNGSTEDLTAR
VLDLASPIGRGQRGLIVAPPKAGKTMLLQNIAQSIAYNHPDCVLMVLLIDERPEEVTEMRRLVKGEVVASTFDEPSSRHV
QVSEMVIEKAKRLVEHKKDVIILLDSITRLARAYNTVVPASGKVLTGGVDANALHRPKRFFGAARNVEEGGSLTIIATAL
IDTGSKMDEVIYEEFKGTGNMELPLSRKIAEKRVFPAIDYNRSGTRKEELLTKSDELQKMWILRKIIHPMSEIDAMEFLI
NKLAMTKTNNEFFDMMKRS
>Q89A90|IPR011129(5...69)|Cold shock-like protein CspE
MSKIKGNVKWFNESKGFGFITPEDGSKDVFVHFSAIQSNGFKTLSEGQSVEFEITEGAKGPSAANVISL
>Q89AM0|IPR011129(23...79)|Exoribonuclease 2
MLRNHPLLSKLKRKLNSNIPRVEGIVKSTEKGFGFLEIDSKTSYFIPFKNMKKVMHGDRITALLKIDNSREIAEPEKLIE
PFLTRFIGTIQVNKSIISIIPDHPFFKEKIVCSVSCILPKCVKTGDWAVAVLMQHKLIQGHYKFLAKLVKYIIKKDDVLV
PWLVTLSRYQLESDCFKLNSSSIIFDNSLKREDLTHLDFITIDNSSTKDIDDALYVEKQSLGAFNLIVAISDPTSYIPFG
SSLDNFALKRSFTNYLPGFTIPMLPSELSENKCSLKVNKSRPVIACKIRIDSDGCILHNYSYFFLAWIKSKATLVYECVS
DWLEHKGKWVPECSNIANQLFMLNSIYNIRRNWRKNYAVLFKEHPEYNFKLSSNFQVLNVFMEMRRTAHKIVEEAMIAAN
ICAAKVLSEKLGFGIYNVHIGFDASNSENVVRLLSKYGFNFCKDEIRTLKGFCKLRRILNKHSYKYLDNRIKKYQSFGEL
QFFPGPHFALGLDAYATWTSPIRKYSDMVNHRLLKSIITHTHVIKPSCDILLKINDRRKRLKMAERDLEDWLYSKFFSSI
EYTKNSFNAEIIDVFRSGIRVRSLKNGANIFIPSSFLHNIRNELLCHQDQGIVYINDKKMYSVSDIIQVKLINIRTQTRN
LIGKPV
>Q8AVK2|IPR011129(34...105)|Protein lin-28 homolog B
MAEGGAARGTREEQGKLPEQEEEEEEDPQVLLGSGHCKWFNVRMGFGFISMTSREGSPLENPVDVFVHQSKLYMDGFRSL
KEGEPVEFTFKKSSKGFESLRVTGPGGNPCLGSERRPKAKTVQKRKPKGDRCYNCGGLDHHAKECNLPPQPKKCHYCQST
MHMVANCPHKIVPQHPTTSQGRYEAEPQPSTSSFQREGGGAFDYSSPSYSQEGRSELSERSSRSPQEASLSKISTSPEEQ
SRKGPSVQKKKK
>Q8CP90|IPR011129(3...66)|Cold shock protein CspA
MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQEGYKSLEEGQSVEFEVVEGDRGPQAANVVKL
>Q8D7K6|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQIQENLPKKEGTIKATEKGFGFLEVDSKTSFFIPPAYMKKCMHGDKVIAIIRTENEREVAEPQELVE
QMLNRFIGRVKMFKGKLNVVPDHPQLKKMSLKAKTKKGLNPQEFAEGDWVVGHLIRHPLKDDNGFFVEISEKITDADDKI
APWWVTLAENDLPNSEPAGIDDWQIKDDADLERIDMTHIPFVTIDGESTKDMDDALYAKKNDAGDFELTIAIADPTAYIT
PDDEMDKVARERGFTIYLPGRNIPMLPRDLADELCSLIEGEIRPALCCTVTVSKDGVIGDDIQFFAANIKSHARLAYDNV
SDWLETGSCEKWQPSEEIAAIVRDLYEFSQARAEWREKNAVVFPDRPDYRFELSEDNDVVAIHADMRRSANRLVEESMIT
ANICAGKTLQGHFGTGVFNCHAGFKPEKIADVVELVNPEGTLEFTAESIATREGFAALRRWLSKQETTYLDNRIRKFQTY
SEVSNQPLPHYAMGLDIYATWTSPIRKYGDMINHRMLKALILNKEPVQKPDDSVGEELALHRKHHKIAERNVADWLYART
LADAPENQTLFTGEIFDINRAGMRIRLLENGAAAFIPGSLIIDNKERIECNGDLGTVSIDKEVVYKLGDVLEVVLADVNQ
ENRSLVAKPTQVFAELPVVEETQN
>Q8FHT6|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVREDLTALDFVTIDSASTEDMDDALFAKALPDGKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSTDGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETAYKVTDVIDVTIAEVRMETRSIIA
RPVA
>Q8JHC4|IPR011129(35...106)|Protein lin-28 homolog A
MGSVSNQEITEGLPKSLDGTADIHKSDKSVIFQGSGVCKWFNVRMGFGFLTMTKKEGTDLETPLDVFVHQSKLHMEGFRS
LKEGESVEFTFKKSSKGLESTQVTGPGGAPCIGSERRPKVKGQQKRRQRGDRCYNCGGLDHHAKECKLPPQPKKCHFCQN
PNHMVAQCPEKAMQAANLEDQPITEEQELIPEIME
>Q8K3Y3|IPR011129(41...112)|Protein lin-28 homolog A
MGSVSNQQFAGGCAKAAEKAPEEAPPDAARAADEPQLLHGAGICKWFNVRMGFGFLSMTARAGVALDPPVDVFVHQSKLH
MEGFRSLKEGEAVEFTFKKSAKGLESIRVTGPGGVFCIGSERRPKGKNMQKRRSKGDRCYNCGGLDHHAKECKLPPQPKK
CHFCQSINHMVASCPLKAQQGPSSQGKPAYFREEEEEIHSPALLPEAQN
>Q8K917|IPR011129(86...145)|Ribonuclease R
MVVDSYQKKETKKYRNFIPRREQILFLLKTDKDLISQKKLEKKFSINSQEQKKALRRRLRAMERDGQIIYTRNRCYITPE
NLKIVTGKVIGHRDGYGFLRTETFKDDLWLSIEQMKLCIHGDVILAHIVKSDRKGRNSAKVLKILRPNDVLIVGRYCVDN
KKKFVIPNDTRFNFKIFILDSLISNENISIGTIVVVKLRENATKKSKIQGTIVEVLGKEMGTNLAIKIALRTHCIPYLWS
KEVEYQLCGIKSKINEKDFKNRIDLRHLPFFTIDEEDARDFDDAIFCKKKTNGEKGWKLWVAISDVSYYIQPDTALDKAA
SKRGTSIYFPSLVIPMLPEKISIDVCSLNPNAERLSLICEMNLSNKGELITYKHYEAVICSHGRFTYNEIFKIWNGDIEL
CFKYKKLLKYIQNLSSLQKILKKYNVSKRGIYFENIEAKFILDSNYRIKNISQNIRNDAHKFIESCMILANIASAEFVKK
HKSPVLFRNHDRPDKDSIINFRSVLKKLGLSLLGGEIPESTDYSELLKKISTRPDYEMIQTILLRSMKQAVYSPDNRGHF
GLSLSSYVHFTSPIRRYPDLLVHRVIKNLLLKEKNLSKYHLYNLNEVTKIGLHCSMTERRADEATRDVLDWLKCDFMQKK
IGDVLTGVISNVTSFGFFVRLNQFFIDGLVHIATLIDDYYYFDSIGLKLIGKSSKNTYCLGDTLKVKVISVNLNERKIEL
SLYMSR
>Q8K9Q5|IPR011129(23...79)|Exoribonuclease 2
MFQNNPLLAQLKKNLHAKTPRVEGIVKSTERGFGFLEVDAQKSYFIPPKNMKNVMHGDKISAVLKIEKDREIAEPEKLIE
PFLNRFVGKIEKKDNKLFIFPDYPFLKDFIACRPKKSCVHVFQTGDWAVAKLIQHKLNGNHIFYAELIEEIVKANNPLIP
WWVTLSRHNLERKEPKIEKDDLILKNNSHREDLTHLNFITIDNFNTKDIDDALFIEEIHNGNLRLIVAIADPTSYIKSGS
KLDITAAKRGFTNYLPGFNVPMLPRSLSEDICSLNPHERRPVLACCITILKDGNICSKINFFLAWIKSKSKLSYDNVSDW
IEKKSSWKPETKSIENQILLLHRLCLLRIKWRTSNAVLFQDSLEYRFQFSETGIVEDVVIEKRRIAHKIIEESMIIANIS
AANFLSKNLGFGIYNTHAGFDPINAENVVSFLNNYNLKFTVKEITTLKGFCNLRRVLNILSDNYINSRIRRYQSFGDFSI
TPSPHFALGLVEYATWTSPIRKYSDMINHRLLKSIINQDTNITKPSEDIKLKISEQKRRNRIAERDISDWLYTLLLQKKE
FKNKKFNAEIIDVSRSGIRAKLLENGANVFIPALFLHPIREELVFNQETGKVFIKGVLYYKISDLITVVLSEIRLQTRSI
IARIDH
>Q8RG42|IPR011129(49...110)|Transcription termination factor Rho
MDILNKLLLKDLQEIAKVMEIEIGVGQKKDELKRIISNSLEENNTELAYGTLDTAPEGFGFLKETTLGKNIYMSASQIKR
FKLRRGDQVLGEVRKPIGEEKNYAIRRVLKANDNDLAALESRVPYEELIPTYPTEQFVLGIEQGNISGRILDLISPIGKG
QRALIIAPPKAGKTTFISSIANALIEGQKDSEVWILLIDERPEEVTDIKENVEGATVFASTFDDDPKNHIKVTEEIIEKA
KMKVEDGENVVILLDSLTRLARAYNIVMPSSGKLLSGGIDPTALYHPKNFFGAARNIKDGGSLTIIATILVDTGSKMDEV
IYEEFKSTGNCDIYLDRQLAEFRIFPAIDITKSGTRKEELLLNKNQIDDIWNLRRLLNDYDNKVSATSALIKAIKTTRNN
DELLAQLPKVLYK
>Q8X7D6|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIIAVIHSEKERESAEPEELVE
PFLTRFVGKVQGKNDRLAIVPDHPLLKDAIPCRAARGLNHEFKEGDWAVAEMRRHPLKGDRSFYAELTQYITFGDDHFVP
WWVTLARHNLEKEAPDGVATEMLDEGLVRKDLTALDFVTIDSASTEDMDDALFAKALPDDKLQLIVAIADPTAWIAEGSK
LDKAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPVLACRMTLSADGTIEDNIEFFAATIESKAKLVYDQVSDWL
ENTGDWQPESEAIAEQVRLLAQICQRRGEWRHNHALVFKDRPDYRFILGEKGEVLDIVAEPRRIANRIVEEAMIAANICA
ARVLRDKLGFGIYNVHMGFDPANADALAALLKTHGLHVDAEEVLTLDGFCKLRRELDAQPTGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGETATRPQDEITVQMAERRRLNRMAERDVGDWLYARFLKDKAGT
DTRFAAEIVDISRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPVA
>Q8Z7C9|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNAAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPALACRMIIAADGTIDDDIAFFAATIESKAKLVYDNVSDWL
ENNSTWQPENEGIAQQIRLLHRICLSRSEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGEAIARPQEDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
NTRFAAEIIDVSRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPAA
>Q8ZED8|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHTQTPRVEGVVKGTEKGFGFLEVDGQKSYFIPPPQMKKVMHGDRIIATLHTDKDREIAEPETLVE
PFLSRFVGRVQRKDDRLSIVPDHPLLRDAIQCRPVRELTHSFQNGDWAVAEMCRHPLKGDRAFQADLTAFITNGEDHFVP
WWVTLARHNLEREAPAMVESALNDAELEREDLTALNFVTIDSASTEDMDDALFVQDNGDGSWLLTIAIADPTAYVVENSE
LDLTARKRAFTNYLPGFNIPMLPRDLSDNLCSLRPNERRPVLVCRVTITEEGTLSNDIRFSAAWVESKAKLVYDDVSDWL
EGNNRWQPQDTAIAEQITLLKRICDARSNWRQQHALVFKDRPDYRFLLGEKGEVLDIIVEHRRIANRIVEECMIAANVCA
ALALREHLGFGIYNVHTGFDPALVEQAASVLKANGVGADPQALLTLPGFCELRRHLDALPTQFLDSRIRRFQTFAEISTV
PGPHFGLGLEAYATWTSPIRKYGDMVNHRLLKAMITGQQAEKPQEEITVQLAERRRLNRMAERDVGDWLYARYLQPQAGT
DTRFTAEIIDITRGGLRVRLLDNGAVAFIPAPFIHAVRDEVVCSQETGTVQIKGETVYSQSDKIEVRIAEVRMETRNVIA
RPVA
>Q8ZP54|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQQLHSQTPRAEGVVKATEKGFGFLEVDAQKSYFIPPPQMKKVMHGDRIVAVIHTEKERESAEPEELIE
PFLTRFVGKVQGKNDRLSIVPDHPLLKDAIPCRAARGVQHEFKEGDWAVAEMRRHPLKGDRSFYADLTQYITFADDHFVP
WWVTLARHNLEKEAPNGVATEMLDEGLERQDLTALNFVTIDSASTEDMDDALYAEELADGRLQLTVAIADPTAWIAEGSK
LDNTAKIRAFTNYLPGFNIPMLPRELSDDLCSLRANEVRPALACRMIIAADGTIDDDIAFFAATIESKAKLAYDNVSDWL
ENNGTWQPDNEGIAQQIRLLHRICLSRSEWRHHHALVFKDRPDYRFVLGEKGEVLDIVAEPRRIANRIVEESMIAANLCA
ARVLRDKLGFGIYNVHTGFDPANADALAALLKTHGLHVDAEEVLTLEGFCKLRRELDAQPSGFLDSRIRRFQSFAEISTE
PGPHFGLGLEAYATWTSPIRKYGDMINHRLLKAVIKGEAIARPQEDITQQMAERRRLNRMAERDVGDWLYARFLNDKAGT
NTRFAAEIIDVSRGGMRVRLVDNGAIAFIPAPFLHAVRDELVCSQENGTVQIKGETVYKVTDVIDVTIAEVRMETRSIIA
RPAA
>Q91W50|IPR011129(27...90;187...248;350...413;520...582;675...738)|Cold shock domain-containing protein E1
MSFDPNLLHNNGHNGYPNGTSAALRETGVIEKLLTSYGFIQCSERQARLFFHCSQYNGNLQDLKVGDDVEFEVSSDRRTG
KPIAIKLVKIKPEIHPEERMNGQVVCAVPHNLESKSPAAPGQSPTGSVCYERNGEVFYLTYTSEDVEGNVQLETGDKINF
VIDNNKHTGAVSARNIMLLKKKQARCQGVVCAMKEAFGFIERGDVVKEIFFHYSEFKGDLETLQPGDDVEFTIKDRNGKE
VATDVRLLPQGTVIFEDISIEHFEGTVTKVIPKVPSKNQNDPLPGRIKVDFVIPKELPFGDKDTKSKVTLLEGDHVRFNI
STDRRDKLERATNIEVLSNTFQFTNEAREMGVIAAMRDGFGFIKCVDRDARMFFHFSEILDGNQLHIADEVEFTVVPDML
SAQRNHAIRIKKLPKGTVSFHSHSDHRFLGTVEKEATFSNPKTTSPNKGKDKEAEDGIIAYDDCGVKLTIAFQAKDVEGS
TSPQIGDKVEFSISDKQRPGQQIATCVRLLGRNSNSKRLLGYVATLKDNFGFIETANHDKEIFFHYSEFSGDVDSLELGD
MVEYSLSKGKGNKVSAEKVNKAHSVNGITEEANPTIYSGKVIRPLRGVDPTQIEYQGMIEIVEEGDMKGEVYPFGIVGMA
NKGDCLQKGESVKFQLCVLGQNAQTMAYNITPLRRATVECVKDQFGFINYEVGDSKKLFFHVKEVQDGVELQAGDEVEFS
VILNQRTGKCSACNVWRVCEGPKAVAAPRPDRLVNRLKNITLDDASAPRLMVLRQPRGPDNSMGFGAERKIRQAGVID
>Q91YQ3|IPR011129(71...136)|Cold shock domain-containing protein C2
MTSESTLPPVVPPLHSPKSPVWPTFPFHREGSRIWERGGGIAPRDLPSPLPTKRTRTYSATARASAGPVFKGVCKQFSRS
QGHGFITPENGSEDIFVHVSDIEGEYVPVEGDEVTYKICPIPPKNQKFQAVEVVLTQLAPHTPHETWSGQVVGS
>Q92GV1|IPR011129(6...70)|Cold shock-like protein CspA
MATNIVGKVKWYNSTKNFGFIEQDNGGKDVFVHKSAVDAAGLHSLEEGQDVIFDLEEKQGKAYAVNLRIK
>Q92HL2|IPR011129(82...148)|Transcription termination factor Rho
MNTTNKESTAELNNTESNNNYNNFAENGNIINLKQLKRKLPEELQAQAEELKIENINSLLKQELVFAILKKSVEQGVLIV
GEGVLEVLPDGFGFLRSPEVNYLAGPDDIYISPSQIRRFGLRTGDTVEGQIRAPKAGERYFALLKVNRVNFEDPSKAYHR
VHFDNLTPLYPDEKLGLELENNSKDSKDFSTRVIELVAPMGKGQRALIVAPPRTGKTVLLQNIAHAITTNNPEVFLIVLL
IDERPEEVTDMQRSVRGEVVSSTFDEPASRHVQLAEMVIKKAKRLVEHKKDVVILVDAITRLARAYNTVVPSSGKVLTGG
VDANALQRPKRFFGAARNIENGGSLTIIGTALIETGSRMDEVIFEEFKGTGNSEIVLDRKIADKRIYPAIDITRSGTRKE
DLLVDKIILNKMWVLRRIIDPMGSSEAIEFLLKKLENTKTNGEFFEMMKSPERPKNGL
>Q94C69|IPR011129(12...77)|Cold shock domain-containing protein 3
MAMEDQSAARSIGKVSWFSDGKGYGFITPDDGGEELFVHQSSIVSDGFRSLTLGESVEYEIALGSDGKTKAIEVTAPGGG
SLNKKENSSRGSGGNCFNCGEVGHMAKDCDGGSGGKSFGGGGGRRSGGEGECYMCGDVGHFARDCRQSGGGNSGGGGGGG
RPCYSCGEVGHLAKDCRGGSGGNRYGGGGGRGSGGDGCYMCGGVGHFARDCRQNGGGNVGGGGSTCYTCGGVGHIAKVCT
SKIPSGGGGGGRACYECGGTGHLARDCDRRGSGSSGGGGGSNKCFICGKEGHFARECTSVA
>Q9CP74|IPR011129(23...78)|Exoribonuclease 2
MFQNNPLLSQLKQQIRDSKQQVEGIVKGSDKAFGFLECDKKSYFIPPAAMKKVMHGDKIKALIEVVGEKEQAEPDALIEP
MLTRFIARVRFNKDKKLQVLVDHPQINQAIGAAQDKSITETLQEGDWVVATLKTHPLRDDRFFFAQIQQFICRAEDELAP
WWVTLARHGQSRYPVQGCADYPMIDQHTREDLTALHFITIDAETTLDMDDALYLEPIHQAEEQIGWRLVVAVADPTAYIP
LDSQIEQEARQRCFTNYLPGFNIPMLPPELSDERCSLMQDEIRPALVCYIETDLTGNITEKPRFVSAYVQSKAKLAYDHV
SDYLENCLDAWQPENPQIAQQIQWLHQFTQARIEWRKQHALLFKEKPDYSFILAENGSVQAIQAQYRRIANQMVEECMIL
ANICAAHYLDEHAKCGIFNTHSGFDKKYLESAHQFLLNQLSDETNQAVLATRYSVANLTTLAGYCQMRHDIELLNSDYLE
LRLRRFLTFAEFKSEIAPHFGLGLSGYATWTSPIRKYSDMVNHRLIKAVLTQQTCEKPQDDLFVRLQEARRQNRLVERDI
ADWLYCRYLATQVEQKPTFQAEIQDVMRGGLRVQLLANGAPMFIPASLIHDNKEAIQVNTDTLTLSIQGEVKYKLGDIIQ
VQLLDVKEETRSIVGTLC
>Q9CR86|IPR011129(65...130)|Calcium-regulated heat stable protein 1
MSSEPPPPPLQPPTHQTSVGLLDTPRTRDRSPSPLRGNVVPSPLPTRRTRTFSATVRASQGPVYKGVCKCFCRSKGHGFI
TPADGGPDIFLHISDVEGEYVPVEGDEVTYKMCSIPPKNEKLQAVEVVITHLAPGTKHETWSGHVISN
>Q9H9Z2|IPR011129(41...112)|Protein lin-28 homolog A
MGSVSNQQFAGGCAKAAEEAPEEAPEDAARAADEPQLLHGAGICKWFNVRMGFGFLSMTARAGVALDPPVDVFVHQSKLH
MEGFRSLKEGEAVEFTFKKSAKGLESIRVTGPGGVFCIGSERRPKGKSMQKRRSKGDRCYNCGGLDHHAKECKLPPQPKK
CHFCQSISHMVASCPLKAQQGPSAQGKPTYFREEEEEIHSPTLLPEAQN
>Q9HTV1|IPR011129(52...118)|Transcription termination factor Rho
MNLTELKQKPIAELLEMSDAMGLENMARSRKQDIIFALLKKHAKSGEEISGDGVLEILQDGFGFLRSADSSYLAGPDDIY
VSPSQIRRFNLRTGDTIIGKIRPPKEGERYFALLKVDSINFDRPENAKNKILFENLTPLFPNERMKMEAGNGSTEDLTGR
VIDLCAPIGKGQRGLIVAPPKAGKTIMLQNIASNITRNNPECHLIVLLIDERPEEVTEMQRTVRGEVVASTFDEPPTRHV
QVAEMVIEKAKRLVEHKKDVVILLDSITRLARAYNTVIPSSGKVLTGGVDAHALEKPKRFFGAARNIEEGGSLTILATAL
VETGSKMDEVIYEEFKGTGNMELPLDRKIAEKRVFPAININRSGTRREELLTSEDELQRMWILRKILHPMDEISAIEFLI
DKLKQTKTNDEFFDSMKRK
>Q9JKB3|IPR011129(84...152)|Y-box-binding protein 3
MSEAGEATTGGTTLPQAAADAPAAAPPDPAPKSPAASGAPQAPAPAALLAGSPGGDAAPGPAPASSAPAGGEDAEKKVLA
TKVLGTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGEKGAEAANVTGPDGVPVEGS
RYAADRRRYRRGYYGRRRGPPRNYAGEEEEEGSGSSEGFEPPAADGQFSGARNQLRRPQYRPPYRQRRFPPYHVGQTFDR
RSRVFPHPNRMQAGEIGEMKDGVPEGTQLQAHRNPTYRPRFRRGPARPRPAPAIGEAEDKENQQAANGPNQPSARRGFRR
PYNYRRRSRPLNAVSQDGKETKAGEAPTENPAPATEQSSAE
>Q9KL16|IPR011129(6...70)|Cold shock protein CspV
MSTKMTGSVKWFNETKGFGFLTQDNGGNDVFVHFNSIQSEGFKTLAEGQRVSFIVEQGKKGPQASNVVAL
>Q9KLE1|IPR011129(23...79)|Exoribonuclease 2
MFQDNPLLAQLKQKIQETLPKKEGTIKASDKGFGFLEVDSKTSYFVPPPYMKKCMHGDKVVAFIRTENEREVAEPSELIE
QSLTRFIGRVKLFKGKLNVAPDHPQLKKLSLKAKTKKGLNEADFQEGDWVVAHLVRHPLKGDDGFFVQISHKITDANDKI
APWWVTLAENDLPNSEPAGIDDWQLKDDADLVREDLTALPFVTIDGESTKDMDDALYAQQLPNGDFALTIAIADPTAYIT
PEDEMDKVARERGFTIYLPGRNIPMLPRDLADELCSLMENQVRPALCCSVTIRKDGVIGDDIRFFAANIKSHARLVYDHV
SDWLETGSSEQWQPSEEIAQVVRDLYAFSQARANWRETHAVVFPDRPDYRFELSADNDVVAIHADMRRTANRLVEESMIT
ANICAGKTLQTTFGFGVFNTHAGFKAEKMADVVELMAVNGAPNADAETLATVEGFAALRRWLATQETSYLDNRIRKYQSY
SEIGNQPLPHFAMGLDVYATWTSPIRKYGDMINHRLLKAHILGKAPVQTPDETVGEELALHRKHHKIAERNVADWLYART
LADEPAKETRFQAEIFDINRPGMRVRLLENGAMAFIPGALILDNKERIECNGEDGTVLIDKEVVYKLGDVLEIVLTEVNQ
ENRSLVGKPTQVFADLVSETQTSAEQPAEGAENNEPQV
>Q9KN00|IPR011129(6...70)|Cold shock-like protein CspA
MSQKMTGSVKWFNETKGFGFISQDNGGQDVFVHFKSIVSEGFKTLAEGQRVSFTVEQGKKGPQAAQVTAL
>Q9KNY1|IPR011129(90...152)|Ribonuclease R
MSDTTHLDPFADREADNYDNPIPSREYILEFLTQANVPMNRNDLFEALKLEGEEQYEGLRRRLRAMERDGQLVFTRRQCY
ALPEKLEMVKGYVIGHKDGHGWVRPEGSLNKEGDILLPHHQMRTLIHGDFVLVQPSGTDKRGRKEGRLVRILEERNGQIV
GRFFFEYGYSYVVPDDSRIHHDILIPNDLRAGARMGNVVVIEITDRGTRNRGMMGKVVEVLGENMAPGMETQIAIRTHQI
PHEWPAEVEQQVAGLTEEVPEEAKQGRVDLRALPLVTIDGEDARDFDDAVYCEAKKGGGWRLWVAIADVSYYVRPDTALD
KEAINRGNSVYFPSQVVPMLPEVLSNGLCSLNPQVDRLCMVCEMTVSETGKLSGYKHYEAVMNSHARLTYTKVHEILEGD
EELRERYKALVPHLEELHKMYQVLKSARDERGAIEFETVETKFIFNAQRKIESIEPVVRNDAHKLIEECMILANIASASL
VEKAKEAALYRVHEPPGEERLTGFRDFLGELGLDLSGGLEPSPTDYANLMKQIGERPDKELIQTMLLRSMKQAVYNADNA
GHFGLALKRYAHFTSPIRRYPDLLLHRAIKYLIAKQEGRNQDRWTPTGGYHYSFDDMDFYGEQCSMTERRADDATREVSD
WLKCEYMQDHVGEELEGVVANVTSFGFFVRLTELHIDGLVHISTLANDYYHYDPIGQRLVGESFGAIYRLGDAVKVKVLA
VNLDDRQIDFELVETSRKLRGQGKTAKKRADEARAKAQGKKEAATKGACGKSPTKSELKPQVEATRRPDSEGRSKPKKTK
APKKRKDQARKKSGKVRDKTK
>Q9KSW4|IPR011129(6...70)|Cold shock-like protein CspD
MYSMATGTVKWFNNAKGFGFICPEGEDGDIFAHYSTIQMDGYRTLKAGQQVSYQVEQGPKGYHASCVVPIEGQSAK
>Q9PA21|IPR011129(45...111)|Transcription termination factor Rho
MPAHKLLEIAEQLNIHEGVARARKQDVIFALLKVLTRHGEGVFADGVLEILPDGFGFLRAAEASYLAGPDDTYISPSQIR
RFNLRTGDHLSGRIRFPKDGERYFALSIVDTINGEPLEASKNKILFENLTPLFPRKRFRLERADGSTEDITGRILDLMAP
QGKGQRALIVSPPKAGKTMLMQQVATAITTNHPEVHLIVLLIDERPEEVTEMQRTVRGEVISSTFDEPAARHVQVAEMVI
ERAKRLIEHKKDVVILLDSITRLARAYNNVVPSSGKVLTGGVDANALHRPKRFFGAARNVEEGGSLTIIATALIDTGSKM
DEVIYEEFKGTGNCELHLNRRIAEKRVYPAIDINRSGTRREDLLIESDLLQKIWILRKLLHPMDEIAAIEFVLDKMKNTK
SNDEFFGSMKR
>Q9PK00|IPR011129(20...84)|Ribonuclease R
MGKAKNKKKVLKNKQQVLVPGILFVHPKKGFGFVSPDQPDLYPFDIFVPASDLKGALDGDHVLVALPFSQRGGEKRKGVI
HKVLSRGKTVLVGTIISLISPTLAMVCVNAISPEVPLKAELLPKRTYKIGDRLLLKTPGWKENYPSKEPPPLAMLEFMGN
ISNAKTDFPVIKAEFSITEEFPEAVVQEASQFLQKHVTQALHSRKDLRDLLCFTIDSASAKDFDDAVSLTYDHEGNYILG
VHIADVSHYVTPNSALDQEAAKRCNSIYFPGKVIPMLPSALSDNLCSLKPNVDRLAVSVFMTFSKEGFLSDYRILRSVIR
SKYRMTYDEVDEIIEKKLAHPISKTILEMAELSRIFSDIREQRGCTRLVLPSFTMSLDNLQEPVALVENKQTAAHKLIEE
FMLKANEVIAYHISHQGITMPFRIHEPPNEENLLLFRETAKAMGFTITQTPTQEPDYQYLLQETSAGHPLEPILHSQFVR
SMKTASYSTENKGHYGLCLDYYTHFTSPIRRYVDLIVHRLLFHPLSVEEGHLEQIVRACSSQERVAAKAEGAFINIKKAR
FLKKFLDEQPATLYKAFIITVSPEGLSFVLPELCHEGFIPAAKLPKKYVIKTKLGLEELPEHLLPGIPISVQLASVTLLT
QAIEWTLIESKERSSSKKKKAKAKSNATQVKKKSSSKKKKAVSKAKKNRGGK
>Q9S170|IPR011129(6...70)|Cold shock-like protein CspG
MSNSTTGLVKWFNEEKGFGFITQDNGGDDVFVHFRSITSDGFKTLAEGQKVSFEVEQGQKGLQAANVVAL
>Q9S1B7|IPR011129(6...70)|Cold shock-like protein CspA
MSDSNTGTVKWFNEDKGFGFLTQDNGGADVFVHFRAIASEGFKTLDEGQKVTFEVEQGPKGLQASNVIAL
>Q9VRN5|IPR011129(40...104)|Protein lin-28 homolog
MENVQLENGLERRTTSQSSTSSANPANLASPTEECGCVRLGKCKWFNVAKGWGFLTPNDGGQEVFVHQSVIQMSGFRSLG
EQEEVEFECQRTSRGLEATRVSSRHGGSCQGSTYRPRINRRTRRMRCYNCGEFANHIASECALGPQPKRCHRCRGEDHLH
ADCPHKNVTQSHSNSKSISNNSSSSAAQEKSEEAT
>Q9VVA0|IPR011129(56...121)|Cold shock domain-containing protein CG9705
MTEPRTPEKLLAAKPPVLHHNSHSPNASLQLPSPIITRRTRTASTSARALENPVVTGMVKSFSRTKGHGFITPNAGGEDV
FCHVSDIEGEYVPMPGDEVKYRLCAIPPKYEKHQAVHVQISHLTPEVHHKWEEPFYGGSSPAK
>Q9WU49|IPR011129(64...129)|Calcium-regulated heat stable protein 1
MSSEPPPPPQPPTHQTSIGLLDTPRARDRSPSPLRGNVVPSPLPTRRTRTFSATVRASQGPVYKGVCKCFCRSKGHGFIT
PADGGPDIFLHISDVEGEYVPVEGDEVTYKMCSIPPKNEKLQAVEVVITHLAPGTKHETWSGHVISS
>Q9WZI1|IPR011129(134...198)|Ribonuclease R
MSSIRKKDVERFILSDDYKPMVLKELYKKFRAKTREQRKKVREVVKKLEKEGRIFRDSRGRYRKLGEDLKVGTIEFTRSG
YVAFVITDDFEEIAVPVEDTKYAMHKDRVVVEITGTWRGLPRGRVVRVLERGLKRVVGVFDHKGTFGFVVPDDPKIAYDF
YVAPENIDGAKPNQKVIAEILKYPSPGKNPEAKVVKVLGDLDDPSIDLPSVIVKHDLPEPGEFPEEVIREANAIPARVRK
KDLVGRKDLRDKVIVTIDGEDAKDFDDAISVEKLPNGNYLLGVHIADVSHYVKEGSALDQEAFKRGTSVYLIDTVIPMLP
FRLSNGICSLVEGKDRLTMSVEMEIDRDGRVVRYDVYPSVIKSKKRMIYERVNEFLEDPSSMKEYEPFKDLIYNAVELAE
ILREARRKRGAILDIESDEVKVILDENGQVVDIVPRKRGIAEKLIEEFMIRANETVAEIFDHAGLPFMYRVHEEPDPETI
FQLKNYLEAMGIRAKFSHKIHPGMLQKLLEKVKDHPLRSSVERLLVRSMKRAMYSAVNIGHFGLASYAYTHFTSPIRRYP
DLVVHRLLKLYLEQNGYFTPEQIEKFSKVLPKIAKHCSRRERVADEAEWDLVAMKKVEYIARHIGEVFNVVVTNITKFGL
FVEIPEKSISGLVHISTLDDYYYYDETRNMLIGKRKGKVFRLGDVLKAKVVRADKIRGEIDFVLVEEDEE
>Q9Y2T7|IPR011129(95...163)|Y-box-binding protein 2
MSEVEAAAGATAVPAATVPATAAGVVAVVVPVPAGEPQKGGGAGGGGGAASGPAAGTPSAPGSRTPGNPATAVSGTPAPP
ARSQADKPVLAIQVLGTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKRNNPRKFLRSVGDGETVEFDVVEGEKGAEATNV
TGPGGVPVKGSRYAPNRRKSRRFIPRPPSVAPPPMVAEIPSAGTGPGSKGERAEDSGQRPRRWCPPPFFYRRRFVRGPRP
PNQQQPIEGTDRVEPKETAPLEGHQQQGDERVPPPRFRPRYRRPFRPRPRQQPTTEGGDGETKPSQGPADGSRPEPQRPR
NRPYFQRRRQQAPGPQQAPGPRQPAAPETSAPVNSGDPTTTILE
>Q9Y2V2|IPR011129(64...129)|Calcium-regulated heat-stable protein 1
MSSEPPPPPQPPTHQASVGLLDTPRSRERSPSPLRGNVVPSPLPTRRTRTFSATVRASQGPVYKGVCKCFCRSKGHGFIT
PADGGPDIFLHISDVEGEYVPVEGDEVTYKMCSIPPKNEKLQAVEVVITHLAPGTKHETWSGHVISS
>Q9Y534|IPR011129(70...135)|Cold shock domain-containing protein C2
MTSESTSPPVVPPLHSPKSPVWPTFPFHREGSRVWERGGVPPRDLPSPLPTKRTRTYSATARASAGPVFKGVCKQFSRSQ
GHGFITPENGSEDIFVHVSDIEGEYVPVEGDEVTYKMCPIPPKNQKFQAVEVVLTQLAPHTPHETWSGQVVGS
>Q9Z2C8|IPR011129(97...165)|Y-box-binding protein 2
MSEAEASVVATAAPAATVPATAAGVVAVVVPVPAGEPQKAGGGAGGGGGAASGPAAGTPLHAPGPRTPGNQATAASGTPA
PPARSQADKPVLAIQVLGTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKRNNPRKFLRSVGDGETVEFDVVEGEKGARAA
NVTGPGGVPVKGSRYAPNRRRFRRFIPRPRPAAPPPMVAEAPSGGTEPGSEGERAEDSGQRPRRRRPPPFFYRRRFVRGP
RPPNQQQPIEGSDGVEPKETAPLEGDQQQGDERVPPPRFRPRYRRPFRPRPPQQPTTEGGDGETKPSQGPTDGSRPEPQR
PRNRPYFQRRRQQPPGPRQPIAAETSAPINSGDPPTTILE
>Q9Z3S6|IPR011129(3...69)|Cold shock protein CspA
MNSGTVKWFNSTKGFGFIQPDDGATDVFVHASAVERAGMRSLVEGQKVTYDIVRDTKSGKSSADNLRAA
>Q9Z848|IPR011129(23...87)|Ribonuclease R
MLKKPKRKPGRRTYGKSLKIFIPGTLFVHARKGFGFVSPDNPEEYPFDIFVPARDLRGALDGDHVIVSVLPYPRDGQKLK
GTISEVLARGKTTLVGTITSLVSPTSALAYTSMSGSQSLIPVELLPGRTYKIGDRILLSTPPWVDKPQEGASPALQMLEF
IGHITNAKADFQAIQAEYNLAEEFPPEVIEEASLFSQKHITQVLHSRKDLRDLLCFTIDSSTARDFDDAISLTYDHNNNY
ILGVHIADVSHYVTPHSHLDKEAAKRCNSTYFPGKVIPMLPSALSDNLCSLKPNVDRLAVSVFMTFTKSGHLSDYQIFRS
VIRSKYRMTYDEVDNIIEKKHSHPLSKILNEMATLSKKFSDIREERGCIRFVLPSVTMSLDNLQEPVALIENHQTFSHKL
IEEFMLKANEVVAYHISHQGVSLPFRSHEPPNDENLLAFQELAKNMGFDITFTPTQEPDYQYLLQTTSAGHPLEQVLHSQ
FVRSMKTASYSTENKGHYGLKLDYYTHFTSPIRRYIDLIVHRLLFNPLSIDQTHLEIIVRACSTKERVSAKAENSFENLK
KTRFINKFLQEQPKTTYHAYIITANHEGLSFVVTEFCHEGFIAAAELPKEYSLKKNALPESIPDKMKPGASIKVTIDSVN
LLTQKIVWSIATTTEDKPKKIKKTPSKKKGTKKRAS
>Q9ZCP9|IPR011129(6...70)|Cold shock-like protein CspA
MATNIVGKVKWYNSTKNFGFIEQDNGGKDVFVHKSAIDAAGLHSLEEGQEVIFDIEEKQGKAYAVNLRVK
>Q9ZD24|IPR011129(81...147)|Transcription termination factor Rho
MNTTNKQLTEELNNTESNNDHNDFAENNIINLKQLKRKLPEELQVQAEELKIENISSLLKQELVFAILKKSVEQGGLIVG
EGVLEVLPDGFGFLRSPEVNYLAGPDDIYISPSQIRRFGLRTGDTVEGQIRAPKAGERYFALLKVNRVNFEDPAKAYHRV
HFDNLTPLYPDEKLGLELENNSKDSKDFSTRVIELVAPMGKGQRALIVAPPRTGKTVLLQNIAHAITTNNPEVFLIVLLI
DERPEEVTDMQRSVRGEVVSSTFDEPASRHVQLAEMVIEKAKRLVEHKKDVVILVDAITRLARAYNTVVPSSGKVLTGGV
DANALQRPKRFFGAARNIENGGSLTIIGTALIETGSRMDEVIFEEFKGTGNSEIVLDRKIADKRIYPAIDITRSGTRKED
LLVDKIILNKMWVLRRIIDPMGSSEAIEFLLKKLENTKTNCAFFEMMKSPERPRNGL
>Q9ZLS9|IPR011129(74...140)|Transcription termination factor Rho
MNENAPTHKSSHKVKTHTPVSGYHIEDLRTYPTEKLLEIANKLKVENPQEFKRQDLMFEILKTQVTQGGYILFTGILEIM
PDGYGFLRGFDGSFSDGHNDTYVSPSQIRRFALRNGDIVTGQVRSPKDQEKYYALLKIEAINYLPSDEIKNRPLFDNLTP
LFPDEQIKLEYEPTKVTGRMLDLFSPVGKGQRALIVAPPRTGKTELMKELAQGITSNHPEVELIILLVDERPEEVTDMQR
SVKGQVFSSTFDLPANNHIRIAELVLERAKRRVEMGKDVVVLLDSITRLARAYNAVTPSSGKVLSGGVDANALHRPKRFF
GAARNIEEGGSLTIIATALIETGSRMDEVIFEEFKGTGNSEIVLARNIADRRIYPAFDILKSGTRKDNILLGKDRLTKVW
VLRNVMQQMDDIEALSFVYSKMQQTKDNEEFLNLMNEK
